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  Endocytic	  downregulation	  plays	  an	  important	  role	  in	  the	  homeostasis	  of	  plasma	  membrane	  (PM)	  proteins.	  	  A	  key	  determinant	  of	  this	  process	  is	  ubiquitin	  modification,	  which	  targets	  surface	  proteins	  for	  endocytosis.	  	  In	  Saccharomyces	  
cerevisiae,	  most	  PM	  proteins	  that	  have	  been	  studied	  undergo	  ubiquitin-­‐dependent	  endocytic	  downregulation	  mediated	  by	  the	  ubiquitin	  ligase	  Rsp5.	  	  Previously,	  we	  identified	  a	  family	  of	  yeast	  arrestin-­‐related	  trafficking	  adaptors,	  or	  ARTs	  that	  function	  as	  adaptors	  for	  Rsp5,	  targeting	  its	  ubiquitin	  ligase	  activity	  to	  specific	  proteins	  at	  cell	  surface.	  	  	  	  	  	  	  	  	  	  The	  goal	  of	  my	  thesis	  research	  has	  been	  to	  understand	  how	  ART	  activity	  is	  regulated	  to	  control	  the	  composition	  of	  protein	  at	  cell	  surface.	  	  In	  the	  first	  part	  of	  my	  thesis,	  I	  demonstrate	  that	  the	  TORC1	  kinase	  signaling	  pathway	  modulates	  the	  protein	  composition	  of	  the	  PM	  by	  regulating	  Art1	  activity	  and	  ubiquitin-­‐mediated	  endocytosis.	  	  This	  research	  elucidates	  a	  novel	  effector	  mechanism	  of	  TORC1,	  underscoring	  how	  TORC1	  coordinates	  ubiquitin-­‐mediated	  endocytosis	  with	  protein	  synthesis	  and	  autophagy	  in	  order	  to	  regulate	  cell	  growth.	  	  In	  the	  second	  part	  of	  my	  thesis,	  I	  demonstrate	  that	  the	  PP1	  family	  Ppz	  phosphatases	  are	  involved	  in	  regulating	  PM	  cargo	  ubiquitination	  and	  endocytosis	  by	  mediating	  the	  Art1	  phospho-­‐regulatory	  cycle.	  	  This	  study	  provides	  a	  potential	  mechanism	  of	  
 how	  Ppz	  phosphatases	  may	  activate	  different	  ART	  family	  proteins	  to	  trigger	  PM	  protein	  turnover.	  	  In	  the	  last	  part	  of	  my	  thesis,	  I	  show	  that	  a	  specialized	  secretion	  pathway	  at	  the	  Golgi	  complex	  plays	  a	  role	  in	  Art1	  PM	  translocation,	  which	  is	  required	  for	  Art1-­‐mediated	  cargo	  endocytosis.	  	  This	  research	  begins	  to	  dissect	  a	  potential	  mechanism	  for	  the	  Golgi-­‐to-­‐PM	  trafficking	  of	  Art1	  during	  endocytic	  targeting.	  	  In	  conclusion,	  based	  on	  our	  various	  genetic,	  biochemical,	  and	  proteomic	  analyses,	  I	  propose	  that:	  1)	  TORC1	  kinase	  signaling	  regulates	  endocytosis	  by	  controlling	  ubiquitin	  ligase	  activity;	  2)	  Art1	  activity	  is	  tightly	  regulated	  by	  a	  complex	  phosphorylation	  cycle	  which	  involves	  in	  Npr1	  kinase,	  Ppz	  phosphatases,	  as	  well	  as	  other	  potential	  phosphor-­‐regulatory	  factors;	  and	  3)	  the	  Golgi-­‐to-­‐PM	  trafficking	  machinery	  plays	  an	  important	  role	  in	  regulating	  PM	  protein	  endocytosis	  via	  mediating	  Art1	  subcellular	  localization	  and	  activity.	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Chapter	  1	  
INTRODUCTION	  
Endocytic	  Downregulation	  of	  Plasma	  Membrane	  Proteins	  	  	  	  	  	  	  	  	  Endocytic	  downregulation	  plays	  a	  pivotal	  role	  in	  the	  homeostasis	  of	  plasma	  membrane	  (PM)	  proteins	  in	  eukaryotic	  cells,	  influencing	  key	  cellular	  processes	  such	  as	  nutrient	  uptake	  and	  signaling	  for	  cell	  growth	  and	  differentiation	  (Ing	  et	  al.,	  2007).	  	  Failure	  to	  properly	  downregulate	  PM	  proteins	  via	  endocytosis	  has	  been	  implicated	  in	  the	  development	  of	  various	  diseases	  ranging	  from	  cancer	  to	  neurodegeneration.	  	  Different	  human	  diseases	  have	  been	  linked	  to	  the	  proper	  regulation	  of	  PM	  protein	  endocytosis.	  	  One	  example	  of	  these	  diseases	  is	  Liddle’s	  syndrome.	  	  Patients	  with	  this	  syndrome	  cannot	  downregulate	  the	  PM	  epithelial	  Na+	  channel	  (ENaC)	  in	  the	  kidney	  and	  have	  abnormal	  reabsorption	  of	  sodium,	  resulting	  in	  hypertension	  (Warnock,	  2001).	  	  	  	  	  	  	  	  	  	  There	  are	  three	  major	  stages	  associated	  with	  the	  endocytic	  downregulation	  of	  PM	  proteins:	  1)	  PM	  protein	  internalization	  by	  endocytosis	  and	  delivery	  to	  the	  endosome;	  2)	  endosomal	  protein	  sorting	  into	  intralumenal	  vesicles,	  forming	  the	  multivesicular	  body	  (MVB);	  3)	  fusion	  of	  the	  endosome	  with	  the	  lysosome	  and	  protein	  degradation	  (Figure	  1.1)	  (Bonifacino	  and	  Weissman,	  1998),	  (Katzmann	  et	  al.,	  2004).	  	  Although	  the	  trafficking	  processes	  that	  govern	  endocytic	  downregulation	  have	  been	  studied	  extensively,	  the	  diversity	  of	  PM	  proteins	  and	  complexity	  of	  extracellular	  signals	  make	  it	  difficult	  to	  study	  how	  cargo-­‐specificity	  of	  endocytosis	  is	  achieved.	  	  One	  classic	  example	  is	  the	  downregulation	  of	  G	  protein-­‐coupled	  receptors	  	  
 	  	   2	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	   	  	  	  	  	  	  	  	  	  Figure	  1-­‐1	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Figure	  1.1.	  	  The	  three	  stages	  of	  endocytic	  pathway.	  	  There	  are	  three	  stages	  for	  plasma	  membrane	  proteins	  undergo	  endocytic	  turnover.	  	  After	  a	  specific	  stimulation,	  PM	  proteins	  are	  internalized	  by	  endocytic	  machinery	  and	  delivered	  to	  the	  endosome.	  	  Next,	  these	  endosomal	  proteins	  are	  sorted	  into	  MVB	  by	  the	  ESCRT	  machinery.	  	  Finally,	  the	  endosome	  is	  fused	  with	  lysosome	  and	  the	  proteins	  are	  degraded.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
 	  	   4	  
	  (GPCRs).	  	  There	  are	  more	  than	  1000	  different	  GPCRs	  encoded	  in	  the	  human	  genome,	  each	  with	  the	  potential	  to	  respond	  to	  different	  extracellular	  stimuli	  (Lefkowitz,	  1998).	  	  Agonist-­‐induced	  GPCR	  activation	  triggers	  both	  a	  signaling	  cascade	  and	  a	  negative	  feedback	  mechanism,	  which	  is	  required	  to	  attenuate	  the	  signaling	  process.	  	  Central	  to	  GPCR	  downregulation	  are	  arrestins.	  	  Following	  GPCR	  activation,	  GPCR	  kinases	  (GRKs)	  phosphorylate	  GPCRs,	  which	  creates	  a	  binding	  surface	  for	  arrestins	  (Moore	  et	  al.,	  2007).	  	  Arrestin	  not	  only	  sterically	  blocks	  G	  protein	  activation	  but	  also	  serves	  as	  an	  adaptor	  to	  recruit	  endocytic	  machinery	  (Kendall	  and	  Luttrell,	  2009).	  	  Interestingly,	  the	  regulation	  of	  arrestins	  themselves	  is	  not	  well	  understood,	  although	  arrestin	  post-­‐translational	  modifications,	  such	  as	  phosphorylation	  and	  ubiquitination,	  and	  subcellular	  localization	  all	  seem	  to	  have	  important	  regulatory	  roles.	  	  	  	  	  	  	  	  	  Four	  well-­‐studied	  human	  arrestins	  have	  been	  reported	  to	  regulate	  GPCR	  turnover	  (Gurevich	  and	  Gurevich,	  2006).	  	  Two	  of	  them,	  visual	  and	  cone	  arrestins,	  are	  only	  expressed	  in	  retina	  cells	  and	  the	  other	  two,	  β-­‐arrestin	  1	  and	  β-­‐arrestin	  2,	  are	  ubiquitously	  expressed.	  	  The	  crystal	  structures	  of	  these	  arrestins	  have	  been	  determined	  and	  all	  of	  them	  form	  a	  conserved	  β-­‐sandwich	  (“arrestin	  fold”)	  structure	  (Aubry	  et	  al.,	  2009).	  	  Interestingly,	  structural	  and	  bioinformatic	  analyses	  have	  indicated	  at	  least	  nine	  proteins	  exhibit	  the	  arrestin	  fold	  structure	  in	  mammalian	  cells.	  	  Although	  most	  of	  these	  proteins	  are	  not	  well	  studied,	  one	  of	  them,	  Vps26,	  has	  been	  demonstrated	  to	  be	  involved	  in	  the	  cargo	  recognition	  subcomplex	  in	  retromer,	  a	  protein	  complex	  that	  mediates	  cargo	  recycling	  from	  the	  endosome	  to	  Golgi	  (Collins	  et	  al.,	  2008).	  	  Thus,	  proteins	  harboring	  an	  arrestin	  fold	  structure	  may	  generally	  be	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responsible	  for	  membrane	  protein	  recognition.	  	  While	  numerous	  studies	  have	  elucidated	  the	  mechanism	  of	  GPCR	  turnover,	  less	  is	  known	  about	  how	  other	  PM	  proteins	  are	  downregulated.	  	  It	  is	  important	  to	  improve	  our	  understanding	  of	  how	  different	  arrestin	  fold	  proteins	  recognize	  specific	  membrane	  cargos	  at	  the	  right	  time	  and	  right	  place.	  	  	  	  	  	  	  	  	  	  A	  key	  determinant	  of	  endocytic	  downregulation	  of	  surface	  proteins	  is	  ubiquitin	  modification,	  which	  is	  thought	  to	  target	  plasma	  membrane	  proteins	  to	  conserved	  ubiquitin-­‐binding	  domains	  of	  the	  endocytic	  machinery.	  	  In	  Saccharomyces	  cerevisiae,	  hundreds	  of	  PM	  cargos	  undergo	  ubiquitin-­‐dependent	  endocytic	  downregulation	  mediated	  by	  the	  ubiquitin	  ligase	  Rsp5.	  	  Recently,	  a	  chemical-­‐genetic	  screen	  led	  to	  the	  identification	  of	  a	  family	  of	  arrestin-­‐related	  trafficking	  adaptors	  (or	  ARTs)	  in	  yeast	  that	  function	  as	  adaptors	  for	  Rsp5,	  targeting	  its	  ubiquitin	  ligase	  activity	  to	  specific	  PM	  cargos	  (Lin	  et	  al.,	  2008).	  	  Yeast	  ARTs	  direct	  ubiquitin	  ligase	  activity	  to	  specific	  PM	  cargoes	  and	  target	  them	  for	  endocytosis.	  	  Art1	  was	  originally	  identified	  based	  on	  its	  hypersensitivity	  to	  canavanine,	  a	  toxic	  analog	  of	  arginine,	  indicating	  involvement	  in	  the	  endocytosis	  of	  the	  arginine	  transporter	  Can1.	  	  Interestingly,	  Art1	  was	  shown	  to	  play	  a	  role	  in	  cargo-­‐specific	  endocytic	  downregulation.	  	  Structural	  modeling	  revealed	  that	  Art1	  contains	  an	  arrestin	  fold	  domain	  at	  the	  N-­‐terminus,	  while	  the	  C-­‐terminus	  contains	  two	  PY	  motifs	  that	  mediate	  interaction	  with	  Rsp5.	  	  Although	  it	  is	  understood	  that	  ARTs	  function	  to	  recruit	  ubiquitin	  ligase	  activity	  to	  specific	  cargo	  at	  the	  PM,	  little	  is	  known	  about	  how	  Art1	  itself	  is	  regulated	  and	  how	  cargo	  specificity	  is	  achieved.	  	  Here	  we	  focus	  on	  dissecting	  the	  molecular	  mechanism	  of	  Art1	  phospho-­‐regulation	  and	  subcellular	  localization.	  
 	  	   6	  
UBIQUITIN-­‐MEDIATED	  TURNOVER	  OF	  PLASMA	  MEMBRANE	  PROTEINS	  	  	  	  	  	  	  	  	  	  	  The	  abundance	  and	  localization	  of	  integral	  membrane	  proteins—including	  nutrient	  transporters,	  ion	  channels,	  and	  signaling	  receptors—play	  a	  critical	  role	  in	  the	  growth,	  differentiation,	  and	  survival	  of	  eukaryotic	  cells.	  	  The	  complex	  process	  of	  remodeling	  cell	  surface	  protein	  composition	  involves	  both	  biosynthetic	  addition	  of	  new	  integral	  membrane	  proteins	  (or	  cargoes)	  to	  the	  PM	  and	  removal	  of	  cargoes	  from	  the	  PM	  by	  endocytosis.	  	  A	  key	  regulator	  of	  the	  sorting,	  trafficking,	  and	  turnover	  of	  integral	  membrane	  proteins	  is	  ubiquitination.	  	  	  	  	  	  	  	  	  	  	  Ubiquitin	  is	  a	  76-­‐amino	  acid	  peptide	  that	  can	  be	  conjugated	  to	  other	  proteins	  by	  the	  formation	  of	  an	  isopeptide	  bond	  between	  the	  COOH-­‐terminal	  glycine	  carboxy	  group	  of	  ubiquitin	  and	  the	  ε-­‐amino	  group	  of	  a	  lysine	  residue	  on	  the	  recipient	  protein	  (Komander,	  2009;	  Ye	  and	  Rape,	  2009).	  	  Ubiquitin	  conjugation,	  or	  ubiquitination,	  is	  the	  end	  result	  of	  three	  sequential	  enzymatic	  reactions	  catalyzed	  by	  a	  ubiquitin-­‐activating	  enzyme	  (E1),	  a	  ubiquitin	  conjugating	  enzyme	  (E2),	  and	  a	  ubiquitin	  ligase	  (E3)	  (Deshaies	  and	  Joazeiro,	  2009;	  Nagy	  and	  Dikic,	  2009;	  Wenzel	  et	  al.,	  2010).	  	  A	  key	  feature	  of	  ubiquitination	  is	  that	  it	  is	  potentially	  recursive:	  Ubiquitin	  can	  modify	  itself	  on	  any	  one	  of	  its	  seven	  lysine	  residues	  (K6,	  K11,	  K27,	  K29,	  K33,	  K48,	  K63)	  or	  on	  its	  N	  terminus,	  leading	  to	  the	  formation	  of	  polyubiquitin	  chains	  that	  have	  different	  structures	  and	  properties	  depending	  on	  how	  the	  chains	  are	  assembled	  (Behrends	  and	  Harper,	  2011;	  Komander,	  2009).	  	  	  	  	  	  	  	  	  E3	  ubiquitin	  ligases	  mediate	  the	  addition	  of	  ubiquitin	  to	  substrates	  and	  thus	  determine	  the	  type	  and	  extent	  of	  ubiquitin	  modification.	  	  There	  are	  two	  major	  ubiquitin	  ligase	  families:	  (a)	  the	  RING	  (really	  interesting	  new	  gene)	  domain	  E3	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ligases	  (616	  in	  humans,	  40	  in	  yeast),	  which	  bind	  to	  E2-­‐ubiquitin	  conjugates	  and	  substrates	  and	  provide	  optimal	  steric	  orientation	  for	  direct	  ubiquitin	  transfer	  to	  substrate	  (Deshaies	  and	  Joazeiro,	  2009;	  Duda	  et	  al.,	  2011);	  and	  (b)	  the	  HECT	  (homologous	  to	  E6-­‐AP	  C	  terminus)	  domain	  E3	  ligases	  (28	  in	  humans,	  5	  in	  yeast),	  which	  accept	  ubiquitin	  from	  E2	  enzymes	  on	  catalytic	  cysteine	  residues	  and	  catalyze	  direct	  transfer	  of	  ubiquitin	  to	  substrates	  (Bernassola	  et	  al.,	  2008;	  Kee	  and	  Huibregtse,	  2007;	  Ye	  and	  Rape,	  2009).	  	  The	  activity	  of	  ubiquitin	  ligases	  can	  be	  antagonized	  by	  deubiquitinating	  enzymes,	  or	  DUBs.	  	  DUBs	  are	  proteases	  that	  catalyze	  the	  cleavage	  of	  ubiquitin-­‐lysine	  isopeptide	  bonds.	  	  There	  are	  roughly	  100	  DUBs	  encoded	  in	  the	  human	  genome	  (less	  than	  20	  in	  yeast),	  which	  can	  be	  classified	  on	  the	  basis	  of	  five	  known	  DUB	  protein	  families:	  the	  Ubiquitin-­‐Specific	  Protease	  (USP)	  family,	  the	  Ubiquitin	  C-­‐Terminal	  Hydrolase	  (UCH)	  family,	  the	  Ovarian	  Tumor	  domain	  (OTU)	  family,	  the	  Machado-­‐Josephin	  domain	  (MJD)	  family,	  and	  the	  JAMM	  (JAB1/MPN/MOV34)	  domain	  family	  (Komander	  et	  al.,	  2009).	  	  DUBs	  from	  the	  USP,	  UCH,	  OTU,	  and	  MJD	  families	  are	  cysteine	  proteases,	  whereas	  JAMM	  family	  DUBs	  are	  metalloproteases.	  	  The	  reversible	  nature	  of	  ubiquitination	  allows	  it	  to	  function	  as	  an	  important	  regulatory	  switch	  in	  the	  cell.	  	  	  	  	  	  	  	  	  It	  is	  well	  established	  that	  protein	  K48-­‐linked	  polyubiquitination	  of	  soluble,	  cytosolic	  proteins	  results	  in	  degradation	  by	  targeting	  to	  the	  proteasome	  and	  thus	  regulates	  protein	  stability	  (Komander,	  2009;	  Xu	  et	  al.,	  2009).	  	  However,	  integral	  membrane	  proteins	  are	  not	  directly	  accessible	  to	  the	  proteasome,	  and	  thus,	  eukaryotic	  cells	  have	  evolved	  elaborate	  mechanisms	  to	  monitor,	  sort,	  and	  degrade	  them.	  	  These	  mechanisms	  rely	  on	  membrane	  trafficking	  events	  in	  the	  cell	  that	  are	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often	  guided	  by	  ubiquitin	  modification	  of	  substrates	  (Figure	  1.2A).	  	  There	  is	  an	  emerging	  consensus	  that,	  although	  K48-­‐linked	  polyubiquitin	  chains	  function	  in	  proteasomal	  degradation,	  ubiquitin-­‐mediated	  membrane	  trafficking	  events	  in	  the	  cell	  are	  largely	  governed	  by	  monoubiquitination	  and	  K63-­‐linked	  polyubiquitination	  (Hoeller	  and	  Dikic,	  2011;	  Lauwers	  et	  al.,	  2010).	  	  Taken	  together,	  ubiquitination	  plays	  an	  important	  role	  in	  the	  sorting,	  trafficking,	  and	  degradation	  of	  integral	  membrane	  proteins.	  	  Here,	  I	  place	  special	  emphasis	  on	  the	  role	  of	  ubiquitin	  in	  the	  quality	  control	  of	  integral	  membrane	  proteins	  at	  the	  PM	  	  (Figure	  1.2B	  and	  Figure	  1.3).	  	  
Ubiquitin-­‐Mediated	  Endocytosis	  	  	  	  	  	  	  	  	  Ubiquitin-­‐mediated	  endocytosis	  first	  came	  into	  focus	  with	  studies	  in	  yeast	  demonstrating	  a	  ubiquitin	  requirement	  for	  endocytosis	  of	  various	  PM	  cargoes,	  including	  Ste6	  (Kolling	  and	  Hollenberg,	  1994),	  Ste2	  (Hicke	  and	  Riezman,	  1996;	  Jenness	  et	  al.,	  1997),	  Pdr5	  (Egner	  and	  Kuchler,	  1996),	  and	  Fur4	  (Galan	  et	  al.,	  1996).	  	  Indeed,	  for	  many	  cargoes	  studied	  in	  yeast,	  ubiquitin	  modifications	  are	  both	  necessary	  and	  sufficient	  for	  endocytosis	  (Hicke	  and	  Riezman,	  1996;	  Shih	  et	  al.,	  2000),	  although	  ubiquitin	  independent	  endocytosis	  of	  cargoes	  has	  also	  been	  described	  (Chen	  and	  Davis,	  2002;	  Tan	  et	  al.,	  1996).	  	  The	  general	  consensus	  is	  that	  ubiquitin-­‐mediated	  endocytosis	  is	  the	  dominant	  mechanism	  for	  internalization	  of	  most	  cargoes	  studied	  in	  yeast.	  	  However,	  in	  mammalian	  cells,	  the	  role	  of	  ubiquitin	  in	  endocytosis	  is	  somewhat	  more	  complicated.	  	  For	  many	  endocytic	  cargoes	  in	  mammalian	  cells,	  including	  receptor	  tyrosine	  kinases	  (RTKs)	  and	  GGPCRs,	  ubiquitin	  modification	  appears	  to	  be	  sufficient	  for	  endocytic	  uptake	  (Haglund	  et	  al.,	  2003;	  Sigismund	  et	  al.,	  2005).	  	  Strikingly,	  although	  many	  of	  these	  cargoes	  exhibit	  ligand	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Figure	  1.2.	  	  Common	  themes	  in	  ubiquitin-­‐mediated	  membrane	  trafficking	  and	  turnover	  events.	  	  (A)	  The	  ubiquitin	  modification	  cycle	  of	  membrane	  protein	  sorting	  and	  trafficking.	  	  (B)	  Ubiquitin	  binding	  proteins	  in	  the	  membrane	  protein	  trafficking	  circuit.	  	  DUB,	  deubiquitinating	  enzyme;	  Eps15,	  epidermal	  growth	  factor	  receptor	  pathway	  15;	  ER,	  endoplasmic	  reticulum;	  ERAD,	  endoplasmic	  reticulum–associated	  degradation;	  ESCRT,	  endosomal	  sorting	  complex	  required	  for	  transport;	  GGA,	  Golgi-­‐localized,	  γ-­‐ear-­‐containing,	  ARF-­‐binding	  protein;	  MVB,	  multivesicular	  body;	  PM,	  plasma	  membrane;	  Ubx,	  ubiquitin	  regulatory	  X	  domain-­‐containing	  proteins;	  p97,	  an	  AAA	  ATPase	  that	  recognizes	  ubiquitinated	  substrates	  at	  the	  ER	  (via	  Ubx	  protein	  adaptors)	  and	  is	  thought	  to	  extract	  substrates	  from	  the	  ER	  membrane.	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Figure	  1.3.	  	  Ubiquitin-­‐mediated	  membrane	  protein	  trafficking	  processes	  in	  the	  cell.	  	  ER,	  endoplasmic	  reticulum;	  ERAD,	  endoplasmic	  reticulum–associated	  degradation;	  ESCRT,	  endosomal	  sorting	  complex	  required	  for	  transport;	  MVB,	  multivesicular	  body;	  PM,	  plasma	  membrane.	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dependent	  ubiquitin	  modification,	  they	  also	  exhibit	  ubiquitin-­‐independent	  endocytosis.	  	  Thus,	  in	  mammalian	  cells,	  ubiquitination	  is	  often	  sufficient	  but	  not	  required	  for	  internalization	  by	  endocytosis.	  	  This	  is	  indicative	  of	  multiple	  redundant	  yet	  distinct	  mechanisms	  of	  endocytosis	  (Goh	  et	  al.,	  2010),	  which	  may	  coordinately	  influence	  the	  fate	  of	  internalized	  cargo	  on	  the	  endosome.	  	  	  	  	  	  	  	  	  	  A	  fundamental	  question	  of	  ubiquitin-­‐mediated	  endocytosis	  is	  how	  ubiquitin	  modified	  cargoes	  are	  recognized	  and	  sorted	  into	  endocytic	  vesicles.	  	  One	  prevailing	  hypothesis	  is	  that	  various	  UBDs	  located	  within	  the	  endocytic	  machinery	  may	  recruit	  ubiquitinated	  cargoes	  for	  internalization.	  	  For	  example,	  epsin	  family	  proteins	  (Ent1	  and	  Ent2	  in	  yeast)	  interact	  with	  clathrin,	  the	  AP-­‐2	  adaptor,	  and	  other	  endocytic	  proteins	  and	  have	  long	  been	  studied	  for	  their	  role	  in	  endocytosis.	  	  Epsins	  interact	  with	  ubiquitin	  via	  tandem	  ubiquitin-­‐interacting	  motif	  (UIM)	  domains,	  which	  have	  been	  proposed	  to	  function	  in	  the	  sorting	  of	  ubiquitinated	  cargoes	  for	  endocytosis.	  	  Similarly,	  the	  eps15	  and	  eps15R	  proteins	  (similar	  to	  yeast	  Ede1)	  interact	  with	  other	  endocytic	  proteins	  via	  N-­‐terminal	  EH	  (Eps15	  homology)	  domains	  and	  also	  interact	  with	  ubiquitin	  via	  C-­‐terminal	  tandem	  UIM	  domains	  (Polo	  et	  al.,	  2002).	  	  In	  both	  yeast	  and	  mammals,	  epsins	  and	  Eps15	  family	  members	  exhibit	  redundant	  functions	  for	  endocytosis	  (Shih	  et	  al.,	  2002;	  Sigismund	  et	  al.,	  2005)	  and	  have	  been	  shown	  to	  bind	  to	  ubiquitinated	  cargo	  (Kazazic	  et	  al.,	  2009;	  Sigismund	  et	  al.,	  2005).	  	  	  	  	  	  	  	  	  	  Many	  UBD-­‐containing	  proteins,	  including	  Eps15	  proteins	  (Polo	  et	  al.,	  2002),	  are	  subject	  to	  coupled	  monoubiquitination	  (Hoeller	  and	  Dikic,	  2011),	  fueling	  speculation	  that	  UBDs	  in	  epsins	  and	  Eps15	  family	  proteins	  may	  function	  in	  the	  assembly	  of	  the	  endocytic	  protein	  interaction	  network.	  	  It	  is	  conceivable	  that	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ubiquitin	  modification	  of	  endocytic	  proteins	  can	  “seed”	  the	  assembly	  of	  endocytic	  protein	  interaction	  networks.	  	  Perhaps	  the	  best	  evidence	  that	  ubiquitin	  modification	  regulates	  the	  function	  of	  endocytic	  proteins	  comes	  from	  the	  investigation	  of	  photoreceptor	  cell	  differentiation	  during	  compound	  eye	  development	  in	  Drosophila.	  	  One	  Drosophila	  mutant	  called	  fat	  facets	  exhibits	  excess	  photoreceptor	  cell	  differentiation,	  indicating	  that	  the	  protein	  encoded	  by	  fat	  facets	  (Faf)	  is	  a	  differentiation	  inhibitor.	  	  The	  Faf	  protein	  was	  shown	  to	  be	  a	  DUB	  (Huang	  et	  al.,	  1995)	  that	  deubiquitinates	  the	  protein	  encoded	  by	  a	  gene	  called	  liquid	  facets	  (Lqf	  ),	  a	  
Drosophila	  epsin	  family	  protein	  (Cadavid	  et	  al.,	  2000;	  Chen	  et	  al.,	  2002).	  	  Faf	  regulates	  the	  stability	  and	  abundance	  of	  Lqf	  (and	  perhaps	  other	  endocytic	  proteins)	  by	  antagonizing	  its	  ubiquitination	  and	  subsequent	  proteasomal	  degradation	  (Chen	  et	  al.,	  2002).	  	  Both	  Faf	  and	  Lqf	  are	  required	  for	  the	  endocytosis	  of	  the	  Notch	  ligand	  Delta	  (Overstreet	  et	  al.,	  2004),	  demonstrating	  how	  ubiquitination/deubiquitination	  dynamics	  of	  an	  endocytic	  protein	  is	  critical	  to	  cell	  differentiation	  and	  patterning	  during	  development.	  	  	  	  	  	  	  	  	  In	  addition	  to	  epsins	  and	  Eps15	  proteins,	  other	  endocytic	  proteins	  have	  been	  shown	  to	  bind	  ubiquitin,	  including	  Cin85	  (yeast	  Sla1)	  (Stamenova	  et	  al.,	  2007),	  amphiphysin	  (Stamenova	  et	  al.,	  2007),	  and	  the	  yeast	  protein	  Lsb5	  (Costa	  et	  al.,	  2005).	  	  The	  molecular	  function	  of	  these	  ubiquitin-­‐binding	  activities	  is	  not	  clear,	  but	  the	  myriad	  of	  ubiquitin-­‐binding	  elements	  within	  the	  endocytic	  machinery,	  possibly	  including	  UBDs	  that	  have	  not	  yet	  been	  described,	  suggests	  either	  significant	  redundancy	  or	  elaborate	  avidity	  affects,	  making	  it	  difficult	  to	  dissect	  precise	  biochemical	  events	  that	  govern	  ubiquitin-­‐mediated	  endocytosis.	  	  Because	  the	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affinity	  of	  interactions	  between	  individual	  UBDs	  and	  monoubiquitin	  is	  low,	  it	  is	  possible	  that	  efficiency	  of	  endocytic	  sorting	  might	  be	  determined	  by	  the	  number	  of	  ubiquitin	  modifications,	  the	  extent	  and	  linkage	  types	  of	  polyubiquitin	  chains,	  lateral	  interaction	  with	  other	  ubiquitinated	  cargoes	  at	  the	  PM,	  as	  well	  as	  orthogonal,	  ubiquitin-­‐independent	  sorting	  signals.	  	  Thus,	  despite	  a	  clear	  regulatory	  role	  of	  ubiquitination	  in	  targeting	  cargo	  for	  endocytosis,	  it	  has	  been	  difficult	  to	  establish	  an	  exclusive	  role	  for	  ubiquitin	  in	  endocytosis	  for	  the	  following	  reasons:	  (1)	  In	  mammalian	  cells,	  there	  are	  different	  kinds	  of	  endocytosis,	  which	  have	  different	  sorting	  determinants	  and	  often	  act	  redundantly	  for	  internalization	  of	  specific	  cargo,	  although	  trafficking	  outcomes	  may	  be	  determined	  by	  the	  route	  of	  entry	  (i.e.,	  lysosomal	  sorting	  versus	  recycling).	  	  (2)	  The	  endocytic	  protein	  interaction	  network	  contains	  many	  UBDs,	  which	  may	  act	  in	  a	  redundant	  manner	  or	  serve	  as	  avidity	  sensors	  to	  determine	  efficiency	  of	  sorting	  for	  endocytosis.	  	  (3)	  Some	  endocytic	  proteins	  are	  ubiquitinated,	  suggesting	  that	  some	  UBDs	  may	  mediate	  interactions	  within	  the	  endocytic	  protein	  network	  and	  that	  others	  may	  mediate	  recognition	  of	  ubiquitinated	  cargo.	  	  (4)	  PM	  cargoes	  participate	  in	  multiple	  interactions	  with	  other	  PM	  cargoes,	  suggesting	  that	  cargo	  homo-­‐	  or	  heterooligomerization	  at	  the	  PM	  may	  allow	  nonubiquitinated	  cargo	  to	  piggyback	  during	  ubiquitin-­‐mediated	  endocytosis.	  
Ubiquitin	  Editing	  at	  the	  Plasma	  Membrane	  and	  Endosome	  	  	  	  	  	  	  	  	  The	  proteasome	  associates	  with	  both	  ubiquitin	  ligases	  and	  DUBs	  which	  edit	  ubiquitin	  chains	  on	  potential	  substrates,	  an	  effect	  that	  can	  either	  rescue	  a	  substrate	  or	  hasten	  its	  demise.	  	  As	  has	  been	  observed	  with	  the	  proteasome,	  the	  
 	  	   16	  
ESCRT	  machinery	  associates	  with	  various	  E3	  ubiquitin	  ligases	  and	  DUBs	  that	  can	  influence	  cargo	  fate	  on	  the	  endosome.	  	  In	  general,	  the	  association	  of	  E3	  ubiquitin	  ligases	  with	  ESCRTs	  is	  thought	  to	  promote	  cargo	  sorting	  for	  lysosomal	  degradation	  (Bhandari	  et	  al.,	  2007;	  Malik	  and	  Marchese,	  2010;	  Ren	  et	  al.,	  2007;	  Zhou	  et	  al.,	  2010),	  although	  there	  are	  some	  cases	  where	  such	  association	  negatively	  regulates	  ESCRT	  stability	  (Kim	  et	  al.,	  2007;	  Kim	  et	  al.,	  2006;	  McDonald	  and	  Martin-­‐Serrano,	  2008).	  	  In	  yeast,	  Rsp5	  clearly	  localizes	  to	  endosomal	  structures	  (Katzmann	  et	  al.,	  2004;	  Wang	  et	  al.,	  2001)	  and	  has	  been	  shown	  to	  interact	  with	  a	  C-­‐terminal	  PY	  motif	  in	  Hse1	  (ESCRT-­‐0),	  an	  interaction	  required	  for	  efficient	  sorting	  of	  some	  cargoes	  (Ren	  et	  al.,	  2007).	  	  Thus,	  even	  as	  cargoes	  are	  being	  sorted	  by	  ESCRTs,	  last-­‐minute	  ubiquitin	  conjugation	  may	  influence	  sorting	  decisions.	  	  	  	  	  	  	  	  	  	  Just	  as	  E3	  ubiquitin	  ligases	  on	  the	  endosome	  can	  nudge	  cargo	  toward	  the	  grave,	  so	  can	  endosomal	  DUBs	  rescue	  cargo	  by	  removing	  ubiquitin,	  antagonizing	  their	  association	  with	  ESCRTs,	  and	  promoting	  their	  recycling	  back	  to	  the	  cell	  surface.	  	  For	  example,	  UCH-­‐L3	  is	  a	  DUB	  that	  promotes	  ENaC	  recycling	  to	  the	  cell	  surface	  by	  catalyzing	  its	  deubiquitination	  (Butterworth	  et	  al.,	  2007).	  	  The	  DUB	  Usp10	  was	  shown	  to	  mediate	  the	  deubiquitination	  of	  cystic	  fibrosis	  transmembrane	  conductance	  regulator	  (CFTR)	  on	  endosomes	  and	  thus	  promote	  recycling	  to	  the	  surface	  (Bomberger	  et	  al.,	  2009).	  	  Two	  DUBs,	  Usp33	  and	  Usp20,	  were	  recently	  shown	  to	  deubiquitinate	  the	  β2-­‐adrenergic	  receptor	  on	  endosomes	  and	  thus	  promote	  recycling	  to	  the	  cell	  surface	  (Berthouze	  et	  al.,	  2009).	  	  AMSH	  (associated	  molecule	  with	  the	  SH3	  domain	  of	  STAM),	  a	  JAMM	  family	  DUB,	  was	  shown	  to	  interact	  with	  STAM	  (McCullough	  et	  al.,	  2004)	  and	  antagonize	  the	  lysosomal	  degradation	  of	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the	  epidermal	  growth	  factor	  receptor	  (EGFR)	  (Kee	  et	  al.,	  2005;	  McCullough	  et	  al.,	  2006).	  	  In	  yeast,	  the	  UBP	  family	  DUB	  Ubp2	  was	  shown	  to	  interact	  with	  Rsp5	  (indirectly	  via	  the	  adaptor	  protein	  Rup1)	  and	  to	  associate	  with	  ESCRT-­‐0	  components	  on	  endosomes	  (Kee	  et	  al.,	  2005;	  Kee	  et	  al.,	  2006;	  Ren	  et	  al.,	  2007),	  although	  a	  role	  for	  Ubp2	  in	  cargo	  recycling	  has	  not	  been	  rigorously	  demonstrated.	  	  	  	  	  	  	  	  	  	  In	  addition	  to	  their	  role	  in	  rescuing	  ubiquitinated	  cargo	  from	  incorporation	  into	  ILVs,	  DUBs	  play	  a	  major	  role	  in	  recycling	  of	  ubiquitin	  from	  cargo	  prior	  to	  the	  ILV	  scission	  event.	  	  The	  recycling	  of	  ubiquitin	  from	  cargo	  significantly	  impacts	  ubiquitin	  homeostasis	  in	  the	  cell,	  a	  mutants	  defective	  for	  ubiquitin	  recycling	  exhibit	  MVB	  sorting	  defects	  (Amerik	  et	  al.,	  2006;	  Amerik	  et	  al.,	  2000;	  Swaminathan	  et	  al.,	  1999).	  	  This	  function	  has	  been	  well	  characterized	  for	  the	  yeast	  DUB	  Doa4	  (Dupre	  and	  Haguenauer-­‐Tsapis,	  2001).	  	  Doa4	  is	  recruited	  to	  Snf7,	  part	  of	  the	  ESCRT-­‐III	  machinery,	  indirectly	  by	  its	  ability	  to	  bind	  the	  Snf7-­‐interacting	  protein	  Bro1	  (Luhtala	  and	  Odorizzi,	  2004;	  Nikko	  et	  al.,	  2003;	  Odorizzi	  et	  al.,	  2003).	  	  In	  mammalian	  cells,	  recycling	  of	  ubiquitin	  from	  cargo	  may	  be	  mediated	  by	  UBPY,	  a	  UBP	  family	  DUB.	  	  Like	  Doa4,	  UBPY	  is	  required	  for	  efficient	  lysosomal	  degradation	  of	  trafficking	  cargo,	  and	  loss	  of	  UBPY	  function	  results	  in	  the	  accumulation	  of	  ubiquitinated	  proteins,	  particularly	  on	  endosomes	  (Mizuno	  et	  al.,	  2006;	  Row	  et	  al.,	  2006).	  	  Consistent	  with	  a	  function	  analogous	  to	  Doa4	  in	  yeast,	  several	  reports	  have	  provided	  evidence	  that	  UBPY	  function	  is	  required	  for	  efficient	  lysosomal	  degradation	  of	  the	  EGFR	  (Alwan	  and	  van	  Leeuwen,	  2007;	  Mizuno	  et	  al.,	  2006;	  Row	  et	  al.,	  2007;	  Row	  et	  al.,	  2006).	  	  Thus,	  both	  AMSH	  and	  UBPY	  may	  each	  contribute	  to	  both	  cargo	  stability	  and	  degradation	  by	  deubiquitinating	  cargo	  at	  different	  stages	  of	  ESCRT	  sorting.	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THE	  ROLE	  OF	  UBIQUITIN	  IN	  CELL	  SURFACE	  REMODELING	  	  	  	  	  	  	  	  	  Cells	  remodel	  protein	  composition	  at	  the	  PM	  to	  attenuate	  signaling	  responses,	  regulate	  nutrient	  uptake,	  and	  control	  ion	  flux	  across	  the	  PM.	  	  For	  single-­‐celled	  eukaryotic	  organisms,	  such	  as	  yeast,	  surface	  remodeling	  plays	  an	  important	  role	  in	  nutrient	  homeostasis,	  stress	  responses,	  and	  pheromone	  signaling.	  	  In	  metazoans,	  surface	  remodeling	  plays	  a	  critical	  role	  in	  cell	  differentiation	  and	  fate	  decisions.	  	  A	  classic	  example	  involves	  T-­‐cell	  maturation,	  which	  utilizes	  cell	  surface	  remodeling	  to	  convert	  thymocytes	  from	  double	  positive	  (CD4+8+)	  to	  single	  positive	  (CD4-­‐8+	  or	  CD4+8-­‐)	  with	  only	  a	  single	  major	  histocompatibility	  complex	  coreceptor	  at	  the	  cell	  surface	  (Zamoyska	  and	  Lovatt,	  2004).	  	  A	  key	  aspect	  of	  cell	  surface	  remodeling	  involves	  the	  targeting	  of	  specific	  proteins	  for	  endocytosis,	  and	  one	  such	  targeting	  determinant	  involves	  ubiquitin	  modification	  of	  trafficking	  cargo.	  	  Therefore,	  to	  understand	  how	  cells	  regulate	  PM	  protein	  composition,	  it	  is	  important	  to	  understand	  how	  specific	  PM	  proteins	  are	  targeted	  for	  ubiquitination	  and	  how	  these	  ubiquitinated	  cargoes	  are	  recognized,	  sorted	  into	  buds,	  and	  internalized	  by	  endocytosis.	  
Regulation	  of	  Signaling	  Receptors	  by	  Ubiquitin	  	  	  	  	  	  	  	  	  One	  of	  the	  first	  PM	  cargoes	  demonstrated	  to	  undergo	  ubiquitin-­‐mediated	  endocytosis	  was	  the	  yeast	  pheromone	  receptor	  Ste2,	  a	  GPCR	  (Hicke	  and	  Riezman,	  1996).	  	  Ubiquitin	  modification	  is	  both	  necessary	  and	  sufficient	  for	  Ste2	  endocytosis	  (Shih	  et	  al.,	  2000),	  leading	  to	  the	  hypothesis	  that	  endocytosis	  of	  GPCRs	  in	  mammalian	  cells	  would	  likewise	  be	  ubiquitin	  dependent.	  	  Given	  their	  pharmacological	  significance	  (Overington	  et	  al.,	  2006),	  mammalian	  GPCRs	  and	  the	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mechanisms	  that	  mediate	  their	  downregulation	  have	  been	  studied	  extensively.	  	  Although	  several	  GPCRs	  studied	  in	  mammalian	  cells	  undergo	  ligand-­‐dependent	  ubiquitination,	  these	  ubiquitination	  events	  are	  not	  required	  for	  internalization	  but	  are	  critical	  for	  MVB	  sorting	  on	  the	  endosome	  (Martin	  et	  al.,	  2003;	  Shenoy	  et	  al.,	  2001;	  Tanowitz	  and	  Von	  Zastrow,	  2002).	  	  	  	  	  	  	  	  	  	  Although	  GPCR	  ubiquitination	  is	  dispensable	  for	  endocytosis	  in	  mammalian	  cells,	  ubiquitin	  modification	  still	  plays	  an	  important	  role	  in	  the	  regulation	  of	  GPCR	  endocytosis.	  	  Following	  ligand	  binding,	  GPCRs	  activate	  associated	  heterotrimeric	  G	  proteins	  by	  promoting	  nucleotide	  exchange,	  leading	  to	  subunit	  release	  and	  dissociation.	  	  A	  ligand	  bound	  GPCR	  can	  subsequently	  be	  recognized	  by	  a	  GPCR	  kinase,	  which	  phosphorylates	  active	  GPCRs,	  causing	  them	  to	  recruit	  specialized	  adaptor	  proteins	  called	  β-­‐arrestins.	  	  β-­‐arrestins	  are	  multifunctional	  scaffold	  proteins	  that	  serve	  a	  variety	  of	  functions	  during	  receptor	  downregulation:	  They	  desensitize	  receptor	  signaling	  by	  preventing	  reassociation	  of	  G	  proteins	  with	  the	  GPCR;	  they	  promote	  GPCR	  endocytosis	  by	  binding	  to	  endocytosis	  proteins,	  including	  clathrin	  and	  AP-­‐2;	  and	  they	  function	  as	  adaptors	  for	  E3	  ubiquitin	  ligases.	  	  Interestingly,	  β-­‐arrestins	  are	  ubiquitinated	  by	  the	  E3	  ligase	  Mdm2,	  and	  this	  modification	  is	  critical	  for	  GPCR	  endocytosis	  (Shenoy	  et	  al.,	  2001).	  	  Furthermore,	  ubiquitination	  of	  β-­‐arrestins	  enhances	  receptor	  interaction	  and	  thus	  promote	  endocytosis	  (Shenoy	  and	  Lefkowitz,	  2003).	  	  Recently,	  the	  deubiquitinating	  enzyme	  Usp33	  was	  shown	  to	  promote	  β-­‐arrestin	  deubiquitination	  and	  to	  antagonize	  arrestin	  function	  (Berthouze	  et	  al.,	  2009).	  	  Thus,	  even	  though	  GPCR	  ubiquitination	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itself	  is	  dispensable	  for	  endocytosis,	  β-­‐arrestin	  ubiquitination	  is	  an	  important	  regulator	  of	  receptor	  internalization	  and	  downregulation.	  	  	  	  	  	  	  	  	  	  It	  is	  worth	  noting	  that	  the	  paradigm	  of	  arrestin-­‐mediated	  downregulation	  has	  recently	  expanded	  beyond	  GPCRs	  to	  many	  additional	  types	  of	  PM	  proteins	  (Lefkowitz	  et	  al.,	  2006;	  Simonin	  and	  Fuster,	  2010).	  	  Furthermore,	  in	  addition	  to	  two	  β-­‐arrestins	  and	  two	  visual	  arrestins,	  the	  human	  genome	  encodes	  at	  least	  five	  additional	  arrestin	  domain-­‐containing	  (ARRDC)	  proteins.	  	  The	  human	  ARRDC	  family	  and	  the	  yeast	  family	  of	  ARTs	  exhibit	  striking	  similarity;	  both	  families	  contain	  N-­‐terminal	  arrestin	  domains	  and	  multiple	  C-­‐terminal	  PY	  motifs	  (Lin	  et	  al.,	  2008).	  	  Although	  the	  function	  of	  the	  ARRDC	  family	  of	  proteins	  is	  still	  under	  investigation,	  ARRDC3	  was	  recently	  shown	  to	  function	  as	  an	  adaptor	  for	  the	  Nedd4	  ubiquitin	  ligase	  and	  is	  required	  for	  the	  ubiquitination	  and	  endocytic	  downregulation	  of	  the	  β2-­‐adrenergic	  receptor	  (Nabhan	  et	  al.,	  2010).	  	  One	  recent	  study	  demonstrated	  that	  
Arrdc3	  null	  mice	  exhibit	  resistance	  to	  obesity	  and	  increased	  energy	  expenditure,	  phenotypes	  that	  suggest	  an	  inability	  to	  downregulate	  β2-­‐	  adrenergic	  receptor	  signaling	  in	  adipose	  tissues	  (Patwari	  et	  al.,	  2011).	  	  Another	  recent	  study	  demonstrated	  that	  decreased	  ARRDC3	  expression	  is	  associated	  with	  certain	  types	  of	  breast	  cancer	  and	  that	  ARRDC3	  may	  suppress	  cancer	  progression	  by	  promoting	  the	  endocytic	  downregulation	  of	  β-­‐4	  integrin	  (Draheim	  et	  al.,	  2010).	  	  Thus,	  the	  growing	  family	  of	  arrestins	  and	  arrestin-­‐related	  proteins	  may	  generally	  function	  as	  a	  family	  of	  ubiquitin	  ligase	  adaptors	  involved	  in	  the	  targeted	  ubiquitination	  and	  endocytic	  downregulation	  of	  GPCRs	  as	  well	  as	  other	  classes	  of	  PM	  cargo.	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  Attenuation	  of	  signaling	  processes	  from	  ligand-­‐bound	  RTKs,	  like	  the	  EGFR,	  have	  been	  studied	  intensely	  because	  these	  signals	  facilitate	  cell	  growth	  and	  proliferation	  and	  can	  contribute	  to	  the	  onset	  of	  various	  cancers.	  	  A	  crucial	  determinant	  of	  the	  internalization	  of	  active	  RTKs	  is	  Cbl,	  a	  RING	  domain	  containing	  E3	  ubiquitin	  ligase.	  	  There	  are	  three	  Cbl	  family	  RING	  E3	  ligases	  encoded	  in	  the	  human	  genome—c-­‐Cbl,	  Cbl-­‐b,	  and	  Cbl-­‐c.	  In	  the	  case	  of	  the	  EGFR,	  ligand	  binding	  promotes	  receptor	  dimerization	  and	  autophosphorylation,	  which	  result	  in	  the	  recruitment	  of	  the	  adaptor	  protein	  Grb2	  complexed	  with	  Cbl.	  	  The	  RING	  domain	  of	  Cbl,	  in	  turn,	  can	  recruit	  an	  E2	  enzyme	  and	  catalyze	  ubiquitin	  transfer	  to	  the	  EGFR.	  	  Although	  ubiquitin	  modification	  is	  sufficient	  to	  trigger	  EGFR	  endocytosis	  (Haglund	  et	  al.,	  2003;	  Huang	  et	  al.,	  2007)	  and	  the	  ubiquitinated	  EGFR	  interacts	  with	  epsin	  UIM	  domains	  (Kazazic	  et	  al.,	  2009),	  EGFR	  ubiquitination	  is	  not	  required	  for	  its	  internalization	  (Figure	  1.4)	  (Haglund	  et	  al.,	  2003;	  Huang	  et	  al.,	  2007).	  	  The	  EGFR	  is	  subject	  to	  at	  least	  two	  modes	  of	  internalization:	  (a)	  ubiquitin-­‐independent,	  clathrin-­‐dependent	  endocytosis	  at	  low	  extracellular	  concentrations	  of	  the	  EGF	  and	  (b)	  ubiquitin-­‐dependent,	  clathrin-­‐independent	  internalization	  at	  high	  extracellular	  concentrations	  of	  the	  EGF	  (Chen	  and	  De	  Camilli,	  2005;	  Sigismund	  et	  al.,	  2008;	  Sigismund	  et	  al.,	  2005).	  	  Although	  the	  mechanism	  of	  ubiquitin-­‐dependent	  internalization	  has	  not	  been	  elucidated,	  it	  requires	  epsins	  and	  Eps15	  family	  proteins	  (Sigismund	  et	  al.,	  2005),	  consistent	  with	  the	  possibility	  that	  UIM	  domains	  in	  these	  proteins	  may	  recognize	  and	  sort	  the	  ubiquitinated	  EGFR.	  	  	  	  	  	  	  	  	  	  Importantly,	  interaction	  of	  the	  EGFR	  with	  Cbl	  is	  required	  for	  ubiquitin-­‐independent	  endocytosis	  of	  the	  EGFR	  (Huang	  et	  al.,	  2007),	  suggesting	  that	  Cbl-­‐	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Figure	  1.4.	  	  Endocytosis	  of	  receptor	  tyrosine	  kinases	  (RTKs)	  can	  be	  ubiquitin-­‐mediated	  but	  is	  not	  always	  ubiquitin-­‐dependent.	  	  Cbl,	  a	  RING	  E3	  ubiquitin	  ligase;	  Cin85,	  ubiquitin-­‐binding	  endocytic	  adaptor	  protein;	  Eps15,	  epidermal	  growth	  factor	  receptor	  substrate	  15;	  Grb2,	  growth	  factor	  receptor-­‐bound	  protein	  2;	  P,	  phosphate.	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mediated	  EGFR	  internalization	  may	  not	  be	  related	  to	  receptor	  ubiquitination.	  	  Such	  a	  function	  may	  be	  related	  to	  Cbl-­‐mediated	  recruitment	  of	  additional	  factors	  to	  active	  RTK	  signaling	  complexes,	  including	  Cin85	  and	  endophilin,	  which	  are	  part	  of	  the	  endocytic	  protein	  interaction	  network.	  	  Furthermore,	  many	  such	  endocytic	  proteins,	  including	  Cin85,	  epsins,	  and	  Eps15	  family	  proteins,	  are	  known	  to	  undergo	  coupled	  monoubiquitination	  (Bezsonova	  et	  al.,	  2008;	  Polo	  et	  al.,	  2002)	  and	  as	  such	  may	  be	  modified	  by	  Cbl.	  	  Thus,	  it	  is	  tempting	  to	  speculate	  that	  EGFR	  interaction	  with	  Cbl	  may	  trigger	  local	  assembly	  of	  endocytic	  machinery,	  although	  future	  work	  must	  determine	  how	  Cbl	  regulates	  interactions	  within	  the	  endocytic	  protein	  network.	  	  	  	  	  	  	  	  	  Although	  ubiquitin-­‐mediated	  endocytosis	  is	  often	  associated	  with	  attenuation	  of	  signaling	  processes,	  there	  are	  also	  examples	  where	  it	  is	  required	  to	  activate	  signaling	  receptors.	  	  Perhaps	  the	  best	  example	  of	  this	  involves	  the	  Drosophila	  Notch	  ligand	  Delta	  (Weinmaster	  and	  Fischer,	  2011).	  	  Surface	  expression	  of	  Delta	  activates	  Notch	  signaling	  in	  adjacent	  cells,	  which	  triggers	  specific	  differentiation	  programs.	  	  The	  RING-­‐type	  E3	  ligase	  neuralized	  (neur)	  was	  found	  to	  promote	  Delta	  endocytosis	  in	  signal-­‐sending	  cells	  but	  also	  to	  promote	  Notch	  signaling	  in	  signal-­‐receiving	  cells.	  	  These	  observations	  are	  paradoxical:	  How	  is	  removal	  of	  a	  Notch	  ligand	  from	  the	  cell	  surface	  required	  for	  Notch	  activation	  in	  a	  neighboring	  cell?	  	  The	  precise	  mechanism	  is	  still	  under	  investigation,	  but	  recent	  studies	  have	  indicated	  that	  neur-­‐mediated	  ubiquitination	  may	  trigger	  transcytosis	  of	  Delta	  from	  the	  basolateral	  membrane	  of	  the	  signal-­‐sending	  cell	  to	  the	  apical	  membrane	  of	  the	  cell	  (Benhra	  et	  al.,	  2010),	  thus	  delivering	  the	  ligand	  to	  sites	  that	  can	  activate	  Notch	  on	  signal-­‐receiving	  cells.	  	  This	  mode	  of	  Notch	  signal	  regulation	  is	  a	  common	  theme	  in	  vertebrate	  development	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(Hansson	  et	  al.,	  2010;	  Koo	  et	  al.,	  2005a;	  Koo	  et	  al.,	  2005b),	  making	  this	  system	  an	  excellent	  example	  of	  how	  ubiquitin-­‐mediated	  endocytosis	  can	  remodel	  the	  cell	  surface	  to	  drive	  cell	  differentiation.	  	  
Ubiquitin-­‐Mediated	  Downregulation	  of	  Ion	  Channels	  	  	  	  	  	  	  	  	  Regulation	  of	  the	  ENaC,	  a	  three-­‐subunit	  complex	  at	  the	  PM,	  is	  critical	  for	  cellular	  ion	  homeostasis.	  	  ENaC	  undergoes	  ubiquitin-­‐dependent	  endocytosis,	  which	  is	  mediated	  by	  its	  interaction	  with	  the	  E3	  ubiquitin	  ligase	  Nedd4-­‐2.	  	  Nedd4	  family	  proteins	  are	  HECT-­‐type	  E3	  ubiquitin	  ligases	  with	  a	  distinct	  domain	  architecture:	  They	  contain	  an	  N	  terminal	  C2	  domain,	  a	  series	  of	  two-­‐to-­‐four	  WW	  domains,	  and	  a	  C-­‐terminal	  HECT	  ubiquitin	  ligase	  domain.	  	  WW	  domains	  typically	  mediate	  protein-­‐protein	  interactions	  responsible	  for	  substrate	  targeting	  and	  are	  known	  to	  bind	  PY	  motifs,	  although	  some	  can	  also	  interact	  with	  phosphopeptides	  (Verdecia	  et	  al.,	  2000).	  	  The	  interaction	  of	  Nedd4-­‐2	  WW	  domains	  with	  C-­‐terminal	  PY	  motifs	  in	  each	  of	  the	  ENaC	  subunits	  is	  required	  for	  ENaC	  ubiquitination	  and	  endocytosis.	  	  Ubiquitin-­‐modified	  ENaC	  has	  been	  shown	  to	  undergo	  clathrin-­‐mediated	  endocytosis,	  which	  requires	  the	  activity	  of	  epsins	  (Figure	  1.5)	  (Wang	  et	  al.,	  2006).	  	  Regulatory	  factors	  can	  also	  influence	  Nedd4	  function:	  The	  Sgk1	  kinase	  was	  shown	  to	  phosphorylate	  Nedd4-­‐2	  and	  abrogate	  its	  interaction	  with	  ENaC	  by	  promoting	  its	  interaction	  with	  a	  14-­‐3-­‐3	  protein	  (Debonneville	  et	  al.,	  2001;	  Ichimura	  et	  al.,	  2005;	  Nagaki	  et	  al.,	  2006),	  whereas	  the	  AM	  sensor	  kinase	  was	  shown	  to	  destabilize	  ENaC	  at	  the	  cell	  surface	  by	  phosphorylating	  Nedd4-­‐2	  and	  enhancing	  its	  association	  with	  ENaC	  (Bhalla	  et	  al.,	  2006).	  	  	  
 	  	   26	  
	  	  	  	  	  	  	  	  	  	  	  


































 	  	   27	  
Figure	  1.5.	  	  Endocytic	  downregulation	  of	  ENaC	  is	  ubiquitin-­‐dependent	  and	  is	  important	  for	  ion	  homeostasis	  in	  epithelial	  cells.	  	  Nedd4,	  HECT-­‐type	  E3	  ubiquitin	  ligase.	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  Aside	  from	  ENaC,	  Nedd4	  family	  members	  have	  been	  implicated	  in	  the	  ubiquitin-­‐mediated	  endocytosis	  of	  many	  other	  ion	  channels	  (He	  et	  al.,	  2008;	  Hryciw	  et	  al.,	  2004;	  Lin	  et	  al.,	  2011).	  	  Importantly,	  many	  ion	  channels	  linked	  to	  channelopathies	  including	  the	  cardiac	  voltage-­‐gated	  sodium	  channel,	  Nav1.5,	  and	  the	  potassium	  channels,	  KCNQ1	  and	  hERG1,	  all	  encode	  PY	  motifs	  and	  may	  be	  regulated	  by	  Nedd4	  family	  E3	  ligases	  (Rougier	  et	  al.,	  2010).	  	  Additionally,	  connexin43,	  a	  gap	  junction	  protein	  that	  facilitates	  ion	  exchange	  between	  cells,	  contains	  a	  PY	  motif	  and	  has	  been	  shown	  to	  undergo	  Nedd4-­‐dependent	  ubiquitination	  and	  endocytosis	  (Leithe	  and	  Rivedal,	  2007).	  	  There	  are	  nine	  Nedd4	  family	  ubiquitin	  ligases	  encoded	  in	  the	  human	  genome,	  and	  although	  not	  all	  have	  been	  characterized,	  several	  Nedd4	  family	  members	  have	  been	  implicated	  in	  the	  ubiquitin-­‐mediated	  endocytosis	  of	  various	  other	  PM	  cargoes,	  including	  amino	  acid	  transporters	  (Hatanaka	  et	  al.,	  2006;	  Vina-­‐Vilaseca	  et	  al.,	  2011),	  RTKs	  (Arevalo	  et	  al.,	  2006;	  Li	  et	  al.,	  2009;	  Lin	  et	  al.,	  2010),	  and	  glucose	  transporters	  (Dieter	  et	  al.,	  2004).	  	  Thus,	  Nedd4	  family	  E3	  ligases	  may	  function	  generally	  to	  target	  a	  variety	  of	  PM	  cargoes	  for	  ubiquitin-­‐mediated	  endocytosis,	  and	  their	  role	  is	  discussed	  throughout	  the	  remainder	  of	  this	  chapter.	  
Ubiquitin-­‐Mediated	  Downregulation	  of	  Transporters	  	  	  	  	  	  	  	  	  A	  clear	  example	  of	  ubiquitin-­‐dependent	  endocytosis	  of	  a	  transporter	  in	  mammalian	  cells	  involves	  the	  dopamine	  transporter	  (DAT).	  	  DAT	  is	  a	  sodium	  chloride	  ion	  symporter	  responsible	  for	  dopamine	  reuptake	  at	  synapses,	  a	  process	  critical	  to	  control	  of	  dopamine	  signaling	  and	  thus	  synaptic	  function.	  	  DAT	  is	  ubiquitinated	  at	  the	  PM	  and	  internalized	  in	  a	  protein	  kinase	  C-­‐dependent	  manner	  (Miranda	  and	  Sorkin,	  2007).	  	  DAT	  ubiquitination	  requires	  the	  activity	  of	  Nedd4-­‐2,	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and	  internalization	  of	  DAT	  is	  clathrin	  dependent	  and	  requires	  epsins	  and	  Eps15	  family	  proteins	  (Sorkina	  et	  al.,	  2006).	  	  Importantly,	  DAT	  endocytosis	  involves	  ubiquitin	  modification	  at	  three	  N-­‐terminal	  lysine	  residues.	  	  Although	  DAT	  ubiquitination	  is	  dependent	  on	  the	  WW4	  domain	  of	  Nedd4-­‐2	  (Vina-­‐Vilaseca	  and	  Sorkin,	  2010),	  it	  is	  unclear	  exactly	  how	  this	  interaction	  is	  mediated	  because	  DAT	  lacks	  a	  PY	  motif.	  	  Further	  studies	  are	  needed	  to	  determine	  (a)	  if	  this	  interaction	  is	  direct	  or	  adaptor	  driven	  and	  (b)	  how	  this	  interaction	  is	  regulated	  in	  a	  protein	  kinase	  C-­‐dependent	  manner.	  	  	  	  	  	  	  	  	  	  Unlike	  DAT,	  some	  transporters	  constitutively	  cycle	  between	  the	  PM	  and	  endosomes	  via	  a	  ubiquitin-­‐independent	  recycling	  pathway.	  	  This	  allows	  nutrient	  receptors,	  such	  as	  the	  transferrin	  receptor	  (TfR)	  and	  the	  low-­‐density	  lipoprotein	  receptor,	  to	  scavenge	  nutrients	  from	  the	  environment,	  deposit	  them	  in	  the	  lumen	  of	  the	  endosome,	  and	  then	  return	  to	  the	  surface	  to	  collect	  more	  nutrients.	  	  However,	  ubiquitination	  of	  these	  nutrient	  receptors	  is	  sufficient	  to	  divert	  such	  cargo	  away	  from	  the	  recycling	  pathway	  and	  instead	  target	  them	  for	  sorting	  into	  MVBs	  and	  lysosomal	  degradation.	  	  For	  example,	  instead	  of	  recycling	  back	  to	  the	  surface,	  the	  TfR	  fused	  to	  ubiquitin	  is	  targeted	  for	  lysosomal	  degradation	  (Raiborg	  et	  al.,	  2002).	  	  Furthermore,	  excess	  iron	  was	  shown	  to	  stimulate	  TfR	  ubiquitination	  and	  lysosomal	  degradation	  (Tachiyama	  et	  al.,	  2011),	  although	  the	  E3	  ligase	  responsible	  is	  not	  known.	  	  Similarly,	  in	  cholesterol-­‐replete	  conditions,	  the	  low-­‐density	  lipoprotein	  receptor	  is	  ubiquitinated	  and	  targeted	  for	  lysosomal	  degradation.	  	  This	  is	  mediated	  by	  the	  RING	  E3	  ligase,	  IDOL	  (Zhang	  et	  al.,	  2011),	  which	  is	  transcriptionally	  induced	  by	  a	  sterol-­‐binding	  transcription	  factor	  (Zelcer	  et	  al.,	  2009).	  	  Thus,	  cells	  upregulate	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ubiquitination	  of	  nutrient	  receptors,	  such	  as	  the	  TfR	  and	  low-­‐density	  lipoprotein	  receptor,	  which	  are	  normally	  recycled,	  to	  reduce	  the	  cellular	  level	  of	  these	  receptors	  and	  thereby	  limit	  nutrient	  accumulation.	  	  	  	  	  	  	  	  	  	  For	  most	  cargoes	  studied	  in	  yeast,	  the	  primary	  determinant	  of	  endocytosis	  appears	  to	  be	  ubiquitin	  modification,	  although	  other	  endocytic	  targeting	  signals	  have	  been	  described	  (Chen	  and	  Davis,	  2002;	  Howard	  et	  al.,	  2002;	  Tan	  et	  al.,	  1996).	  	  Thus,	  cargo	  ubiquitination	  at	  the	  PM	  represents	  a	  critical	  point	  of	  regulation	  for	  internalization.	  	  The	  primary	  E3	  ubiquitin	  ligase	  that	  mediates	  cargo	  ubiquitination	  and	  targeting	  for	  endocytosis	  is	  Rsp5,	  the	  lone	  Nedd4	  family	  member	  encoded	  in	  the	  yeast	  genome.	  	  Because	  most	  yeast	  PM	  proteins	  do	  not	  contain	  PY	  motifs	  and	  thus	  cannot	  interact	  directly	  with	  Rsp5,	  this	  presents	  a	  conundrum:	  How	  does	  one	  ubiquitin	  ligase	  selectively	  regulate	  the	  abundance	  of	  perhaps	  hundreds	  of	  different	  proteins	  at	  the	  PM?	  	  The	  answer	  appears	  to	  lie	  in	  the	  existence	  of	  an	  elaborate	  network	  of	  adaptor	  proteins,	  each	  capable	  of	  targeting	  Rsp5	  ubiquitin	  ligase	  activity	  to	  specific	  substrates	  at	  specific	  locations	  in	  the	  cell	  in	  a	  highly	  regulated	  manner.	  	  At	  the	  core	  of	  this	  adaptor	  network	  is	  a	  family	  of	  yeast	  ART	  proteins.	  There	  are	  10	  ARTs	  encoded	  in	  the	  yeast	  genome;	  each	  ART	  contains	  an	  N-­‐terminal	  arrestin-­‐like	  domain	  and	  multiple	  C-­‐terminal	  PY	  motifs	  that	  interact	  with	  the	  WW	  domains	  of	  Rsp5.	  	  Like	  F-­‐box	  proteins,	  which	  function	  in	  the	  recruitment	  of	  specific	  substrates	  to	  SCF	  ubiquitin	  ligase	  complexes,	  ARTs	  recruit	  Rsp5	  ubiquitin	  ligase	  activity	  to	  specific	  proteins	  at	  the	  PM	  and	  thus	  play	  a	  critical	  role	  in	  regulating	  which	  PM	  proteins	  are	  selectively	  targeted	  for	  endocytosis.	  	  Other	  proteins,	  including	  Bul1,	  Bul2,	  Ear1,	  and	  Ssh4,	  also	  act	  as	  specificity	  adaptors	  for	  Rsp5.	  	  It	  has	  been	  proposed	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that	  Bul1	  and	  Bul2	  may	  in	  fact	  be	  bona	  fide	  members	  of	  the	  ART	  protein	  family	  (Nikko	  and	  Pelham,	  2009),	  although	  these	  proteins	  do	  not	  appear	  to	  contain	  significant	  primary	  sequence	  homology	  with	  ARTs.	  	  Despite	  their	  divergence,	  it	  is	  tempting	  to	  speculate	  that	  Bul1	  and	  Bul2	  could	  contain	  arrestin-­‐like	  domains,	  but	  confirmation	  will	  require	  structural	  analysis	  of	  these	  proteins.	  	  	  	  	  	  	  	  	  	  The	  mechanism	  of	  ART-­‐mediated	  regulation	  of	  endocytosis	  was	  recently	  elucidated	  in	  two	  studies	  directed	  at	  understanding	  how	  PM	  proteins	  in	  yeast	  are	  ubiquitinated.	  	  ART1	  was	  identified	  in	  a	  chemical-­‐genetic	  screen	  for	  mutants	  with	  defects	  in	  the	  endocytosis	  of	  Can1,	  the	  arginine	  transporter	  in	  yeast	  (Lin	  et	  al.,	  2008).	  	  Importantly,	  Dart1	  cells	  are	  defective	  for	  endocytosis	  of	  a	  few	  specific	  cargoes,	  including	  Can1	  and	  the	  methionine	  transporter,	  Mup1,	  but	  are	  not	  defective	  for	  endocytosis	  of	  most	  other	  cargoes	  (Lin	  et	  al.,	  2008).	  	  Art1	  interacts	  with	  Rsp5	  via	  two	  C-­‐terminal	  PY	  motifs,	  an	  interaction	  required	  for	  cargo	  ubiquitination	  (Lin	  et	  al.,	  2008).	  	  Additionally,	  Art1	  localizes	  to	  the	  PM	  and	  interacts	  with	  cargo,	  confirming	  its	  role	  as	  a	  ubiquitin	  ligase	  adaptor	  (Figure	  1.6).	  	  Bioinformatic	  analysis	  identified	  additional	  ART	  proteins	  encoded	  in	  the	  yeast	  genome	  (Art1-­‐Art10),	  each	  capable	  of	  binding	  to	  Rsp5.	  	  Endocytosis	  of	  the	  lysine	  transporter	  Lyp1	  is	  dependent	  on	  Art2,	  and	  Can1-­‐	  Lyp1	  cargo	  chimera	  experiments	  revealed	  that	  ART	  specificity	  for	  these	  cargoes	  is	  mediated	  through	  the	  N-­‐terminal	  cytosolic	  tail	  (Lin	  et	  al.,	  2008).	  	  A	  parallel	  study	  revealed	  that	  ART	  family	  proteins	  function	  redundantly	  in	  the	  ubiquitination	  and	  endocytosis	  of	  the	  yeast	  manganese	  transporter,	  Smf1.	  	  In	  this	  investigation,	  simultaneous	  deletion	  of	  seven	  ART	  family	  proteins,	  as	  well	  as	  the	  Rsp5-­‐interacting	  protein,	  Bsd2,	  was	  required	  to	  block	  Smf1	  ubiquitination	  and	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Figure	  1.6.	  	  Model	  of	  ART	  family	  protein	  function	  as	  Rsp5	  adaptors	  in	  yeast.	  	  Yeast	  ARTs	  are	  adaptors	  for	  the	  ubiquitin	  E3	  ligase,	  Rsp5,	  directing	  ubiquitin	  ligase	  activity	  to	  specific	  PM	  cargoes	  and	  targeting	  them	  for	  endocytosis.	  	  ART,	  arrestin-­‐related	  trafficking	  adaptor	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endocytosis	  (Nikko	  et	  al.,	  2008).	  	  This	  endocytic	  defect	  could	  be	  complemented	  by	  reintroduction	  of	  wild-­‐type	  ART2	  but	  not	  by	  an	  allele	  of	  art2	  with	  point	  mutations	  in	  its	  C-­‐terminal	  PY	  motifs	  (Nikko	  et	  al.,	  2008).	  	  Both	  of	  these	  studies	  contributed	  to	  a	  model	  of	  ARTs	  as	  Rsp5	  adaptors	  that	  function	  in	  targeting	  PM	  proteins	  for	  endocytosis.	  	  Since	  then,	  other	  reports	  have	  described	  similar	  endocytic	  functions	  for	  other	  ART	  family	  proteins	  (Hatakeyama	  et	  al.,	  2010;	  Nikko	  and	  Pelham,	  2009).	  	  It	  has	  also	  recently	  been	  reported	  that	  Art3	  and	  Art6	  may	  function	  in	  Golgi-­‐to-­‐endosome	  traffic,	  but	  it	  is	  unclear	  if	  this	  relates	  to	  their	  role	  as	  ubiquitin	  ligase	  adaptors	  (O'Donnell	  et	  al.,	  2010).	  	  This	  study	  is	  noteworthy	  because	  it	  suggests	  that	  ART	  proteins	  have	  nonendocytic	  trafficking	  functions,	  and	  it	  demonstrated	  that	  Art3	  and	  Art6	  interact	  with	  clathrin	  and	  AP-­‐1.	  	  The	  later	  observation	  is	  reminiscent	  of	  β-­‐arrestins	  in	  mammalian	  cells,	  which	  serve	  as	  endocytic	  adaptors	  by	  binding	  to	  clathrin	  and	  AP-­‐2.	  	  	  	  	  	  	  	  	  	  To	  drive	  Rsp5	  specificity,	  ART	  family	  proteins	  must	  be	  capable	  of	  interacting	  with	  specific	  PM	  proteins	  in	  a	  regulated	  manner	  (Figure	  1.7).	  	  ART-­‐cargo	  interactions	  have	  been	  demonstrated	  (Hatakeyama	  et	  al.,	  2010;	  Lin	  et	  al.,	  2008;	  Nikko	  et	  al.,	  2008),	  and	  although	  the	  precise	  cargo-­‐binding	  domain	  has	  not	  yet	  been	  mapped,	  the	  best	  candidate	  is	  the	  arrestin	  domain.	  	  More	  experimentation	  is	  required	  to	  map	  and	  characterize	  cargo	  specificity	  determinants	  within	  the	  ART	  family	  of	  proteins.	  	  Importantly,	  ART	  function	  is	  tightly	  regulated	  and	  often	  appears	  to	  be	  “activated”	  by	  specific	  stimuli.	  	  For	  example,	  stimulation	  of	  yeast	  cells	  with	  methionine	  activates	  Art1	  to	  target	  the	  methionine	  transporter	  Mup1,	  resulting	  in	  rapid	  ubiquitination	  and	  endocytic	  downregulation	  (Lin	  et	  al.,	  2008).	  	  One	  major	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Figure	  1.7.	  	  Model	  for	  adaptor-­‐driven	  substrate	  targeting	  of	  the	  Rsp5	  ubiquitin	  ligase	  in	  yeast.	  	  Structural	  modeling	  revealed	  that	  Art1	  contains	  an	  arrestin	  fold	  domain	  at	  the	  N-­‐terminus,	  while	  the	  C-­‐terminus	  contains	  two	  PY	  motifs	  that	  mediate	  interaction	  with	  WW	  domains	  in	  Rsp5.	   ART,	  arrestin-­‐related	  trafficking	  adaptor;	  Bul1,	  another	  known	  adaptor	  for	  Rsp5;	  Can1,	  yeast	  arginine	  transporter;	  C2,	  a	  domain	  that	  binds	  to	  calcium	  and	  lipids;	  Dip5,	  yeast	  dicarboxylic	  amino	  acid	  transporter;	  Gap1,	  yeast	  general	  amino	  acid	  transporter;	  Lyp1,	  yeast	  lysine	  transporter;	  Mup1,	  yeast	  methionine	  transporter;	  PM,	  plasma	  membrane.	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mechanism	  of	  regulation	  may	  involve	  stimulus-­‐induced	  cargo	  phosphorylation,	  as	  is	  the	  case	  with	  the	  recognition	  of	  GPCRs	  by	  β–arrestins	  in	  mammalian	  cells.	  	  Indeed,	  Smf1	  phosphorylation	  correlates	  with	  increased	  Art2	  binding,	  and	  substrate-­‐induced	  phosphorylation	  of	  the	  dicarboxylic	  amino	  acid	  transporter,	  Dip5,	  triggers	  increased	  binding	  to	  Art3	  (Hatakeyama	  et	  al.,	  2010),	  although	  the	  regulatory	  kinases	  and/or	  phosphatases	  in	  these	  cases	  are	  not	  known.	  	  It	  is	  also	  possible	  that	  substrate	  binding	  and	  transport	  might	  trigger	  conformational	  changes	  in	  cargo	  proteins	  that	  are	  recognized	  by	  ARTs.	  	  Recognition	  of	  either	  conformational	  changes	  or	  cargo	  phosphorylation	  represents	  a	  local	  regulatory	  mechanism	  that	  is	  based	  on	  sensing	  cargo	  activity.	  	  	  	  	  	  	  	  	  An	  alternative	  regulatory	  mechanism	  for	  ART-­‐cargo	  recognition	  may	  involve	  posttranslational	  modifications	  of	  the	  ART	  proteins	  themselves.	  	  Most	  ARTs	  appear	  to	  be	  ubiquitinated,	  and	  in	  the	  case	  of	  Art1,	  this	  is	  Rsp5	  dependent	  (Lin	  et	  al.,	  2008).	  Art1	  ubiquitination	  occurs	  on	  a	  single	  lysine	  residue	  (Hatakeyama	  et	  al.,	  2010;	  Hitchcock	  et	  al.,	  2003);	  mutation	  of	  this	  residue	  prevents	  ubiquitin	  modification	  and	  results	  in	  a	  loss-­‐of-­‐function	  phenotype	  (Lin	  et	  al.,	  2008).	  	  	  Such	  coupled	  ubiquitination	  events	  are	  not	  uncommon	  for	  ubiquitin	  ligase	  adaptors,	  and	  although	  its	  functional	  significance	  is	  clear,	  further	  experimentation	  is	  required	  to	  determine	  precisely	  how	  ubiquitin	  modification	  regulates	  Art1	  function.	  	  ART	  proteins	  are	  extensively	  phosphorylated	  (Albuquerque	  et	  al.,	  2008)	  and	  are	  likely	  subject	  to	  phosphoregulation.	  	  	  	  	  	  	  	  	  	  Although	  human	  homologs	  of	  ARTs	  are	  not	  obvious	  on	  the	  basis	  of	  their	  primary	  sequence,	  domain	  architecture	  suggests	  that	  yeast	  ARTs	  are	  similar	  to	  the	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family	  of	  ARRDC	  proteins	  in	  mammalian	  cells	  (Lin	  et	  al.,	  2008;	  Nabhan	  et	  al.,	  2010).	  	  Like	  ARTs,	  ARRDC	  proteins	  have	  an	  N-­‐terminal	  arrestin	  domain	  and	  C-­‐terminal	  PY	  motifs,	  which	  have	  been	  shown	  to	  mediate	  interactions	  with	  Nedd4	  family	  proteins	  (Nabhan	  et	  al.,	  2010).	  	  Thus,	  elucidating	  mechanisms	  of	  ART	  function	  in	  yeast	  may	  have	  important	  implications	  for	  understanding	  arrestin	  and	  ARRDC	  protein	  function	  in	  mammalian	  cells.	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Chapter	  2	  
TORC1	  Regulates	  Endocytosis	  via	  Npr1-­‐mediated	  Phosphoinhibition	  of	  a	  
Ubiquitin	  Ligase	  Adaptor	  
INTRODUCTION	  Decisions	  of	  cell	  growth	  and	  differentiation	  are	  made	  by	  complex	  signaling	  networks	  that	  integrate	  various	  environmental	  and	  nutritional	  inputs	  and	  respond	  by	  coordinating	  diverse	  cellular	  processes	  towards	  a	  specific	  outcome.	  	  One	  example	  involves	  the	  target	  of	  rapamycin	  complex	  1,	  or	  TORC1,	  a	  highly	  conserved	  multi-­‐protein	  kinase	  complex	  that	  senses	  various	  cellular	  and	  environmental	  cues	  including	  nutrient	  availability,	  energy	  status,	  and	  growth	  signals	  and	  responds	  by	  coordinating	  activities	  associated	  with	  cell	  growth	  and	  proliferation.	  	  In	  general,	  signals	  that	  promote	  TORC1	  kinase	  activity	  also	  promote	  cell	  growth	  and	  proliferation,	  while	  signals	  that	  inhibit	  TORC1	  kinase	  activity	  tend	  to	  induce	  a	  starvation	  response.	  	  For	  example,	  TORC1	  kinase	  phosphorylates	  both	  ribosomal	  S6	  kinases	  and	  inhibitory	  eIF4E	  binding	  proteins,	  activities	  which	  promote	  translation	  initiation	  (Holz	  et	  al.,	  2005a,	  b).	  	  The	  TORC1	  kinase	  also	  phosphorylates	  Atg13,	  preventing	  its	  association	  with	  Atg1	  and	  thereby	  inhibiting	  the	  initiation	  of	  autophagy	  (Kamada	  et	  al.,	  2010),	  a	  conserved	  protein	  degradation	  pathway	  crucial	  to	  the	  starvation	  response	  in	  eukaryotic	  cells.	  	  Thus,	  TORC1	  signaling	  coordinates	  cell	  growth	  by	  simultaneously	  promoting	  protein	  synthesis	  and	  inhibiting	  autophagy,	  while	  loss	  of	  TORC1	  signaling	  triggers	  the	  onset	  of	  the	  starvation	  response	  by	  decreasing	  protein	  synthesis	  and	  inducing	  autophagy.	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Some	  of	  the	  factors	  that	  regulate	  TORC1	  signaling	  have	  been	  studied	  in	  detail.	  	  One	  important	  upstream	  activator	  of	  TORC1	  signaling	  is	  Rheb,	  a	  lysosome-­‐localized	  small	  GTPase	  that	  is	  antagonized	  by	  the	  GAP	  activity	  of	  TSC1-­‐TSC2	  heterodimers	  (Inoki	  et	  al.,	  2003).	  	  TSC2	  is	  a	  key	  point	  of	  signal	  integration	  for	  TORC1	  signaling:	  	  growth	  factors	  can	  stimulate	  TORC1	  signaling	  via	  Akt/PKB-­‐mediated	  inhibition	  of	  TSC2	  (Inoki	  et	  al.,	  2002;	  Manning	  et	  al.,	  2002),	  while	  energy	  starvation	  can	  inhibit	  TORC1	  signaling	  via	  AMPK-­‐dependent	  phosphoactivation	  of	  TSC2	  (Inoki	  et	  al.,	  2003).	  	  TORC1	  signaling	  also	  responds	  to	  protein	  misfolding	  and	  quality	  control	  by	  sensing	  the	  availability	  of	  molecular	  chaperones,	  allowing	  the	  cell	  to	  regulate	  growth	  in	  response	  to	  protein	  folding	  stress	  (Qian	  et	  al.,	  2010).	  	  By	  mechanisms	  that	  are	  not	  completely	  understood,	  TORC1	  also	  senses	  and	  responds	  to	  amino	  acid	  availability.	  	  This	  mode	  of	  TORC1	  regulation	  involves	  the	  activity	  of	  four	  Rag	  GTPases	  which	  regulate	  amino	  acid-­‐dependent	  localization	  of	  TORC1	  to	  the	  lysosome,	  thus	  promoting	  interaction	  with	  and	  activation	  by	  Rheb	  (Sancak	  et	  al.,	  2010).	  	  Despite	  numerous	  reports	  elucidating	  the	  nutritional	  and	  environmental	  cues	  that	  influence	  TORC1	  signaling	  and	  its	  downstream	  effector	  responses,	  a	  mechanistic	  understanding	  of	  how	  TORC1	  integrates	  multiple	  signals	  to	  coordinate	  a	  holistic	  growth	  strategy	  for	  the	  cell	  remains	  to	  be	  elucidated.	  	  	  	   Another	  way	  that	  eukaryotic	  cells	  regulate	  growth	  and	  proliferation	  in	  response	  to	  environmental	  changes	  is	  by	  regulating	  the	  activity	  and	  abundance	  of	  specific	  proteins	  at	  the	  cell	  surface.	  	  This	  is	  largely	  achieved	  via	  endocytic	  downregulation,	  which	  involves	  the	  endocytosis	  of	  cell	  surface	  proteins	  followed	  by	  delivery	  to	  the	  lysosome	  (or	  vacuole)	  where	  degradation	  occurs.	  	  Such	  endocytic	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downregulation	  is	  critical	  to	  human	  health	  and	  disease.	  	  For	  example,	  failure	  to	  attenuate	  growth	  factor	  signaling	  from	  ligand-­‐bound	  EGF	  receptor	  by	  endocytic	  downregulation	  can	  result	  in	  the	  aberrant	  proliferation	  of	  cells	  and	  cause	  cancer.	  	  To	  prevent	  hyperproliferation,	  the	  ubiquitin	  ligase	  Cbl	  and	  the	  adaptor	  protein	  Grb2	  mediate	  the	  ubiquitination	  of	  stimulated	  EGFR	  molecules	  at	  the	  cell	  surface,	  targeting	  them	  for	  endocytosis	  and	  subsequent	  lysosomal	  degradation	  (Miranda	  and	  Sorkin,	  2007).	  	  This	  example	  highlights	  the	  key	  role	  that	  endocytic	  downregulation	  plays	  in	  growth	  signal	  attenuation.	  While	  endocytic	  downregulation	  has	  been	  extensively	  studied	  as	  a	  mechanism	  for	  attenuation	  of	  signaling	  processes,	  less	  is	  known	  about	  how	  cells	  regulate	  surface	  protein	  abundance	  in	  response	  to	  changes	  in	  nutrient	  availability	  or	  cellular	  stress.	  	  Understanding	  how	  cells	  regulate	  the	  abundance	  and	  activity	  of	  cell	  surface	  proteins	  in	  response	  to	  changes	  in	  environment	  and	  nutritient	  availability	  is	  key	  to	  deciphering	  cellular	  strategies	  for	  adaptive	  growth.	  	  	  	  	  	  	  	  	  	  	  In	  this	  study,	  we	  report	  that	  TORC1	  signaling	  controls	  nutrient	  uptake	  by	  targeting	  the	  ubiquitin-­‐mediated	  endocytosis	  of	  specific	  amino	  acid	  transporters.	  	  The	  mechanism	  involves	  a	  negative	  kinase	  signaling	  cascade	  in	  which	  TORC1	  kinase	  inhibits	  the	  nitrogen	  permease	  reactivator	  1	  (Npr1)	  kinase,	  which	  in	  turn	  inhibits	  a	  ubiquitin	  ligase	  adaptor.	  	  This	  ubiquitin	  ligase	  adaptor,	  the	  arrestin-­‐related	  protein	  Art1,	  was	  previously	  shown	  to	  recruit	  Rsp5,	  the	  yeast	  homolog	  of	  Nedd4,	  to	  specific	  proteins	  at	  the	  plasma	  membrane	  (PM)	  in	  order	  to	  target	  them	  for	  endocytosis	  (Lin	  et	  al.,	  2008).	  	  We	  show	  that	  the	  TORC1-­‐Npr1	  negative	  kinase	  signaling	  cascade	  regulates	  Art1	  translocation	  to	  the	  PM	  by	  N-­‐terminal	  phosphorylation.	  	  Our	  results	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demonstrate	  that	  a	  key	  effector	  pathway	  of	  TORC1	  signaling	  coordinates	  the	  targeting	  of	  a	  ubiquitin	  ligase	  in	  order	  to	  regulate	  the	  endocytosis	  and	  vacuolar	  trafficking	  of	  specific	  nutrient	  transporters	  at	  the	  plasma	  membrane.	  	  Furthermore,	  these	  findings	  reveal	  that	  TORC1	  controls	  amino	  acid	  uptake	  by	  tuning	  the	  abundance	  of	  transporters	  at	  the	  cell	  surface	  and	  that	  coordination	  of	  endocytosis	  with	  other	  cellular	  processes	  such	  as	  transcription,	  translation,	  and	  autophagy	  is	  critical	  for	  the	  ability	  of	  cells	  to	  adapt	  to	  changes	  in	  nutrient	  availability.	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MATERIAL	  AND	  METHODS	  
Plasmids,	  Strains	  and	  Yeast	  Plating	  Assays	  All	  plasmids	  and	  yeast	  strains	  used	  in	  this	  study	  are	  listed	  in	  Table	  S1	  and	  Table	  S2,	  respectively.	  	  Canavanine	  plating	  assays	  were	  performed	  as	  previously	  described	  (Lin	  et	  al.,	  2008).	  	  Briefly,	  yeast	  cultures	  grown	  overnight	  in	  YPD	  were	  normalized	  to	  1	  OD/mL,	  serially	  diluted	  and	  plated	  onto	  SCD	  plates	  using	  a	  pin-­‐frogger.	  	  The	  following	  concentrations	  of	  canavanine	  were	  tested	  in	  each	  experiment:	  	  0	  µg/mL,	  1.0	  µg/mL,	  2.0	  µg/mL,	  and	  4.0	  µg/mL.	  
Microscopy	  All	  microscopy	  was	  performed	  using	  an	  Olympus	  IX71	  microscopy	  equipped	  with	  FITC	  and	  rhodamine	  filters.	  	  Deconvolution	  and	  image	  analysis	  was	  performed	  using	  Softworx	  software	  (Applied	  Precision).	  	  For	  cargo	  trafficking	  assays,	  strains	  expressing	  chromosomally-­‐tagged	  Vph1-­‐mCherry	  were	  used	  to	  label	  the	  vacuolar	  membrane.	  	  In	  most	  experiments,	  cells	  were	  either	  mock-­‐treated	  or	  treated	  with	  cycloheximide	  (CHX)	  (50	  µg/mL)	  and/or	  rapamycin	  (RAP)	  (200	  ng/mL)	  for	  1.5	  hours	  prior	  to	  imaging	  cells.	  	  Vacuolar	  trafficking	  of	  cargo	  was	  quantified	  by	  measuring	  fluorescence	  intensity	  of	  cargo	  signal	  (GFP)	  in	  the	  vacuole	  normalized	  to	  signal	  at	  the	  PM.	  	  For	  Art1-­‐GFP	  and	  Npr1-­‐GFP	  localization	  experiments,	  cells	  were	  stimulated	  with	  CHX,	  RAP,	  or	  both	  for	  10	  minutes	  prior	  to	  imaging.	  	  Art1	  PM	  translocation	  was	  quantified.	  
Amino	  Acid	  Uptake	  Assays	  To	  measure	  amino	  acid	  (arginine)	  uptake,	  yeast	  cells	  were	  grown	  to	  mid-­‐log	  phase	  in	  SCD	  media	  and	  then	  labeled	  by	  addition	  of	  5	  µCi	  [3H]	  arginine	  (Perkin	  Elmer).	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Samples	  were	  collected	  at	  indicated	  timepoints	  by	  addition	  of	  ice-­‐cold	  stopping	  solution	  (20mM	  NaN3,	  20mM	  NaF).	  	  Cells	  were	  pelleted,	  and	  the	  amount	  of	  [3H]	  arginine	  remaining	  in	  the	  supernatant	  was	  measured	  using	  a	  Beckman	  Coutner	  LS	  6500	  scintillation	  counter.	  
Npr1	  in	  vitro	  kinase	  assay	  Recombinant	  Art1-­‐6xHis-­‐FLAG	  was	  incubated	  with	  yeast	  purified	  wild	  type	  or	  kinase	  dead	  GST-­‐Npr1	  for	  30	  minutes	  at	  30°C	  in	  kinase	  buffer	  (50mM	  Tris	  pH7.5,	  20mM	  MgCl2,	  1mM	  DTT,	  25	  µM	  [γ-­‐32P]-­‐ATP	  (Perkin	  Elmer)).	  	  (See	  Supplemental	  Materials	  for	  detailed	  protein	  purification	  protocols).	  	  Subsequently,	  Art1-­‐6xHis-­‐FLAG	  was	  purified	  by	  incubating	  with	  M2	  Flag	  beads	  for	  1	  hour	  at	  4	  °C.	  	  Beads	  were	  washed	  in	  TBS	  (50mM	  Tris	  pH7.5	  and	  150mM	  NaCl)	  and	  eluted	  in	  elution	  buffer	  (TBS	  with	  5	  mg/ml	  3X	  FLAG	  Peptide	  (Sigma-­‐Aldrich)).	  	  Protein	  samples	  were	  resolved	  by	  SDS-­‐PAGE.	  	  Gels	  were	  both	  subjected	  to	  Western	  blot	  and	  dried	  for	  autoradiographing	  with	  Kodak	  BioMax	  MS	  film	  (Sigma-­‐Aldrich)).	  	  	  	  	  	  
SILAC	  and	  Quantitative	  Mass	  Spectrometry	  All	  quantitative	  mass	  spectrometry	  analysis	  was	  performed	  using	  SILAC	  labelling	  of	  yeast	  strains	  auxotrophic	  for	  lysine	  and	  arginine.	  	  Cells	  were	  grown	  to	  mid-­‐log	  phase	  in	  the	  presence	  of	  either	  heavy	  or	  light	  isotopes	  (lysine	  and	  arginine)	  and	  affinity	  purification	  was	  performed	  as	  described	  in	  Supplemental	  Methods.	  	  Heavy	  and	  light	  purified	  samples	  were	  mixed	  and	  digested	  with	  1μg	  of	  trypsin	  for	  2	  hours	  at	  37˚C.	  	  For	  phosphoprofiling	  experiments,	  phosphopeptides	  were	  purified	  using	  IMAC	  chromatography	  as	  previously	  described	  (Albuquerque	  et	  al.,	  2008).	  	  Purified	  peptides	  were	  dried,	  reconstituted	  in	  0.1%	  trifluoroacetic	  acid,	  and	  analysed	  by	  LC-­‐
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MS/MS	  using	  an	  Orbitrap	  XL	  mass	  spectrometer.	  	  Database	  search	  and	  SILAC	  quantitation	  was	  performed	  using	  Sorcerer	  software.	  	  	  
Quantitative	  Immunoblot	  Analysis	  Quantitative	  fluorescence	  imaging	  of	  Western	  blots	  was	  performed	  using	  an	  Odyssey	  infrared	  imaging	  system	  (LI-­‐COR	  Biosciences)	  as	  illustrated	  in	  Figure	  2.5D.	  	  Antibodies	  used	  in	  this	  study	  include:	  α-­‐FLAG	  (M2,	  Sigma);	  α-­‐HA	  (12CA5,	  Roche).	  	  	  
32P	  Labelling	  for	  Analysis	  of	  Protein	  Phosphorylation	  in	  Yeast	  To	  measure	  32P	  incorporation	  into	  Art1,	  5	  ODs	  of	  yeast	  cells	  expressing	  Art1	  fused	  to	  a	  C-­‐terminal	  3xFLAG-­‐6XHis	  tandem	  tag	  were	  labelled	  with	  0.8	  mCi	  of	  32P-­‐Na	  orthophosphate	  (Perkin	  Elmer)	  for	  two	  hours	  at	  26˚C.	  	  Cells	  were	  then	  subject	  to	  treatment	  for	  10	  minutes	  with	  cycloheximide	  (50	  μg/mL)	  or	  mock	  treatment,	  followed	  by	  precipitation	  of	  the	  cells	  in	  10%	  trichloracetic	  acid	  (TCA).	  	  TCA	  pellets	  were	  then	  solubilised	  in	  cracking	  buffer	  (8M	  urea	  +	  1%	  SDS	  in	  50mM	  Tris)	  and	  diluted	  in	  lysis	  buffer	  (1X	  PBS	  +	  1%	  Triton	  X-­‐100	  +	  protease	  inhibitors	  +	  phosphatase	  inhibitors)	  and	  bound	  to	  M2	  affinity	  gel.	  	  After	  washing	  the	  beads,	  the	  sample	  was	  eluted	  with	  3x-­‐FLAG	  peptide	  (150	  ng/μL)	  in	  phosphate	  buffer	  (50mM	  Na-­‐phosphate,	  pH	  8.0,	  300mM	  NaCl,	  0.1%	  Tween-­‐20).	  	  The	  sample	  was	  further	  purified	  by	  binding	  to	  TALON	  Dynabeads	  (Invitrogen),	  washing	  with	  phosphate	  buffer,	  and	  eluting	  with	  150	  mM	  imidazole	  in	  phosphate	  buffer.	  	  This	  sample	  was	  then	  resolved	  by	  SDS-­‐PAGE	  and	  analysed	  by	  Western	  Blot	  and	  by	  Phosphorimager	  (Molecular	  Dynamics).	  	  32P	  incorporation	  was	  imaged	  using	  a	  Typhoon	  scanner	  and	  quantified	  using	  Image	  J	  software.	  	  	  	  	  	  	  	  
Affinity	  Purification	  of	  Yeast	  Proteins	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For	  purification	  of	  affinity-­‐tagged	  yeast	  proteins,	  yeast	  cells	  were	  grown	  to	  mid-­‐log	  phase,	  pelleted,	  washed	  with	  TE	  and	  then	  frozen	  as	  a	  dry	  pellet.	  	  Cell	  lysates	  were	  prepared	  by	  bead-­‐beating	  for	  30	  minutes	  in	  lysis	  buffer	  (50mM	  Tris,	  0.2%	  NP-­‐40,	  0.4%	  Triton	  X-­‐100,	  150mM	  NaCl,	  5mM	  EDTA,	  2X	  Complete	  EDTA-­‐Free	  protease	  inhibitor	  tablets	  (Roche),	  1X	  PhosStop	  (Roche),	  pH7.5).	  	  M2	  flag	  beads	  (Sigma)	  were	  added	  to	  cleared	  yeast	  lysates	  and	  rotated	  for	  1	  hour	  at	  4⁰	  C.	  	  Beads	  were	  washed	  three	  times	  in	  lysis	  buffer,	  then	  eluted	  in	  elution	  buffer	  (100mM	  Tris	  pH8.0,	  1%	  SDS)	  at	  95⁰	  C	  for	  5	  minutes.	  	  Eluates	  were	  reduced	  by	  addition	  of	  10mM	  DTT	  and	  then	  alkylated	  by	  addition	  of	  iodoacetimide	  (20mM).	  	  For	  SILAC	  experiments,	  heavy	  and	  light	  samples	  were	  mixed,	  precipitated	  by	  adding	  (3:1)	  50%	  acetone,	  49.9%	  ethanol,	  and	  0.1%	  acetic	  acid,	  resuspended	  (8M	  urea,	  50mM	  Tris	  pH8.0),	  diluted	  3:1	  with	  water	  and	  digested	  with	  1µg	  of	  trypsin	  overnight.	  For	  purification	  of	  yeast	  Npr1	  for	  in	  vitro	  kinase	  assays,	  GST-­‐tagged	  Npr1	  (wildtype	  or	  kinase	  dead)	  driven	  by	  the	  ADH1	  promoter	  (pJAM608	  and	  pJAM609)	  was	  transformed	  into	  ∆npr1	  cells	  (JMY527).	  	  300mLs	  cultures	  were	  grown	  to	  mid-­‐log	  phase	  (OD600=0.7)	  and	  treated	  with	  rapamycin	  for	  15	  minutes	  prior	  to	  harvest.	  	  Cells	  were	  washed	  in	  TE	  (10mM	  Tris	  pH7.5	  and	  0.5mM	  EDTA)	  and	  lysed	  by	  bead-­‐beating	  in	  lysis	  buffer	  (50mM	  Tris	  pH7.5,	  0.1%	  Triton	  X-­‐100,	  100mM	  NaCl,	  1mM	  EDTA,	  0.1%	  βME,	  2XComplete	  EDTA-­‐Free	  Protease	  Inhibitor	  tablets	  (Roche)).	  	  Glutathione	  Sepharose	  beads	  (GE	  Healthcare)	  were	  added	  to	  cleared	  yeast	  lysates	  and	  rotated	  for	  1	  hour	  at	  4	  °C.	  	  Beads	  were	  washed	  in	  wash	  buffer	  (50mM	  Tris	  pH7.5,	  1%	  Triton	  X-­‐100,	  750mM	  NaCl,	  1mM	  EDTA,	  0.1%	  βME),	  then	  eluted	  in	  elution	  buffer	  (50mM	  Tris	  pH7.5,	  1%	  Triton	  X-­‐100,	  750mM	  NaCl,	  1mM	  EDTA,	  0.1%	  βME,	  10mM	  reduced	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L-­‐glutathione	  (Sigma-­‐Aldrich)).	  	  Eluted	  GST-­‐Npr1	  was	  dialyzed	  in	  dialysis	  buffer	  (50mM	  Tris	  pH7.5,	  20mM	  MgCl2,	  1mM	  DTT)	  at	  4	  °C,	  overnight.	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RESULTS	  
TORC1	  Regulates	  Endocytosis	  of	  Amino	  Acid	  Transporters	  Previously	  we	  demonstrated	  that	  treatment	  of	  yeast	  cells	  with	  cycloheximide	  triggers	  the	  endocytosis	  and	  vacuolar	  trafficking	  of	  various	  plasma	  membrane	  proteins	  (Lin	  et	  al.,	  2008).	  	  We	  hypothesized	  that	  this	  might	  be	  part	  of	  a	  global	  cellular	  response	  to	  changes	  in	  nutrient	  availability,	  especially	  considering	  that	  cycloheximide	  has	  been	  shown	  to	  hyperactivate	  TORC1	  signaling	  (Binda	  et	  al.,	  2009).	  	  We	  decided	  to	  test	  whether	  TORC1	  signaling	  regulates	  the	  endocytosis,	  trafficking,	  or	  activity	  of	  cell	  surface	  proteins.	  	  First,	  we	  took	  advantage	  of	  the	  toxic	  arginine	  analog	  canavanine,	  which	  enters	  the	  cell	  through	  the	  arginine	  transporter	  Can1.	  	  Thus,	  sensitivity	  to	  canavanine	  is	  a	  function	  of	  the	  PM	  localization	  and	  activity	  of	  Can1.	  	  Previously,	  we	  used	  canavanine	  sensitivity	  to	  identify	  mutant	  strains	  defective	  for	  Can1	  endocytosis	  (Lin	  et	  al.,	  2008).	  	  We	  observed	  that	  cells	  deleted	  for	  
TCO89,	  a	  subunit	  of	  the	  yeast	  TORC1	  signaling	  complex,	  exhibited	  canavanine	  hypersensitivity	  (Figure	  2.1A)	  consistent	  with	  a	  potential	  defect	  in	  endocytosis.	  	  In	  contrast,	  mutants	  defective	  for	  TORC2,	  a	  related	  but	  distinct	  signaling	  complex	  that	  controls	  cell	  growth,	  survival	  and	  polarization,	  did	  not	  exhibit	  canavanine	  hypersensitivity	  (Figure	  1A).	  	  These	  results	  suggested	  that	  TORC1	  signaling	  may	  play	  a	  role	  in	  the	  endocytosis	  or	  the	  activity	  of	  Can1	  at	  the	  cell	  surface.	  	  	   To	  determine	  if	  TORC1	  signaling	  is	  required	  for	  cycloheximide-­‐triggered	  endocytosis,	  we	  examined	  Can1-­‐GFP	  vacuolar	  trafficking	  in	  wildtype	  yeast	  cells	  treated	  with	  either	  cycloheximide	  or	  cycloheximide	  and	  rapamycin,	  a	  potent	  TORC1	  inhibitor.	  	  Interestingly,	  rapamycin	  inhibited	  the	  endocytosis	  and	  vacuolar	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Figure	  2.1.	  TORC1	  regulates	  the	  endocytosis	  of	  amino	  acid	  transporters.	  	  (A)	  Wildtype	  (background	  BY4741),	  TORC1,	  and	  TORC2	  deficient	  yeast	  cells	  from	  the	  yeast	  deletion	  strain	  collection	  were	  scored	  for	  growth	  in	  the	  presence	  of	  canavanine.	  	  (B)	  Fluorescence	  distribution	  of	  Can1-­‐GFP	  (green)	  was	  analyzed	  in	  wildtype	  yeast	  cells	  expressing	  the	  vacuolar	  marker	  Vph1-­‐mCherry	  (red).	  	  Cells	  were	  either	  mock-­‐treated	  (“unstimulated”)	  or	  treated	  with	  cycloheximide	  (“CHX”)	  or	  cycloheximide	  and	  rapamycin	  (“CHX+RAP”)	  for	  4	  hours.	  	  Plasma	  membrane	  (“PM”)	  and	  vacuole	  (“vac”)	  localization	  are	  indicated.	  	  (C)	  The	  uptake	  of	  [3H]arginine	  was	  measured	  in	  cells	  that	  were	  mock	  treated	  (blue),	  cycloheximide	  treated	  (red),	  or	  treated	  with	  cycloheximide	  and	  rapamycin	  (green).	  	  Error	  bars	  indicate	  standard	  deviation	  calculated	  from	  three	  replicate	  experiments.	  	  (D)	  Fluorescence	  distribution	  of	  Fur4-­‐GFP	  (green)	  was	  analyzed	  in	  wildtype	  yeast	  cells	  expressing	  the	  vacuolar	  marker	  Vph1-­‐mCherry	  (red).	  	  The	  affect	  of	  the	  following	  treatments	  were	  analyzed:	  mock-­‐treated	  (“unstimulated”),	  cycloheximide-­‐treated	  (“CHX”),	  cycloheximide-­‐	  and	  rapamycin-­‐treated	  (“CHX+RAP”),	  uracil-­‐treated	  (“URA”),	  uracil-­‐	  and	  rapamycin-­‐treated	  (“URA+RAP”).	  	  All	  cells	  were	  imaged	  after	  60	  minutes	  of	  treatment.	  	  (E)	  Fluorescence	  distribution	  of	  Mup1-­‐GFP	  (green)	  was	  analyzed	  in	  wildtype	  yeast	  cells	  expressing	  the	  vacuolar	  marker	  Vph1-­‐mCherry	  (red).	  	  Cells	  were	  either	  mock-­‐treated	  (“unstimulated”)	  or	  treated	  with	  cycloheximide	  for	  4	  hours	  (“CHX”),	  cycloheximide	  and	  rapamycin	  (“CHX+RAP”)	  for	  4	  hours,	  methionine	  for	  60	  minutes,	  or	  methionine	  and	  rapamycin	  for	  60	  minutes.	  	  (D)	  TORC1-­‐regulated	  endocytosis	  may	  be	  mediated	  via	  the	  regulation	  of	  ART-­‐Rsp5	  ubiquitin	  ligase	  complexes.	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  trafficking	  of	  Can1-­‐GFP	  in	  cycloheximide-­‐treated	  cells	  (Figure	  2.1B),	  suggesting	  a	  role	  for	  TORC1	  in	  the	  endocytosis	  of	  Can1.	  	  Consistent	  with	  these	  results,	  we	  found	  that	  treatment	  of	  yeast	  cells	  with	  cycloheximide	  dramatically	  reduced	  arginine	  uptake,	  while	  simultaneous	  treatment	  with	  rapamycin	  abrogated	  this	  affect	  (Figure	  2.1C).	  	  These	  results	  demonstrate	  that	  TORC1	  signaling	  promotes	  the	  endocytic	  downregulation	  of	  the	  arginine	  transporter	  Can1.	  	   Since	  many	  PM	  proteins	  undergo	  endocytosis	  and	  vacuolar	  trafficking	  in	  response	  to	  cycloheximide	  treatment,	  we	  tested	  additional	  cargo	  proteins	  and	  found	  that	  the	  cycloheximide-­‐triggered	  endocytosis	  of	  the	  uracil	  transporter	  Fur4	  and	  the	  methionine	  transporter	  Mup1	  was	  abrogated	  in	  the	  presence	  of	  rapamycin	  (Figure	  2.1D	  and	  2.1E,	  respectively).	  	  Interestingly,	  rapamycin	  treatment	  did	  not	  affect	  the	  uracil-­‐induced	  endocytosis	  of	  Fur4	  (Figure	  2.1D)	  or	  the	  methionine-­‐induced	  endocytosis	  of	  Mup1	  (Figure	  2.1E),	  indicating	  that	  TORC1	  signaling	  is	  not	  required	  for	  substrate-­‐triggered	  endocytosis.	  	  Instead,	  these	  results	  suggest	  that	  TORC1	  signaling	  promotes	  the	  endocytosis	  of	  multiple	  cell	  surface	  proteins	  as	  a	  general	  mechanism	  to	  limit	  protein	  abundance	  at	  the	  PM.	  	  Given	  our	  previous	  findings	  that	  cycloheximide-­‐induced	  endocytosis	  of	  Can1	  depends	  on	  the	  arrestin-­‐like	  adaptor	  protein	  Art1	  (Lin	  et	  al.,	  2008),	  which	  targets	  the	  Rsp5	  ubiquitin	  ligase	  to	  specific	  cargoes	  at	  the	  PM,	  we	  hypothesized	  that	  TORC1	  control	  of	  ubiquitin-­‐mediated	  endocytosis	  may	  occur	  via	  regulation	  of	  Art1	  function	  (Figure	  2.1F).	  	  	  We	  set	  out	  to	  elucidate	  the	  molecular	  mechanisms	  that	  govern	  TORC1-­‐mediated	  endocytosis.	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   To	  determine	  how	  TORC1	  regulates	  endocytosis,	  we	  scored	  the	  canavanine	  growth	  phenotypes	  of	  yeast	  deletion	  strains	  lacking	  different	  candidate	  effector	  kinases	  downstream	  of	  TORC1.	  	  We	  hypothesized	  that	  yeast	  cells	  deleted	  for	  TORC1-­‐activated	  effector	  pathways	  that	  mediate	  Can1	  endocytosis	  would	  exhibit	  hypersensitivity	  to	  canavanine.	  	  Although	  we	  did	  not	  observe	  any	  significant	  canavanine	  hypersensitive	  phenotypes	  among	  these	  deletion	  strains	  (Figure	  2.2A,	  middle	  panel),	  we	  did	  observe	  a	  striking	  canavanine	  resistance	  phenotype	  in	  ∆npr1	  cells	  (Figure	  2.2A,	  right	  panel).	  	  Npr1	  is	  a	  protein	  kinase	  known	  to	  be	  phosphorylated	  and	  inhibited	  in	  a	  TORC1-­‐dependent	  manner	  by	  a	  mechanism	  that	  likely	  involves	  both	  direct	  phosphorylation	  (Breitkreutz	  et	  al.,	  2010)	  and	  indirect	  control	  by	  regulation	  of	  a	  phosphatase	  that	  dephosphorylates	  and	  activates	  Npr1	  (Figure	  2.2B)	  (Bonenfant	  et	  al.,	  2003).	  	  We	  found	  that	  complementation	  of	  the	  canavanine	  resistance	  phenotype	  of	  ∆npr1	  cells	  required	  the	  Npr1	  kinase	  activity	  (Figure	  2.2C),	  suggesting	  that	  the	  Npr1	  kinase	  negatively	  regulates	  Can1	  endocytosis.	  	  We	  also	  observed	  that	  the	  canavanine	  resistance	  phenotype	  in	  ∆npr1	  cells	  required	  intact	  endocytic	  machinery	  (Figure	  2.2D),	  suggesting	  that	  this	  phenotype	  is	  linked	  to	  endocytosis	  and	  not	  a	  Golgi-­‐to-­‐endosome	  shunt.	  	  To	  explore	  this	  further,	  we	  examined	  the	  steady	  state	  localization	  of	  Can1-­‐GFP	  in	  wildtype	  and	  
∆npr1	  cells	  and	  found	  that	  deletion	  of	  the	  Npr1	  kinase	  resulted	  in	  constitutive	  endocytosis	  and	  vacuolar	  trafficking	  of	  Can1-­‐GFP	  (Figure	  2.2E).	  	  Additional	  analysis	  revealed	  a	  similar	  role	  for	  Npr1	  in	  the	  negative	  regulation	  of	  Fur4	  and	  Lyp1	  endocytosis	  (Figures	  2.2F	  and	  2.2G),	  while	  Mup1-­‐GFP	  was	  unaffected	  in	  ∆npr1	  cells	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Figure	  2.2.	  	  The	  TORC1	  effector	  Npr1	  negatively	  regulates	  endocytosis	  	  (A)	  Wildtype	  (background	  BY4741)	  yeast	  cells	  and	  yeast	  cells	  defective	  for	  effector	  pathways	  downstream	  of	  TORC1	  were	  scored	  for	  growth	  in	  the	  presence	  of	  canavanine.	  	  (B)	  Model	  for	  TORC1-­‐mediated	  phosphoregulation	  of	  Npr1,	  based	  on	  previous	  studies	  (Breitkreutz	  et	  al.,	  2010;	  Gander	  et	  al.,	  2008;	  Jacinto	  et	  al.,	  2001).	  	  (C)	  Complementation	  of	  the	  canavanine	  resistance	  phenotype	  exhibited	  by	  Δnpr1	  yeast	  cells	  was	  tested	  using	  vectors	  expressing	  NPR1	  alleles	  under	  the	  control	  of	  its	  native	  promoter.	  	  Tested	  alleles	  included	  wildtype	  (WT)	  NPR1,	  a	  kinase	  activation	  loop	  mutant	  (npr1-­‐G581W),	  a	  catalytic	  site	  mutant	  (npr1-­‐D561A),	  and	  an	  ATP-­‐binding	  pocket	  mutant	  (npr1-­‐K467R).	  	  (D)	  Genetic	  interaction	  analysis	  of	  NPR1	  with	  RVS167	  (yeast	  homolog	  of	  amphiphysin),	  a	  protein	  required	  for	  efficient	  endocytosis.	  	  (E)	  Fluorescence	  microscopy	  analysis	  of	  Can1-­‐GFP	  (green)	  in	  unstimulated	  wildtype	  and	  Δnpr1	  yeast	  cells.	  	  	  Vph1-­‐mCherry	  (red)	  was	  used	  to	  label	  vacuoles.	  	  Plasma	  membrane	  (PM)	  and	  vacuole	  (Vac)	  are	  indicated.	  	  Quantitative	  analysis	  of	  Fur4-­‐GFP	  and	  Lyp1-­‐GFP	  (F)	  distribution	  in	  yeast	  cells.	  	  Fluorescence	  intensity	  of	  PM	  and	  vacuole	  was	  averaged	  over	  a	  population	  of	  cells	  (n>50)	  for	  each	  genotype.	  	  (G)	  Wildtype	  and	  Δnpr1	  yeast	  cells	  (BY4741)	  were	  grown	  in	  the	  absence	  or	  presence	  of	  thialysine,	  a	  toxic	  analog	  of	  lysine,	  to	  assess	  Lyp1	  activity	  at	  the	  cell	  surface.	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(Figure	  2.3A).	  	  Npr1-­‐related	  kinases	  such	  as	  Hrk1	  (26.4%	  identical)	  and	  Prr2	  (34.5%	  identical)	  do	  not	  exhibit	  growth	  phenotypes	  in	  the	  presence	  of	  canavanine	  (Figure	  2.3B),	  highlighting	  the	  specialized	  role	  of	  Npr1	  as	  a	  negative	  regulator	  of	  endocytosis.	  	   To	  confirm	  the	  relationship	  between	  Npr1	  and	  TORC1	  kinases,	  we	  analyzed	  the	  canavanine	  growth	  phenotype	  of	  ∆tco89∆npr1	  double	  mutant	  cells	  and	  determined	  that	  they	  exhibited	  a	  canavanine	  resistance	  similar	  to	  ∆npr1	  cells	  (Figure	  2.3C).	  	  The	  observation	  that	  canavanine	  hypersensitivity	  of	  ∆tco89	  cells	  is	  dependent	  on	  the	  presence	  of	  Npr1	  indicates	  that	  TORC1	  controls	  endocytosis	  via	  negative	  regulation	  of	  the	  Npr1	  kinase.	  	  To	  confirm	  that	  Npr1	  activity	  negatively	  regulates	  endocytosis,	  we	  analyzed	  the	  affect	  of	  titrating	  Npr1	  expression	  in	  wildtype	  yeast	  cells.	  	  We	  found	  that	  increased	  expression	  of	  the	  Npr1	  kinase	  translated	  to	  a	  corresponding	  increase	  in	  canavanine	  sensitivity	  (Figure	  2.3D),	  demonstrating	  that	  increased	  levels	  of	  Npr1	  protein	  result	  in	  hyper-­‐stabilization	  of	  Can1	  at	  the	  plasma	  membrane.	  
Npr1	  Regulates	  Art1	  Activity	  Via	  Phosphoinhibition	  	   To	  decipher	  the	  mechanism	  by	  which	  Npr1	  negatively	  regulates	  endocytosis,	  we	  used	  stable	  isotope	  labeling	  of	  amino	  acids	  in	  culture	  (SILAC)	  followed	  by	  phosphopeptide	  enrichment	  and	  quantitative	  mass	  spectrometry	  analysis	  to	  identify	  candidate	  substrates	  of	  the	  Npr1	  kinase	  in	  an	  unbiased	  fashion.	  	  Since	  rapamycin	  is	  known	  to	  stimulate	  Npr1	  kinase	  activity	  via	  inhibition	  of	  TORC1	  (Gander	  et	  al.,	  2008),	  we	  compared	  the	  phosphoproteome	  of	  wildtype	  yeast	  cells	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Figure	  2.3.	  	  Npr1	  kinase	  negatively	  regulates	  endocytosis	  	  (A)	  Quantitative	  analysis	  of	  Mup1-­‐GFP	  distribution	  in	  yeast	  cells.	  	  Fluorescence	  intensity	  of	  PM	  and	  vacuole	  was	  averaged	  over	  a	  population	  of	  cells	  (n>50)	  for	  each	  genotype.	  	  	  (B)	  Wildtype,	  Δnpr1,	  Δhrk1,	  and	  Δprr2	  yeast	  cells	  (SEY6210)	  were	  analyzed	  for	  their	  ability	  to	  grow	  in	  the	  presence	  of	  canavanine.	  	  (C)	  Growth	  of	  wildtype	  (BY4741),	  Δnpr1,	  Δtco89,	  and	  Δnpr1Δtco89	  yeast	  cells	  in	  the	  presence	  of	  canavanine	  was	  compared.	  	  (D)	  Expression	  of	  wildtype	  Npr1	  was	  titrated	  using	  the	  following	  series	  of	  promoters:	  	  pNpr1	  (endogenous),	  pCPY,	  pADH,	  and	  pTDH3.	  	  The	  affects	  of	  Npr1	  titration	  on	  Can1	  trafficking	  were	  determined	  by	  assaying	  growth	  in	  the	  presence	  of	  canavanine.	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treated	  with	  rapamycin	  to	  that	  of	  ∆npr1	  cells	  treated	  with	  rapamycin	  in	  order	  to	  identify	  modifications	  that	  are	  dependent	  on	  Npr1	  kinase	  activity	  (Table	  1).	  	  Using	  this	  approach	  we	  identified	  several	  candidate	  Npr1	  substrates,	  including	  several	  proteins	  with	  established	  roles	  in	  membrane	  traffic	  and	  nutrient	  transport.	  	  One	  of	  the	  candidates	  identified	  by	  this	  approach	  was	  Art1,	  which	  is	  required	  for	  cycloheximide-­‐induced	  ubiquitination	  and	  endocytosis	  of	  Can1	  (Figure	  2.1F)(Lin	  et	  al.,	  2008).	  	  The	  identification	  of	  Art1	  as	  a	  candidate	  substrate	  of	  Npr1	  suggested	  that	  Npr1	  may	  negatively	  regulate	  endocytosis	  via	  phosphoregulation	  of	  Art1.	  	  Genetic	  interaction	  analysis	  revealed	  that	  the	  canavanine	  resistance	  phenotype	  of	  ∆npr1	  cells	  is	  dependent	  upon	  the	  presence	  of	  Art1	  (Figure	  2.4A),	  suggesting	  that	  Npr1	  negatively	  regulates	  endocytosis	  via	  inhibition	  of	  Art1.	  	  Furthermore,	  the	  constitutive	  endocytosis	  and	  vacuolar	  trafficking	  of	  Can1-­‐GFP	  observed	  in	  ∆npr1	  cells	  was	  suppressed	  in	  ∆npr1∆art1	  double	  mutant	  cells	  (Figure	  2.4B	  and	  2.4C),	  indicating	  that	  the	  aberrant	  endocytosis	  of	  Can1-­‐GFP	  observed	  in	  ∆npr1	  cells	  is	  mediated	  by	  Art1.	  	  	  	   Based	  on	  these	  results,	  we	  hypothesized	  that	  the	  TORC1-­‐Npr1	  negative	  kinase	  signaling	  cascade	  regulates	  Art1	  activation	  by	  phosphoinhibition	  (Figure	  2.4D).	  	  A	  key	  prediction	  of	  this	  hypothesis	  is	  that	  loss	  of	  Npr1	  kinase	  activity	  would	  alter	  the	  phospho-­‐status	  of	  the	  Art1	  protein.	  	  Consistent	  with	  this	  hypothesis,	  we	  found	  that	  Art1	  recovered	  from	  ∆npr1	  cells	  exhibited	  a	  >50%	  decrease	  in	  the	  amount	  of	  phosphate	  incorporation	  relative	  to	  wildtype	  cells	  (Figure	  2.4E).	  	  Furthermore,	  we	  found	  that	  the	  Art1	  protein	  recovered	  from	  wildtype	  cells	  exists	  in	  two	  distinct	  forms,	  resolved	  as	  a	  doublet	  by	  SDS-­‐PAGE	  (Figure	  2.4F,	  lane	  1).	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Table	  1:	  	  The	  Npr1	  phosphoproteome	  reveals	  Art1	  as	  a	  downstream	  effector	  	  
Category	   Protein	   Description	   Xpress	  
Ratios	  Control	   Npr1	   Protein	  Kinase	   107	  
Trafficking	   Art1	   Rsp5	  ubiquitin	  ligase	  adaptor	   27,	  11	  SEC7	   Arf	  GEF	   27,	  24	  TRS120	   TRAPP	  complex	  component	   121,	  60	  LSP1	   Eisosome	  component	   79	  Integral	  membrane	  proteins	  and	  transporters	  
VCX1	   ion	  antiporter	   117,	  46,	  17	  AGP1	   amino	  acid	  transporter	   98	  ITR1	   inositol	  transporter	   10	  GNP1	   amino	  acid	  transporter	   21,	  10	  Actin	  and	  polarization	   RHO1	   GTPase	   215	  BEM3	   RhoGAP	   12	  Lipid	  synthesis	  and	  binding	   NUS1	   prenyltransferase	   10	  PIB2	   PI3P	  binding	  protein	   36	  ORM1	   lipid	  homeostasis	   39,	  28,	  12	  Metabolic	  enzymes	   IPP1	   pyrophosphatase	   88	  Mito.	  import	   TOM22	   mitochondrial	  protein	  import	   27	  Function	  unknown	   YLR257W	   function	  unknown	   62,	  46,	  32,	  12	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Table	  1.	  	  The	  Npr1	  phosphoproteome	  reveals	  Art1	  as	  a	  downstream	  effector.	  	  Wildtype	  cells	  (labeled	  with	  heavy	  isotopes)	  and	  Δnpr1	  cells	  (labeled	  with	  light	  isotopes)	  were	  treated	  with	  rapamycin	  for	  15	  minutes	  and	  the	  phosphoproteome	  of	  each	  was	  quantitatively	  assessed	  using	  SILAC.	  	  A	  total	  of	  3652	  phosphopeptides	  were	  identified	  in	  this	  experiment.	  	  Xpress	  ratio	  indicates	  the	  fold	  enrichment	  in	  wildtype	  cells	  compared	  to	  Δnpr1	  cells.	  	  This	  table	  shows	  proteins	  containing	  phosphopeptides	  that	  exhibited	  at	  least	  a	  10-­‐fold	  increase	  in	  wildtype	  cells	  relative	  to	  Δnpr1	  cells.	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Figure	  2.4.	  	  Npr1	  regulates	  Art1	  activity	  via	  phosphoinhibition	  	  (A)	  Canavanine	  sensitivity/resistance	  phenotypes	  were	  determined	  for	  wildtype	  (WT),	  Δart1,	  Δnpr1,	  Δart1Δnpr1	  cells.	  	  (B)	  Fluorescence	  microscopy	  analysis	  of	  Can1-­‐GFP	  (green)	  in	  unstimulated	  Δart1Δnpr1	  yeast	  cells.	  	  Vph1-­‐mCherry	  (red)	  was	  used	  to	  label	  vacuoles.	  	  (C)	  Quantitative	  analysis	  of	  Can1-­‐GFP	  distribution	  in	  cells	  from	  (B)	  and	  Figure	  2C.	  	  Fluorescence	  intensity	  of	  PM	  and	  vacuole	  was	  averaged	  over	  a	  population	  of	  cells	  (n>50)	  for	  each	  genotype.	  	  (D)	  Based	  on	  genetic	  interaction	  data,	  we	  devised	  a	  model	  pathway	  for	  the	  TORC1-­‐Npr1	  negative	  signaling	  cascade	  that	  results	  in	  phosphoregulation	  of	  Art1.	  	  This	  pathway	  controls	  the	  cycling	  of	  Art1	  between	  a	  phosphorylated	  inactive	  state	  and	  a	  dephosphorylated	  active	  state.	  	  (E)	  Art1	  was	  affinity	  purified	  from	  unstimulated	  wildtype	  and	  Δnpr1	  yeast	  cells	  labeled	  with	  32P.	  	  Top	  panel	  depicts	  Western	  blot	  of	  total	  Art1	  protein	  recovered,	  while	  bottom	  panel	  shows	  32P	  incorporation	  into	  Art1.	  	  Quantitation	  was	  performed	  by	  scanning	  Phosphorimager	  (bottom	  labels).	  	  (F)	  Art1	  was	  affinity	  purified	  from	  wildtype	  or	  Δnpr1	  yeast	  cells	  and	  subject	  to	  phosphatase	  treatment	  or	  mock	  treatment.	  	  Affinity	  purified	  Art1	  from	  wildtype	  cells	  can	  be	  resolved	  as	  two	  distinct	  bands,	  indicated	  by	  red	  arrows	  on	  the	  right.	  	  (G)	  Western	  blot	  analysis	  of	  Npr1	  expression	  levels	  (top	  panel)	  and	  Art1	  phosphorylation	  patterns	  (bottom	  panel).	  	  Red	  asterisk	  indicates	  a	  non-­‐specific	  band.	  	  (H)	  Expression	  of	  wildtype	  Npr1	  was	  titrated.	  	  Npr1	  expression	  (top	  panel)	  and	  Art1	  phosphorylation	  patterns	  (bottom	  panel)	  were	  analyzed	  by	  Western	  blot.	  	  	  (I)	  In	  a	  yeast	  strain	  overexpressing	  Npr1	  from	  the	  ADH1	  promoter,	  Art1	  expression	  was	  titrated	  up.	  	  The	  resulting	  yeast	  cells	  were	  analyzed	  for	  the	  ability	  to	  grow	  in	  the	  presence	  of	  canavanine.	  	  (J)	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Phosphorylation	  of	  recombinant	  Art1	  was	  reconstituted	  using	  wildtype	  (WT)	  but	  not	  kinase	  dead	  (kd)	  Npr1	  purified	  from	  yeast.	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Following	  phosphatase	  treatment,	  the	  Art1	  doublet	  collapses	  to	  a	  single	  band	  (Figure	  2.4F,	  lane	  2),	  indicating	  that	  the	  lower	  mobility	  form	  of	  Art1	  is	  phosphorylated.	  	  Interestingly,	  Art1	  protein	  recovered	  from	  ∆npr1	  cells	  did	  not	  exhibit	  the	  phospho-­‐shift	  observed	  in	  wildtype	  cells	  (Figure	  2.4F,	  lanes	  3-­‐4).	  	  Art1	  phosphorylation	  was	  complemented	  by	  expression	  of	  wildtype	  Npr1	  but	  not	  kinase-­‐dead	  mutant	  alleles	  (Figure	  2.4G).	  	  Furthermore,	  increasing	  Npr1	  expression	  led	  to	  corresponding	  increases	  in	  Art1	  phosphorylation	  (Figure	  2.4H	  and	  2.4I).	  	  Finally,	  we	  were	  able	  to	  demonstrate	  that	  Art1	  is	  a	  substrate	  for	  active	  Npr1	  kinase	  but	  not	  a	  kinase	  dead	  mutant	  in	  vitro	  (Figure	  2.4J),	  providing	  evidence	  for	  direct	  phosphorylation.	  	  In	  summary,	  these	  results	  suggest	  that	  Npr1	  negatively	  regulates	  endocytosis	  by	  phosphorylating	  Art1,	  a	  ubiquitin	  ligase	  adaptor.	  
TORC1	  Signaling	  Tunes	  Art1	  Activity	  By	  Modulating	  Phosphoinhibition	  To	  test	  whether	  TORC1	  activity	  mediates	  Art1	  dephosphorylation,	  we	  examined	  radioactive	  phosphate	  incorporation	  into	  Art1	  under	  conditions	  of	  TORC1	  hyperactivation.	  	  We	  found	  that	  hyperactivation	  of	  TORC1	  signaling	  by	  treatment	  of	  yeast	  cells	  with	  cycloheximide	  resulted	  in	  a	  >60%	  decrease	  in	  Art1	  phosphorylation	  (Figure	  2.5A).	  	  Based	  on	  our	  data,	  we	  propose	  a	  TORC1-­‐Npr1	  negative	  kinase	  signaling	  cascade	  that	  activates	  Art1	  via	  sequential	  repression	  (Figure	  2.5B).	  	  In	  this	  model,	  inhibition	  of	  TORC1	  signaling	  (by	  starvation	  conditions	  or	  treatment	  of	  cells	  with	  rapamycin)	  triggers	  Npr1	  activation	  by	  dephosphorylation.	  	  The	  increased	  Npr1	  kinase	  activity	  leads	  to	  inhibition	  of	  Art1,	  which	  decreases	  endocytosis	  and	  stabilizes	  Can1	  at	  the	  PM	  (Figure	  2.5C	  lane	  1,	  4D	  and	  2.5D).	  	  When	  TORC1	  activity	  is	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Figure	  2.5.	  	  TORC1	  tunes	  Art1	  activity	  by	  modulating	  phosphorylation	  	  (A)	  Art1	  recovered	  from	  wildtype	  yeast	  cells	  labeled	  with	  32P	  and	  subject	  to	  cycloheximide	  stimulation	  or	  mock	  treatment.	  	  Top	  panel	  depicts	  Western	  blot	  of	  total	  Art1	  protein	  recovered,	  while	  bottom	  panel	  shows	  32P	  incorporation	  into	  Art1.	  	  Quantitation	  was	  performed	  by	  scanning	  Phosphorimager	  (bottom	  labels).	  	  (B)	  Model	  for	  TORC1	  activation	  of	  Art1-­‐mediated	  endocytosis	  of	  Can1	  by	  a	  sequential	  repression	  mechanism.	  	  (C)	  Wildtype	  yeast	  cells	  were	  treated	  with	  rapamycin	  (200ng/mL),	  cycloheximide	  (50	  μg/mL),	  or	  mock	  treated	  (DMSO)	  for	  15	  minutes	  and	  analyzed	  for	  Npr1	  phosphoshift	  (top	  panel),	  Art1	  phosphoshift	  (middle	  panel),	  and	  Can1	  abundance	  (lower	  panel).	  	  Values	  indicate	  Npr1	  Pratio	  (below	  top	  panel),	  Art1	  Pratio	  (below	  middle	  panel),	  and	  Can1	  relative	  abundance	  (below	  bottom	  panel)	  all	  normalized	  to	  the	  mock	  condition.	  	  Indicators	  of	  TORC1	  signaling	  activity	  (-­‐,	  +,	  +++)	  are	  based	  on	  previous	  reports	  that	  RAP	  inhibits	  TORC1	  signaling	  and	  CHX	  activates	  TORC1	  signaling,	  both	  relative	  to	  mock	  treatment.	  	  Quantitation	  of	  data	  is	  shown	  on	  the	  right	  panel.	  	  Quantitation	  of	  immunoblots	  using	  fluorescence	  scanning	  was	  performed	  as	  in	  (D)	  as	  illustrated.	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high	  (in	  nutrient-­‐replete	  conditions	  or	  by	  treatment	  of	  cells	  with	  cycloheximide),	  Npr1	  is	  hyperphosphorylated	  and	  its	  kinase	  activity	  is	  inhibited.	  	  This	  state	  favors	  Art1	  dephosphorylation,	  which	  leads	  to	  increased	  Can1	  endocytosis	  and	  vacuolar	  degradation	  (Figure	  2.5C	  lane	  3,	  4D	  and	  2.5D).	  	  	  During	  normal	  log	  phase	  growth	  conditions,	  TORC1	  signals	  at	  an	  intermediate	  level,	  maintaining	  both	  Art1	  and	  Npr1	  in	  a	  meta-­‐phosphorylated	  state	  (Figure	  2.5C	  lane	  2,	  4D	  and	  2.5D).	  	  This	  system	  endows	  TORC1	  with	  fine	  control	  over	  the	  endocytic	  equilibrium	  of	  Can1,	  effectively	  tuning	  nutrient	  transport	  over	  a	  wide	  range	  of	  conditions.	  	  This	  signaling	  pathway	  responds	  to	  perturbations	  in	  TORC1	  signaling	  within	  minutes	  (Figure	  2.6A,	  2.6B	  and	  unpublished	  results)	  and	  the	  response	  to	  both	  cycloheximide	  and	  rapamycin	  is	  dependent	  on	  TORC1	  but	  not	  TORC2	  (data	  not	  shown).	  	  Consistent	  with	  these	  results,	  the	  ability	  of	  cycloheximide	  to	  activate	  Art1	  by	  inhibiting	  Npr1	  is	  blocked	  by	  simultaneous	  treatment	  with	  rapamycin	  (Figure	  2.6C).	  	  We	  also	  found	  that	  regulation	  of	  Can1	  endocytosis	  by	  TORC1	  translates	  to	  corresponding	  affects	  on	  arginine	  uptake:	  	  TORC1	  signaling	  increased	  Can1	  endocytosis	  and	  thus	  blocked	  arginine	  uptake,	  while	  TORC1	  inhibition	  stabilized	  Can1	  at	  the	  PM	  and	  thus	  increased	  the	  rate	  of	  arginine	  uptake	  (Figure	  2.6D).	  	  These	  data	  support	  a	  model	  whereby	  TORC1	  regulates	  endocytosis	  via	  a	  negative	  kinase	  cascade	  that	  tunes	  Art1	  activity	  by	  phosphoinhibition.	  To	  further	  explore	  the	  basis	  for	  TORC1	  regulation	  of	  endocytosis,	  we	  examined	  Art1	  phosphorylation	  across	  a	  variety	  of	  media	  conditions	  and	  cellular	  stresses.	  	  Similar	  to	  our	  results	  with	  rapamycin	  treatment,	  we	  found	  that	  shifting	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Figure	  2.6.	  	  Nutrient	  availability	  regulates	  Art1	  activity	  by	  modulating	  phosphorylation	  	  (A)	  Timecourse	  analysis	  of	  the	  TORC1-­‐Npr1	  signaling	  response	  was	  quantified	  (B)	  using	  fluorescence	  scanning.	  	  (C)	  The	  signaling	  response	  from	  (Figure	  2.5C)	  was	  analyzed	  in	  response	  to	  either	  co-­‐treatment	  with	  or	  different	  orders	  of	  addition	  of	  cycloheximide	  and	  rapamycin.	  	  (D)	  Wildtype	  yeast	  cells	  were	  treated	  with	  either	  cycloheximide	  or	  rapamycin	  for	  15	  minutes	  and	  uptake	  of	  radioactive	  arginine	  was	  measured	  at	  the	  indicated	  timepoints.	  	  (E)	  The	  phospho-­‐status	  of	  Art1	  was	  analyzed	  in	  response	  to	  changes	  nutrient	  availability,	  including	  a	  shift	  from	  minimal	  media	  to	  YPD	  for	  2	  hours	  (nutrient	  surplus)	  or	  a	  shift	  from	  minimal	  media	  to	  PBS	  for	  12	  hours	  (starvation).	  	  (F)	  Quantitation	  of	  the	  Art1	  phosphorylation	  ratio	  (Pratio)	  for	  the	  results	  in	  (E)	  along	  with	  additional	  treatments	  including	  200	  µg/mL	  Hygromycin	  B	  for	  15	  minutes	  (HmB),	  heat	  shock	  at	  37⁰	  for	  30	  minutes	  (HS),	  0.4M	  NaCl	  for	  30	  minutes	  (Salt),	  or	  4	  µg/mL	  tunicamycin	  for	  15	  minutes	  (TM).	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from	  minimal	  media	  to	  PBS,	  a	  physiological	  starvation	  condition,	  triggered	  Art1	  hyperphosphorylation	  (Figure	  2.6E	  lane	  3).	  	  In	  contrast,	  shifting	  yeast	  cells	  from	  minimal	  media	  to	  nutrient	  rich	  YPD	  triggered	  Art1	  dephosphorylation	  (Figure	  2.6E	  lane	  2).	  	  Interestingly,	  Art1	  phospho-­‐status	  was	  not	  sensitive	  to	  other	  cellular	  stresses	  tested	  (Figure	  2.6F).	  	  In	  summary,	  our	  results	  indicate	  that	  TORC1	  senses	  nutrient	  availability	  and	  responds	  by	  regulating	  endocytosis	  in	  order	  to	  tune	  the	  activity	  of	  amino	  acid	  transporters	  at	  the	  cell	  surface.	  
Inhibition	  of	  Art1	  Is	  Mediated	  By	  N-­‐terminal	  Phosphorylation	  To	  better	  understand	  the	  mechanism	  of	  Art1	  phosphoinhibition,	  we	  employed	  quantitative	  mass	  spectrometry	  methodologies	  to	  map	  specific	  phosphosites	  in	  Art1	  that	  are	  dependent	  on	  the	  TORC1-­‐Npr1	  negative	  kinase	  signaling	  cascade.	  	  First,	  we	  trypsin	  digested	  affinity	  purified	  Art1	  from	  wildtype	  cells,	  enriched	  for	  phosphopeptides	  using	  immobilized	  metal	  affinity	  chromatography	  (IMAC),	  and	  analyzed	  samples	  using	  LC-­‐MS/MS.	  	  This	  analysis	  revealed	  many	  phosphorylated	  residues	  in	  Art1,	  including	  an	  N-­‐terminal	  phosphocluster	  (between	  amino	  acids	  79	  and	  124),	  a	  series	  of	  mostly	  proline-­‐directed	  phosphosites	  at	  the	  C-­‐terminus	  of	  Art1	  (from	  amino	  acids	  599	  to	  722),	  and	  a	  few	  phosphosites	  in	  the	  arrestin	  fold	  domain	  (Figure	  2.7A).	  	  Next,	  we	  used	  SILAC	  to	  determine	  which	  sites	  were	  dependent	  on	  Npr1	  activity	  (Figure	  2.7B).	  	  We	  found	  that	  both	  the	  N-­‐terminal	  phosphocluster	  and	  the	  proline-­‐directed	  phosphocluster	  were	  dependent	  on	  the	  presence	  of	  Npr1	  (Figure	  2.7C).	  	  Similarly,	  both	  clusters	  increased	  significantly	  during	  rapamycin-­‐induced	  Art1	  hyperphosphorylation	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H: Art1 from rapamycin-treated WT cells

























H: Art1 from rapamycin-treated WT cells
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H: Art1 from ∆npr1 cells + pADH1-Npr1 (WT)
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Figure	  2.7.	  	  Inhibition	  of	  Art1	  is	  mediated	  by	  N-­‐terminal	  phosphorylation	  	  (A)	  Schematic	  dividing	  the	  Art1	  protein	  into	  three	  regions:	  	  an	  N-­‐terminal	  domain	  (red),	  the	  arrestin	  fold	  domain	  (blue),	  and	  a	  C-­‐terminal	  domain	  (brown).	  	  Phosphorylation	  sites	  identified	  by	  mass	  spectrometry	  analysis	  are	  indicated.	  	  (B)	  Schematic	  demonstrating	  how	  SILAC	  followed	  by	  quantitative	  mass	  spectrometry	  analysis	  is	  used	  to	  measure	  changes	  at	  specific	  Art1	  phosphosites.	  	  SILAC	  combined	  with	  quantitative	  mass	  spectrometry	  analysis	  was	  used	  to	  measure	  changes	  in	  phosphorylation	  at	  specific	  Art1	  residues	  for	  pair	  wise	  comparisons	  of	  wildtype	  (WT)	  cells	  versus	  Δnpr1	  cells	  (C),	  rapamycin-­‐treated	  WT	  cells	  versus	  mock-­‐treated	  WT	  cells	  (D),	  rapamycin-­‐treated	  WT	  cells	  versus	  rapamycin-­‐treated	  Δnpr1	  cells	  (E),	  and	  Δnpr1	  cells	  overexpressing	  WT	  Npr1	  versus	  Δnpr1	  cells	  overexpressing	  the	  kinase	  dead	  npr1-­‐K467R	  allele	  (F).	  	  For	  each	  of	  C-­‐F,	  bars	  are	  color-­‐coded	  to	  reflect	  the	  position	  of	  the	  phosphosites	  in	  the	  Art1	  protein.	  	  The	  y-­‐axis	  values	  represent	  the	  Log2	  of	  the	  Xpress	  (H:L)	  ratio,	  a	  quantitative	  measure	  of	  isotopic	  representation.	  	  Western	  blots	  showing	  phosphoshifts	  as	  resolved	  by	  SDS-­‐PAGE	  are	  shown	  in	  the	  upper	  right	  of	  each	  profiling	  experiment.	  	  Not	  all	  phosphopeptides	  were	  detected	  in	  every	  experiment,	  leading	  to	  variation	  in	  what	  can	  be	  scored	  for	  each	  condition.	  	  (G)	  Schematic	  of	  Art1	  illustrating	  N-­‐terminal	  and	  C-­‐terminal	  (proline-­‐directed)	  phosphorylation	  sites.	  	  (H)	  Npr1	  in	  vitro	  kinase	  assays	  were	  performed	  by	  using	  recombinant	  purified	  Art1	  fragments	  corresponding	  to	  the	  N-­‐terminus	  (amino	  acids	  1-­‐397)	  or	  the	  C-­‐terminus	  (amino	  acids	  398-­‐818).	  	  The	  two	  fragments	  exhibit	  the	  similar	  mobility	  by	  SDS-­‐PAGE.	  	  Consistent	  with	  these	  results,	  we	  also	  determined	  by	  mass	  spectrometry	  that	  Npr1	  phosphorylation	  of	  full	  length	  Art1	  in	  vitro	  is	  directed	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to	  the	  N-­‐terminus,	  particularly	  S79	  (data	  not	  shown).	  	  (I)	  Art1	  from	  yeast	  cell	  extracts	  was	  analyzed	  by	  SDS-­‐PAGE	  and	  Art1	  point	  mutants	  were	  scored	  as	  either	  a	  doublet	  (wildtype)	  or	  singlet.	  	  Importantly,	  these	  results	  demonstrate	  that	  the	  bandshift	  is	  the	  result	  of	  phosphorylation	  at	  a	  C-­‐terminal	  residue,	  T619,	  and	  that	  the	  mobility	  shift	  assay	  does	  not	  perfectly	  correlate	  with	  N-­‐terminal	  phosphorylation	  of	  Art1.	  	  This	  is	  consistent	  with	  our	  results	  that	  loss	  of	  Npr1	  in	  vivo	  causes	  a	  bandshift	  that	  cannot	  be	  reconstituted	  in	  vitro.	  	  T619	  is	  a	  proline-­‐directed	  phosphorylation	  site,	  and	  thus	  is	  not	  a	  substrate	  for	  Npr1	  phosphorylation	  (Gander	  et	  al.,	  2009).	  	  However,	  phosphorylation	  at	  T619	  is	  regulated	  by	  Npr1	  (Figure	  5C,	  5D,	  and	  5E).	  	  These	  results	  suggest	  that	  there	  is	  a	  second	  Art1	  kinase	  which	  targets	  that	  C-­‐terminus	  of	  Art1,	  and	  that	  these	  proline-­‐directed	  phosphorylation	  events	  are	  somehow	  dependent	  on	  Npr1	  kinase	  activity.	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  (Figure	  2.7D).	  	  Interestingly,	  when	  we	  compared	  Art1	  phosphopeptides	  from	  rapamycin-­‐treated	  wildtype	  cells	  (hyperphosphorylated)	  and	  rapamycin-­‐treated	  
Δnpr1	  cells	  (hypophosphorylated),	  we	  observed	  a	  dramatic	  30-­‐	  to	  60-­‐fold	  difference	  in	  phosphorylation	  at	  the	  N-­‐terminal	  phosphocluster	  and	  only	  modest	  (4-­‐	  to	  10-­‐fold)	  increases	  for	  the	  proline-­‐directed	  phosphocluster	  (Figure	  2.7E).	  	  Furthermore,	  we	  found	  that	  overexpression	  of	  wildtype	  Npr1	  resulted	  in	  similarly	  dramatic	  increases	  in	  phosphorylation	  at	  the	  N-­‐terminal	  sites	  compared	  to	  overexpression	  of	  a	  kinase-­‐dead	  variant	  (Figure	  2.7F).	  	  	  	  Our	  quantitative	  mass	  spectrometry	  data	  strongly	  suggests	  that	  Npr1	  promotes	  phosphorylation	  at	  the	  N-­‐terminus	  of	  Art1	  (especially	  Ser79,	  Ser82,	  Ser96	  and	  Ser99).	  	  Our	  results	  suggest	  that	  Npr1	  indirectly	  affects	  phosphorylation	  at	  C-­‐terminal	  proline-­‐directed	  sites	  in	  Art1	  as	  previous	  studies	  have	  shown	  that	  a	  +1	  proline	  is	  strongly	  disfavored	  by	  the	  Npr1	  kinase	  (Gander	  et	  al.,	  2009)	  making	  these	  sites	  unlikely	  targets	  for	  direct	  regulation	  by	  Npr1.	  	  Indeed,	  using	  the	  in	  vitro	  kinase	  assay,	  Npr1	  was	  capable	  of	  phosphorylating	  an	  N-­‐terminal	  fragment	  of	  Art1,	  but	  not	  a	  C-­‐terminal	  fragment	  that	  contains	  the	  proline-­‐directed	  phosphorylation	  sites	  (Figure	  2.7G	  and	  2.7H).	  	  Importantly,	  we	  found	  that	  the	  Art1	  bandshift	  observed	  by	  SDS-­‐PAGE	  is	  dependent	  on	  the	  C-­‐terminal	  proline-­‐directed	  phosphorylation	  events,	  indicating	  it	  is	  the	  result	  of	  both	  Npr1	  and	  yet	  another	  kinase	  (Figure	  2.7I).	  	  Although	  in	  vitro	  phosphorylation	  of	  Art1	  by	  Npr1	  did	  not	  reconstitute	  the	  bandshift	  observed	  in	  vivo	  (Figure	  2.7J),	  mass	  spectrometry	  analysis	  of	  Art1	  phosphorylated	  by	  Npr1	  in	  vitro	  identified	  the	  same	  N-­‐terminal	  phosphorylation	  pattern	  (particularly	  at	  S79,	  data	  not	  shown)	  observed	  in	  vivo.	  	  Since	  Art1	  C-­‐terminal	  proline-­‐directed	  phosphorylation	  events	  are	  in	  fact	  regulated	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by	  Npr1	  in	  vivo	  (Figure	  2.7C,	  2.7D,	  and	  2.7E),	  our	  results	  suggest	  a	  possible	  interaction	  between	  N-­‐terminal	  and	  C-­‐terminal	  phosphorylation	  events,	  and	  further	  investigation	  will	  be	  required	  to	  determine	  the	  function	  of	  proline-­‐directed	  phosphorylation	  at	  the	  C-­‐terminus	  of	  Art1.	  TORC1-­‐dependent	  phosphoregulation	  of	  other	  ART	  family	  proteins	  was	  not	  evident	  by	  SDS-­‐PAGE	  (Figure	  2.8A),	  however	  quantitative	  mass	  spectrometry	  analysis	  revealed	  that	  other	  ART	  family	  proteins,	  most	  notably	  Art2	  and	  Art3,	  may	  also	  be	  regulated	  by	  Npr1	  (Figure	  2.8B).	  	  These	  results	  suggest	  that	  TORC1	  signaling	  does	  not	  regulate	  all	  ART	  family	  proteins,	  but	  rather	  appears	  to	  specifically	  regulate	  Art1	  as	  well	  as	  perhaps	  Art2	  and	  Art3.	  	  We	  also	  performed	  similar	  quantitative	  mass	  spectrometry	  analysis	  of	  Npr1	  phosphorylation	  in	  response	  to	  changes	  in	  TORC1	  signaling.	  	  We	  identified	  numerous	  Npr1	  phosphosites	  primarily	  clustered	  at	  the	  N-­‐terminus	  of	  the	  protein	  (Figure	  2.8C).	  	  Consistent	  with	  our	  observations	  in	  Figure	  4,	  this	  N-­‐terminal	  phosphorylation	  of	  Npr1	  is	  significantly	  reduced	  when	  TORC1	  is	  inhibited	  (Figure	  2.8D)	  and	  significantly	  increased	  when	  TORC1	  is	  hyperactivated	  (Figure	  2.8E).	  	  These	  results	  are	  consistent	  with	  previously	  reported	  mass	  spectrometry	  analysis	  of	  Npr1	  phosphorylation	  (Gander	  et	  al.,	  2008).	  	  Given	  the	  large	  number	  of	  N-­‐terminal	  phosphorylation	  events	  that	  respond	  in	  this	  manner,	  we	  deleted	  the	  N-­‐terminal	  phosphocluster	  of	  Npr1	  (∆40-­‐360)	  and	  found	  that	  the	  truncated	  protein	  does	  not	  complement	  canavanine	  resistance	  or	  Art1	  phosphorylation	  (Figure	  2.8F	  and	  2.8G).	  	  These	  results	  indicate	  that	  Npr1	  undergoes	  N-­‐terminal	  phosphoinhibition	  similar	  to	  Art1,	  but	  that	  this	  N-­‐terminal	  region	  is	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H: Rsp5 (bait) from rapamycin-treated WT cells
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H: Npr1 from rapamycin-treated WT cells

















































































































































































H: Npr1 from CHX-treated WT cells
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Figure	  2.8.	  	  Phosphoregulation	  of	  ART	  family	  proteins	  and	  inhibition	  of	  Npr1	  is	  mediated	  by	  N-­‐terminal	  phosphorylation	  	  (A)	  Analysis	  of	  chromosomally	  expressed	  FLAG-­‐tagged	  ART	  family	  proteins	  by	  SDS-­‐PAGE.	  	  Expression	  of	  Art4,	  Art5,	  and	  Art9	  were	  undetectable	  by	  Western	  blot.	  	  (B)	  Phosphoprofiling	  experiment	  similar	  to	  those	  in	  Figure	  2.7C-­‐F,	  except	  Rsp5	  was	  used	  as	  the	  bait.	  	  This	  enabled	  the	  detection	  of	  phosphopeptides	  from	  many	  ART	  family	  proteins,	  which	  are	  known	  to	  interact	  with	  Rsp5.	  	  Analysis	  of	  experiments	  comparing	  mock-­‐treated	  wildtype	  cells	  to	  rapamycin-­‐treated	  wildtype	  cells,	  yielded	  similar	  results.	  	  (C)	  Schematic	  dividing	  the	  Npr1	  protein	  into	  two	  regions:	  	  an	  N-­‐terminal	  phosphocluster	  domain	  (green)	  and	  a	  C-­‐terminal	  kinase	  domain	  (blue).	  	  SILAC	  combined	  with	  quantitative	  mass	  spectrometry	  analysis	  was	  used	  to	  measure	  changes	  in	  phosphorylation	  at	  specific	  Npr1	  residues	  for	  pair	  wise	  comparisons	  of	  rapamycin-­‐treated	  WT	  cells	  versus	  mock-­‐treated	  WT	  cells	  (D)	  or	  mock-­‐treated	  WT	  cells	  versus	  cycloheximide	  -­‐treated	  WT	  cells	  (E).	  	  Bars	  are	  color-­‐coded	  to	  reflect	  the	  position	  of	  the	  phosphosites	  in	  the	  Npr1	  protein	  (as	  indicated	  in	  C).	  	  The	  y-­‐axis	  values	  represent	  the	  Log2	  of	  the	  Xpress	  (H:L)	  ratio,	  a	  quantitative	  measure	  of	  isotopic	  representation.	  	  Western	  blots	  showing	  phosphoshifts	  as	  resolved	  by	  SDS-­‐PAGE	  are	  shown	  in	  the	  upper	  right	  of	  each	  profiling	  experiment.	  	  	  (F)	  Functional	  analysis	  was	  performed	  using	  N-­‐terminal	  truncation	  of	  Npr1	  (Δ40-­‐360)	  deleted	  for	  the	  key	  phosphocluster	  observed	  in	  D	  and	  E.	  	  (G)	  The	  N-­‐terminal	  truncation	  of	  Npr1	  (Δ40-­‐360)	  was	  tested	  for	  the	  ability	  to	  complement	  Art1	  phosphorylation.	  	  Alanine	  substitution	  mutant	  alleles	  (H)	  and	  phosphomimetic	  substitution	  alleles	  (I)	  of	  Art1	  were	  analyzed	  for	  growth	  in	  the	  presence	  of	  canavanine.	  	  Labels	  correspond	  to	  the	  following	  substitution	  mutations.	  	  
 	  	   94	  
5xA:	  S79,	  82-­‐85A.	  	  7xA:	  S79,	  82-­‐85,	  92,	  93A.	  	  10xA:	  S79,	  82-­‐85,	  92,	  93,	  96,	  99,	  100A.	  	  5xD:	  S79,	  82-­‐85D.	  	  8xD:	  S79,	  82-­‐85,	  92,	  93,	  96D.	  9xD:	  S79,	  82-­‐85,	  92,	  93,	  96,	  113D.	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essential	  for	  Npr1-­‐mediated	  regulation	  of	  endocytosis.	  	  To	  address	  the	  function	  of	  the	  Art1	  N-­‐terminal	  phosphocluster,	  we	  analyzed	  the	  effect	  of	  alanine	  (phospho-­‐dead)	  or	  aspartic	  acid	  (phospho-­‐mimetic)	  substitutions	  at	  these	  residues.	  	  Interestingly,	  we	  found	  that	  no	  single	  site	  substitution	  had	  a	  significant	  effect	  on	  Art1	  function.	  	  However,	  we	  observed	  dramatic	  changes	  in	  Art1	  function	  when	  multiple	  phosphosites	  were	  mutated.	  	  For	  example,	  multiple	  alanine	  substitutions	  at	  N-­‐terminal	  phosphosites	  of	  Art1	  led	  to	  a	  striking	  canavanine	  resistance	  phenotype	  (Figure	  2.8H),	  similar	  to	  that	  observed	  with	  Δnpr1	  cells.	  	  Additionally,	  multiple	  aspartic	  acid	  substitutions	  at	  N-­‐terminal	  phosphosites	  resulted	  in	  canavanine	  hypersensitivity	  (Figure	  2.8I),	  indicating	  Art1	  is	  stuck	  in	  an	  inhibited,	  phosphomimetic	  state.	  	  These	  results	  indicate	  that	  (1)	  Npr1	  mediates	  the	  phosphorylation	  of	  a	  distinct	  cluster	  of	  residues	  at	  the	  N-­‐terminus	  of	  Art1,	  (2)	  phosphorylation	  of	  these	  N-­‐terminal	  residues	  inhibits	  Art1-­‐mediated	  Can1	  endocytosis,	  and	  (3)	  dephosphorylation	  of	  these	  residues	  results	  in	  activation	  of	  Art1-­‐mediated	  Can1	  endocytosis.	  	  Thus,	  the	  N-­‐terminal	  phosphocluster	  of	  Art1	  is	  a	  critical	  feature	  of	  the	  regulated	  endocytosis	  of	  Can1.	  	  	  
N-­‐terminal	  Phosphorylation	  Antagonizes	  Art1	  PM	  Recruitment	  We	  next	  investigated	  how	  N-­‐terminal	  phosphorylation	  of	  Art1	  inhibits	  Can1	  endocytosis.	  	  First,	  we	  considered	  the	  possibility	  that	  N-­‐terminal	  phosphorylation	  could	  lower	  the	  affinity	  of	  Art1	  for	  Rsp5,	  however	  our	  quantitative	  mass	  spectrometry	  results	  indicated	  that	  changes	  in	  Art1	  phospho-­‐status	  do	  not	  affect	  its	  interaction	  with	  Rsp5	  (Figure	  2.9A).	  
 	  	   96	  
Previously,	  we	  showed	  that	  GFP-­‐tagged	  Art1	  in	  unstimulated	  wildtype	  cells	  localizes	  to	  the	  cytosol,	  Golgi	  and	  plasma	  membrane	  (Figure	  2.9B,	  top	  panels)	  and	  cycloheximide-­‐induced	  activation	  of	  endocytosis	  results	  in	  translocation	  of	  Art1	  to	  the	  PM	  (Figure	  2.9C,	  top	  panels)	  (Lin	  et	  al.,	  2008).	  	  Interestingly,	  we	  found	  that	  cycloheximide-­‐induced	  PM	  recruitment	  of	  Art1	  was	  blocked	  by	  addition	  of	  rapamycin	  (Figure	  2.9C,	  bottom	  panels),	  and	  that	  wildtype	  cells	  treated	  with	  rapamycin	  exhibited	  less	  Art1-­‐GFP	  at	  the	  plasma	  membrane	  compared	  to	  untreated	  cells	  (Figure	  2.9B,	  bottom	  panels).	  	  Since	  these	  treatments	  “toggle”	  Art1	  between	  phosphorylated	  and	  dephosphorylated	  states,	  the	  effect	  of	  rapamycin	  and	  cycloheximide	  on	  Art1	  localization	  suggested	  that	  N-­‐terminal	  phosphorylation	  may	  regulate	  Art1	  recruitment	  to	  the	  plasma	  membrane.	  	  	  To	  further	  explore	  this	  possibility,	  we	  mixed	  wildtype	  cells	  (marked	  with	  Sec7-­‐Mars)	  and	  Δnpr1	  cells	  both	  expressing	  Art1-­‐GFP.	  	  We	  treated	  this	  mixed	  culture	  with	  rapamycin,	  so	  that	  Art1	  in	  wildtype	  cells	  would	  be	  hyperphosphorylated	  and	  Art1	  in	  Δnpr1	  cells	  would	  be	  hypophosphorylated	  (Figure	  2.9D	  inset).	  	  Interestingly,	  when	  we	  analyzed	  Art1-­‐GFP	  distribution	  in	  the	  mixed	  culture,	  we	  found	  that	  hyperphosphorylated	  Art1	  in	  the	  wildtype	  cells	  was	  localized	  primarily	  to	  the	  cytosol	  and	  Golgi,	  while	  hypophosphorylated	  Art1	  in	  the	  Δnpr1	  cells	  accumulated	  extensively	  at	  the	  plasma	  membrane	  (Figure	  2.9D	  and	  2.9F).	  	  Furthermore,	  we	  found	  that	  alanine	  substitution	  at	  the	  N-­‐terminal	  phosphosites	  resulted	  in	  increased	  PM	  recruitment	  even	  after	  treatment	  of	  cells	  with	  rapamycin	  	  (Figure	  2.9E	  and	  2.9F).	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Figure	  2.9.	  	  Art1	  phosphorylation	  inhibits	  PM	  recruitment	  	  (A)	  Quantitative	  mass	  spectrometry	  (SILAC)	  was	  used	  to	  monitor	  changes	  in	  the	  interaction	  of	  Art1	  with	  Rsp5	  in	  ∆npr1	  mutant	  cells	  (compared	  to	  wildtype	  cells)	  or	  in	  response	  to	  treatment	  with	  rapamycin	  (200ng/mL	  for	  15	  minutes)	  or	  cycloheximide	  (50	  μg/mL	  for	  15	  minutes)	  compared	  to	  mock	  treatment.	  	  XPRESS	  ratio	  represents	  the	  average	  H:L	  ratio	  of	  Rsp5	  peptides,	  normalized	  to	  the	  average	  H:L	  ratio	  of	  Art1	  peptides	  within	  each	  experiment.	  	  (B)	  Wildtype	  yeast	  cells	  expressing	  Art1-­‐GFP	  (green)	  and	  Sec7-­‐Mars	  (red)	  were	  analyzed	  by	  fluorescence	  microscopy.	  	  (C)	  Subcellular	  localization	  of	  Art1-­‐GFP	  (green)	  was	  determined	  using	  fluorescence	  microscopy	  imaging	  of	  wildtype	  yeast	  cells.	  	  Cells	  were	  either	  treated	  with	  cycloheximide	  (“CHX”)	  or	  co-­‐treated	  with	  cycloheximide	  and	  rapamycin	  (“CHX+RAP”).	  	  (D)	  Wildtype	  yeast	  cells	  (labeled	  with	  Sec7-­‐Mars	  (red))	  or	  Δnpr1	  cells	  expressing	  Art1-­‐GFP	  were	  mixed	  and	  treated	  with	  rapamycin	  (200	  ng/mL	  for	  15	  minutes)	  and	  Art1	  subcellular	  localization	  was	  analyzed	  using	  fluorescence	  microscopy.	  	  The	  inset	  is	  a	  Western	  blot	  demonstrating	  the	  phospho-­‐status	  of	  Art1	  in	  each	  condition.	  	  (E)	  Wildtype	  yeast	  cells	  expressing	  wildtype	  Art1-­‐GFP	  (labeled	  with	  Vph1-­‐mCherry	  (red))	  or	  the	  N-­‐terminal	  alanine	  substitution	  mutant	  (art1-­‐8xA)	  were	  analyzed	  by	  fluorescence	  microscopy	  following	  mock	  (top	  panel)	  or	  rapamycin	  (bottom	  panel)	  treatment.	  	  (F)	  Art1-­‐GFP	  PM	  localization	  was	  quantified	  (n=40	  cells).	  	  Results	  are	  normalized	  to	  the	  percent	  PM	  localized	  Art1	  from	  wildtype	  cells	  treated	  with	  rapamycin,	  a	  condition	  where	  we	  do	  not	  see	  Art1	  PM	  recruitment.	  	  (G)	  GFP-­‐Npr1	  (green)	  subcellular	  localization	  was	  analyzed	  by	  fluorescence	  microscopy	  following	  mock,	  cycloheximide,	  or	  rapamycin	  treatments	  in	  wildtype	  yeast	  cells	  expressing	  Mup1-­‐
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Mars	  (red)	  to	  label	  the	  PM.	  	  (H)	  Npr1	  PM	  localization	  was	  quantified	  (n=40	  cells).	  	  Results	  are	  normalized	  to	  the	  percent	  PM	  localized	  Npr1	  from	  wildtype	  cells	  treated	  with	  cycloheximide,	  a	  condition	  where	  we	  do	  not	  see	  Npr1	  PM	  recruitment.	  	  (I)	  Cells	  expressing	  wildtype	  GFP-­‐Npr1	  (green)	  or	  GFP-­‐npr1Δ40-­‐360	  (green)	  were	  mixed	  and	  treated	  with	  rapamycin	  (200ng/mL	  for	  15	  minutes)	  prior	  to	  imaging	  by	  fluorescence	  microscopy.	  	  Cells	  expressing	  GFP-­‐npr1Δ40-­‐360	  were	  also	  expressing	  Mup1-­‐Mars	  (red),	  a	  plasma	  membrane	  marker.	  	  (J)	  Wildtype	  yeast	  cells	  expressing	  Npr1-­‐GFP	  and	  Art1-­‐mCherry	  were	  grown	  to	  mid-­‐log	  phase	  in	  the	  presence	  of	  methionine	  and	  treated	  with	  rapamycin	  (200	  ng/mL	  for	  5	  minutes).	  	  Both	  Npr1	  and	  Art1	  subcellular	  localization	  was	  determined	  using	  fluorescence	  microscopy	  imaging.	  	  **	  indicated	  P	  <	  0.005.	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To	  determine	  where	  in	  the	  cell	  Npr1	  might	  phosphorylate	  Art1,	  we	  analyzed	  the	  subcellular	  localization	  of	  GFP-­‐Npr1	  and	  found	  that	  in	  unstimulated	  or	  cycloheximide-­‐treated	  cells	  Npr1	  was	  exclusively	  cytosolic	  (Figure	  2.9G,	  left	  and	  middle	  panels).	  	  In	  contrast,	  treatment	  of	  cells	  with	  rapamycin	  resulted	  in	  the	  PM	  recruitment	  of	  GFP-­‐Npr1	  (Figure	  2.9G,	  right	  panels,	  2.9H,	  and	  2.9I).	  	  To	  test	  the	  possibility	  that	  Art1	  and	  Npr1	  interact	  on	  the	  plasma	  membrane,	  we	  performed	  fluorescence	  co-­‐localization	  microscopy	  using	  Art1-­‐mCherry	  and	  GFP-­‐Npr1.	  	  Interestingly,	  when	  cells	  were	  treated	  with	  rapamycin	  to	  trigger	  Npr1	  PM	  recruitment,	  we	  observed	  co-­‐localization	  of	  GFP-­‐Npr1	  punctae	  with	  Art1-­‐mCherry	  punctae	  at	  the	  plasma	  membrane	  (Figure	  2.9J).	  	  Although	  the	  co-­‐localization	  we	  observed	  was	  limited,	  this	  result	  is	  consistent	  with	  a	  transient	  association	  of	  Npr1	  with	  Art1	  at	  the	  plasma	  membrane,	  whereby	  phosphorylation	  of	  Art1	  limits	  its	  PM	  association.	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DISCUSSION	  We	  have	  uncovered	  an	  effector	  pathway	  downstream	  of	  TORC1	  that	  regulates	  the	  composition	  of	  proteins	  at	  the	  PM	  by	  controlling	  endocytosis.	  	  Specifically,	  we	  show	  that	  (i)	  TORC1	  signaling	  regulates	  ubiquitin	  ligase	  targeting	  and	  endocytosis	  of	  nutrient	  transporters	  at	  the	  PM,	  (ii)	  the	  effector	  mechanism	  that	  regulates	  endocytosis	  involves	  a	  TORC1-­‐Npr1	  negative	  kinase	  signaling	  cascade	  that	  tunes	  the	  phosphoinhibition	  of	  the	  ubiquitin	  ligase	  adaptor	  Art1,	  and	  (iii)	  the	  inhibition	  of	  Art1	  requires	  phosphorylation	  at	  an	  N-­‐terminal	  cluster	  of	  residues	  that	  control	  Art1	  translocation	  to	  the	  PM	  (Figure	  2.10).	  	  These	  findings	  establish	  a	  unique	  effector	  branch	  of	  the	  TORC1	  signaling	  pathway	  that	  allows	  the	  cell	  to	  coordinate	  the	  activity	  of	  nutrient	  transporters	  at	  the	  PM	  as	  part	  of	  a	  global	  cellular	  strategy	  to	  regulate	  cell	  growth	  (Figure	  2.10).	  	  
A	  Global	  Strategy	  for	  Regulating	  Endocytosis	  The	  role	  of	  TORC1	  as	  a	  regulator	  of	  ubiquitin-­‐mediated	  endocytosis	  is	  intriguing	  because	  it	  demonstrates	  how	  diverse	  environmental	  and	  nutritional	  cues	  such	  as	  amino	  acid	  availability,	  energy	  status,	  and	  protein	  folding	  stress	  can	  affect	  changes	  in	  the	  abundance	  of	  proteins	  at	  the	  cell	  surface.	  	  In	  contrast	  to	  this	  global	  mode	  of	  TORC1-­‐mediated	  endocytosis,	  many	  well-­‐studied	  systems	  of	  endocytic	  downregulation	  involve	  specific	  targeting	  mechanisms,	  exemplified	  by	  the	  endocytosis-­‐mediated	  attenuation	  of	  activated	  cell	  surface	  receptors	  such	  as	  EGFR	  and	  GPCRs	  in	  mammalian	  cells.	  	  The	  results	  presented	  in	  this	  study	  demonstrate	  that	  nutrient	  transporters	  in	  yeast	  are	  subject	  to	  both	  global	  signals	  mediated	  by	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Figure	  2.10.	  	  A	  mechanism	  for	  TORC1	  regulation	  of	  endocytosis.	  	  When	  TORC	  signaling	  is	  “on”	  (left	  panel),	  Npr1	  is	  phosphoinhibited	  which	  promotes	  endocytosis	  of	  specific	  transporters	  by	  promoting	  Art1-­‐Rsp5	  translocation	  to	  the	  PM.	  	  When	  TORC1	  signaling	  is	  “off”	  (right	  panel),	  as	  occurs	  during	  rapamycin	  treatment	  or	  starvation	  conditions,	  Npr1	  is	  active	  and	  can	  phosphorylate	  Art1,	  an	  inhibited	  state	  that	  favors	  Golgi	  and	  cytosol	  localization.	  	  This	  novel	  effector	  mechanism	  allows	  TORC1	  to	  modulate	  ubiquitin-­‐mediated	  endocytosis	  and	  provides	  new	  insights	  into	  TORC1-­‐mediated	  coordination	  of	  diverse	  cellular	  processes	  to	  achieve	  growth	  control	  (top	  diagrams).	  	  Gray	  arrows	  and	  bars	  indicate	  the	  release	  of	  a	  regulatory	  interaction	  due	  to	  upstream	  regulatory	  effects	  in	  the	  pathway.	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TORC1	  and	  specific	  signals	  that	  are	  substrate-­‐dependent.	  	  Although	  these	  global	  and	  specific	  pathways	  operate	  independently	  in	  response	  to	  distinct	  cues	  (Figure	  2.1D	  and	  S1),	  they	  converge	  on	  the	  same	  molecular	  mechanism	  of	  control	  by	  regulating	  the	  function	  of	  ubiquitin	  ligase	  adaptors	  (Figure	  2.1F).	  	  This	  sort	  of	  signal	  integration	  allows	  TORC1	  to	  bypass	  specific	  mechanisms	  of	  endocytic	  downregulation,	  adding	  a	  substrate-­‐independent	  layer	  of	  endocytic	  control	  that	  is	  sensitive	  to	  the	  growth	  conditions	  of	  the	  cell.	  	  	  	  Proteome-­‐wide	  analysis	  of	  phosphorylation	  in	  yeast	  has	  demonstrated	  that	  ART	  family	  proteins	  are	  extensively	  phosphorylated	  (Albuquerque	  et	  al.,	  2008)	  and	  one	  recent	  study	  demonstrated	  that	  Npr1	  can	  phosphorylate	  Art3	  in	  vitro,	  although	  the	  functional	  significance	  of	  this	  modification	  remains	  unclear	  (O'Donnell	  et	  al.,	  2010).	  	  Interestingly,	  Art3	  was	  recently	  shown	  to	  regulate	  the	  ubiquitination	  and	  endocytosis	  of	  the	  aspartic	  acid	  transporter	  Dip5	  (Hatakeyama	  et	  al.,	  2010).	  	  We	  speculate	  that	  Npr1	  could	  negatively	  regulate	  the	  endocytosis	  of	  Dip5	  via	  phosphoinhibition	  of	  Art3,	  similar	  to	  its	  role	  as	  a	  negative	  regulator	  of	  Art1.	  	  Our	  phosphoprofiling	  experiments	  (Figure	  2.7I)	  reveal	  that,	  while	  most	  ART	  phosphopeptides	  detected	  appeared	  to	  be	  Npr1-­‐independent,	  Npr1-­‐dependent	  phosphorylation	  events	  were	  detected	  in	  Art2	  and	  Art3.	  	  Whether	  or	  not	  these	  phosphorylation	  events	  regulate	  endocytosis	  remains	  to	  be	  elucidated,	  but	  it	  seems	  likely	  given	  that	  both	  Art2	  and	  Art3	  have	  been	  shown	  to	  function	  in	  the	  endocytosis	  of	  specific	  cargoes	  (Hatakeyama	  et	  al.,	  2010;	  Lin	  et	  al.,	  2008).	  	  Furthermore,	  it	  is	  conceivable	  that	  other	  signaling	  pathways	  may	  similarly	  affect	  PM	  protein	  composition	  by	  regulating	  the	  activity	  of	  other	  ART	  family	  proteins.	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A	  parallel	  strategy	  in	  mammalian	  cells	  might	  involve	  the	  family	  of	  uncharacterized	  arrestin-­‐domain	  containing	  (ARRDC)	  proteins,	  which	  exhibit	  a	  domain	  structure	  similar	  to	  ART	  family	  proteins	  with	  N-­‐terminal	  arrestin	  domains	  and	  C-­‐terminal	  PY	  motifs.	  	  One	  mammalian	  ARRD	  family	  protein,	  ARRDC3,	  was	  recently	  shown	  to	  associate	  with	  the	  Nedd4	  ubiquitin	  ligase	  and	  mediate	  the	  endocytic	  downregulation	  of	  β2-­‐adrenergic	  receptor	  (Nabhan	  et	  al.,	  2010).	  	  It	  is	  tempting	  to	  speculate	  that	  mammalian	  ARRD	  family	  proteins	  may	  be	  subject	  to	  regulation	  by	  mTORC1	  signaling,	  thus	  providing	  an	  mTORC1	  effector	  branch	  analogous	  to	  the	  one	  presented	  in	  this	  study.	  	  Interestingly,	  mammalian	  β-­‐arrestins	  are	  subject	  to	  a	  regulatory	  cycle	  that	  involves	  phosphoinhibition	  and	  activation	  by	  dephosphorylation	  (Lin	  et	  al.,	  2002),	  however	  further	  study	  will	  be	  required	  to	  determine	  the	  extent	  to	  which	  TORC1	  signaling	  regulates	  the	  function	  of	  arrestin-­‐related	  proteins	  in	  mammalian	  cells.	  
The	  Npr1	  Kinase	  Links	  Nutrient	  Sensing	  to	  Endocytosis	  Previous	  studies	  have	  suggested	  a	  role	  for	  Npr1	  in	  the	  trafficking	  of	  amino	  acid	  transporters,	  however	  a	  consensus	  role	  for	  Npr1	  has	  been	  elusive.	  	  For	  example,	  one	  study	  presents	  evidence	  that	  the	  Npr1	  kinase	  promotes	  endocytosis	  of	  the	  tryptophan	  transporter	  TAT2	  (Schmidt	  et	  al.,	  1998).	  	  In	  contrast,	  other	  studies	  have	  provided	  evidence	  that	  the	  Npr1	  kinase	  functions	  to	  stabilize	  transporters	  at	  the	  plasma	  membrane	  (De	  Craene	  et	  al.,	  2001).	  	  Our	  analysis	  demonstrates	  that	  Npr1	  stabilizes	  the	  arginine	  transporter	  Can1	  at	  the	  plasma	  membrane	  by	  antagonizing	  the	  function	  of	  Art1.	  	  Interestingly,	  the	  phosphoproteomic	  data	  presented	  in	  this	  paper	  (Table	  1)	  may	  actually	  reconcile	  the	  seemingly	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contradictory	  reports	  regarding	  the	  role	  of	  Npr1	  with	  respect	  to	  endocytosis.	  	  For	  example,	  although	  our	  results	  demonstrate	  that	  Npr1	  negatively	  regulates	  endocytosis	  via	  phosphoinhibition	  of	  Art1,	  we	  also	  found	  several	  candidate	  Npr1	  substrates	  that	  were	  plasma	  membrane-­‐localized	  nutrient	  transporters.	  	  This	  result,	  combined	  with	  our	  observation	  that	  active	  Npr1	  is	  recruited	  to	  the	  PM,	  suggests	  that	  Npr1	  may	  phosphorylate	  both	  Art1	  and	  transporters	  at	  the	  PM.	  	  The	  consequence	  of	  cargo	  phosphorylation	  is	  unclear	  but	  we	  speculate	  that	  this	  may	  either	  regulate	  transporter	  activity	  or	  promote	  endocytosis.	  	  Thus,	  a	  better	  understanding	  of	  Npr1-­‐mediated	  phosphorylation	  of	  nutrient	  transporters	  at	  the	  PM	  may	  help	  to	  resolve	  some	  of	  the	  contradictory	  reports	  regarding	  the	  role	  of	  Npr1	  as	  a	  regulator	  of	  endocytosis.	  	  	   The	  Npr1	  kinase	  represents	  an	  important	  mediator	  of	  TORC1	  control	  of	  endocytosis	  in	  yeast,	  but	  the	  existence	  of	  an	  analogous	  pathway	  in	  mammalian	  cells	  is	  unclear.	  	  Although	  Npr1	  has	  no	  obvious	  homolog	  in	  human	  cells,	  it	  is	  part	  of	  a	  large	  family	  of	  kinases	  that	  includes	  the	  glucose-­‐sensing	  kinase	  Snf1,	  the	  yeast	  homolog	  of	  the	  mammalian	  AMP-­‐activated	  kinase.	  	  We	  speculate	  that	  the	  family	  of	  AMPK/Snf1-­‐related	  kinases	  in	  both	  yeast	  and	  mammals	  may	  have	  evolved	  as	  sensors	  of	  nutrient	  availability	  that	  regulate	  growth	  responses	  including	  endocytosis	  and	  membrane	  traffic.	  	  Consistent	  with	  our	  observation	  that	  part	  of	  this	  response	  may	  involve	  regulation	  of	  endocytosis,	  Snf1	  was	  shown	  to	  phosphorylate	  the	  arrestin-­‐related	  protein	  Art4	  (Shinoda	  and	  Kikuchi,	  2007)	  and	  related	  kinases	  Hal4	  and	  Hal5	  have	  been	  implicated	  in	  stabilizing	  potassium	  transporters	  at	  the	  plasma	  membrane	  by	  an	  unknown	  mechanism	  (Pérez-­‐Valle	  et	  al.,	  2007).	  	  Although	  it	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remains	  to	  be	  seen	  if	  mTORC1	  regulates	  endocytosis	  in	  mammalian	  cells,	  we	  speculate	  that	  such	  regulation	  could	  involve	  effectors	  which	  include	  AMPK/Snf1-­‐related	  kinases.	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Chapter	  3	  
Ppz	  Phosphatases	  Regulate	  Endocytosis	  via	  Dephosphorylation	  of	  a	  Ubiquitin	  
Ligase	  Adaptor	  
INTRODUCTION	  	  	  	  	  	  	  	  	  Post-­‐translational	  modification	  of	  proteins	  provides	  an	  efficient	  mechanism	  for	  regulation	  of	  protein	  activity	  (Chen	  et	  al.,	  1994;	  Cohen,	  1989;	  Stark,	  1996).	  	  Just	  as	  important	  is	  the	  reversibility	  of	  post-­‐translational	  modifications,	  which	  facilitates	  regulation	  of	  proteins	  via	  regulatory	  cycles.	  	  In	  chapter	  2,	  we	  demonstrated	  how	  Art1	  activity	  is	  phospho-­‐inhibited	  by	  the	  Npr1	  kinase,	  which	  itself	  is	  ultimately	  controlled	  by	  signaling	  through	  TORC1	  kinase.	  	  These	  results	  provide	  a	  mechanism	  for	  phosphoinhibition	  of	  Art1	  and	  they	  demonstrate	  that	  Art1	  activation	  is	  associated	  with	  dephosphorylation	  (Figure	  2.6	  A	  and	  B),	  however	  they	  do	  not	  address	  the	  mechanism	  of	  Art1	  activation	  by	  dephosphorylation.	  	  Recently,	  it	  was	  reported	  that	  the	  activity	  of	  Art4/Rod1,	  another	  Rsp5	  E3	  ubiquitin	  ligase	  adaptor,	  can	  be	  mediated	  through	  a	  phospho-­‐regulatory	  cycle	  (Becuwe	  et	  al.,	  2012).	  	  The	  Glc7/Reg1	  phosphatase	  reverses	  the	  AMPK	  Snf1	  kinase-­‐mediated	  phospho-­‐inhibition	  of	  Art4,	  triggering	  the	  endocytosis	  of	  a	  monocarboxylate	  transporter	  Jen1.	  	  Understanding	  Art1	  activation	  will	  require	  the	  identification	  of	  the	  Art1	  phosphatase(s)	  and	  dissection	  of	  their	  role	  in	  the	  Art1	  phosphorylation	  cycle.	  	  	  	  	  	  	  	  	  	  It	  has	  been	  reported	  that	  several	  phosphatases	  play	  important	  roles	  in	  regulating	  ubiquitination	  and	  endocytosis	  (Becuwe	  et	  al.,	  2012;	  Goebel-­‐Goody	  et	  al.,	  2011;	  Smillie	  and	  Cousin,	  2012).	  	  Here,	  we	  performed	  a	  phosphatase	  canavanine	  screen	  to	  identify	  potential	  Art1	  phosphatases.	  	  The	  dephosphorylation	  of	  Art1	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might	  through	  (1)	  a	  non-­‐specific	  phosphatase	  activity	  (ie,	  massive	  redundancy)	  or	  (2)	  a	  specific	  phosphatase.	  	  For	  (1),	  we	  may	  not	  be	  able	  to	  identify	  any	  single	  phosphatase	  mutant	  showing	  a	  canavanine	  phenotype.	  	  However,	  for	  (2),	  several	  phosphatase	  mutants	  may	  show	  a	  canavanine	  phenotype.	  	  They	  include	  phosphatases	  that	  have	  been	  implicated	  in	  regulating	  endocytosis	  or	  phosphatases	  that	  localize	  at	  PM	  and/or	  Golgi,	  where	  Art1	  localizes.	  	  As	  discussed	  in	  Chapter	  2,	  the	  phosphatases	  in	  the	  TORC1	  pathway	  upstream	  of	  Npr1	  are	  also	  the	  phosphatases	  that	  regulate	  Art1	  phosphorylation	  and	  activity.	  	  By	  doing	  this	  screen,	  we	  identified	  several	  phosphatases	  that	  might	  be	  involved	  in	  regulating	  of	  cargo	  endocytosis.	  	  	  	  	  	  	  	  	  	  	  	  In	  this	  chapter,	  I	  will	  report	  two	  major	  findings	  of	  that	  contribute	  to	  our	  understanding	  of	  how	  cargo	  at	  the	  PM	  are	  targeted	  for	  ubiquitination	  and	  endocytosis:	  1)	  Ppz	  phosphatases	  positively	  regulate	  ubiquitination	  and	  endocytosis	  of	  different	  cargoes	  in	  response	  to	  various	  stimulations;	  2)	  The	  likely	  mechanism	  of	  this	  regulation	  involves	  dephosphorylation	  of	  Art1,	  an	  Rsp5	  adaptor.	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MATERIAL	  AND	  METHODS	  
Plasmids,	  Strains	  and	  Screening	  for	  Canavanine	  Phenotypes	  All	  plasmids	  and	  yeast	  strains	  used	  in	  this	  study	  are	  listed	  in	  Table	  S1	  and	  Table	  S2,	  respectively.	  	  Canavanine	  plating	  assays	  were	  performed	  as	  previously	  described	  (Lin	  et	  al.,	  2008).	  	  Briefly,	  yeast	  mutant	  cultures	  grown	  overnight	  in	  YPD	  were	  normalized	  to	  1	  OD/mL,	  serially	  diluted	  and	  plated	  onto	  SCD	  plates	  using	  a	  pin-­‐frogger.	  	  The	  following	  concentrations	  of	  canavanine	  were	  tested	  in	  each	  experiment:	  	  0	  µg/mL,	  0.6	  µg/mL,	  0.8	  µg/mL,	  1.0	  µg/mL,	  2.0	  µg/mL,	  4.0	  µg/mL	  and	  6.0	  µg/mL.	  	  	  
Yeast	  Thialysine	  Plating	  Assays	  Yeast	  cultures	  grown	  overnight	  in	  YPD	  were	  normalized	  to	  1	  OD/mL,	  serially	  diluted	  and	  plated	  onto	  SCD	  plates	  using	  a	  pin-­‐frogger.	  	  The	  following	  concentrations	  of	  thialysine	  were	  tested	  in	  each	  experiment:	  	  0	  µg/mL,	  1.0	  µg/mL,	  2.5	  µg/mL,	  5.0	  µg/mL,	  and	  10.0	  µg/mL	  
Fluorescence	  Quenching	  Flow	  Cytometry	  Assays	  	  This	  assay	  was	  modified	  from	  (Prosser	  et	  al.)	  by	  Nicholas	  Buchkovich.	  	  In	  brief,	  WT	  and	  mutant	  cells	  were	  grown	  at	  26°C	  until	  midlog	  phase	  and	  stimulated	  by	  Methionine	  to	  trigger	  Mup1-­‐pH	  endocytosis.	  	  The	  fluorescent	  intensity	  of	  each	  cell	  was	  measured	  by	  using	  flow	  cytometry	  every	  3.5	  minutes	  for	  2.5	  hours.	  	  The	  intensity	  gate	  for	  positive	  cells	  was	  set	  up	  according	  to	  the	  WT	  cells	  under	  unstimulated	  condition	  (around	  99.5%	  of	  cells).	  	  	  
Mup1-­‐HTF	  Ub	  Ladder	  Immunoblot	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WT	  and	  mutant	  cells	  with	  chromosomal	  tagged	  Mup-­‐HTF	  were	  grown	  at	  26°C	  until	  midlog	  phase	  and	  treated	  with	  methionine.	  	  After	  stimulation	  for	  0,	  5,	  10,	  and	  20	  minutes,	  cells	  were	  harvested	  and	  subjected	  to	  TCA	  precipitation.	  	  0.1	  OD	  of	  whole	  cell	  lysate	  in	  each	  sample	  was	  loaded	  to	  10%	  SDS-­‐PAGE	  and	  protein	  were	  imaged	  by	  Western	  blot	  by	  using	  α-­‐FLAG	  (M2,	  Sigma)	  antibody.	  	  
Microscopy	  All	  microscopy	  was	  performed	  using	  an	  Olympus	  IX71	  microscopy	  equipped	  with	  FITC	  and	  rhodamine	  filters.	  	  Deconvolution	  and	  image	  analysis	  was	  performed	  using	  Softworx	  software	  (Applied	  Precision).	  	  For	  cargo	  trafficking	  assays,	  strains	  expressing	  chromosomally-­‐tagged	  Vph1-­‐mCherry	  were	  used	  to	  label	  the	  vacuolar	  membrane.	  	  Cells	  were	  grown	  at	  26°C	  and	  either	  mock-­‐treated	  or	  treated	  with	  cycloheximide	  (CHX)	  (50	  µg/mL),	  and/or	  rapamycin	  (RAP)	  (200	  ng/mL),	  and	  methionine	  prior	  to	  imaging	  cells.	  	  For	  screening	  potential	  endocytic	  phosphatase	  mutants,	  cells	  were	  grown	  at	  30°C	  and	  without	  any	  stimulation	  prior	  to	  imaging	  cells.	  	  For	  Art1-­‐GFP	  and	  Ppz1-­‐MARS	  co-­‐localization	  experiment,	  cells	  were	  stimulated	  with	  CHX	  for	  30	  minutes	  prior	  to	  imaging.	  Additional	  related	  material	  and	  methods	  are	  the	  same	  as	  described	  in	  Chapter	  2	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RESULTS	  
Identification	  of	  Phosphatases	  that	  Regulate	  Trafficking	  of	  the	  Arginine	  
Transporter	  Can1	  	  	  	  	  	  	  	  	  Since	  the	  completion	  of	  the	  genome	  sequencing	  project	  of	  Saccharomyces	  
cerevisiae,	  proteins	  in	  the	  budding	  yeast	  can	  be	  easily	  identified	  and	  grouped	  according	  to	  their	  enzymatic	  functions	  (Goffeau	  et	  al.,	  1996).	  	  Based	  on	  sequence	  analysis	  of	  the	  kinase	  and	  phosphatases	  catalytic	  domains,	  there	  are	  a	  total	  of	  117	  protein	  kinases	  and	  32	  protein	  phosphatases	  genes	  in	  the	  yeast	  genome	  (Sakumoto	  et	  al.,	  1999).	  	  Among	  these	  phospho-­‐regulating	  proteins,	  there	  are	  102	  and	  30	  viable	  deletion	  kinase	  and	  phosphatase	  strains,	  respectively	  (Hirasaki	  et	  al.,	  2011;	  Sakumoto	  et	  al.,	  1999).	  	  To	  identify	  the	  potential	  phosphatases	  that	  regulate	  the	  endocytic	  pathway,	  we	  performed	  a	  canavanine	  screen	  for	  all	  the	  phosphatase	  null	  strains.	  	  According	  to	  our	  phospho-­‐regulatory	  cycle	  proposed	  in	  Figure	  2.4F,	  deletion	  of	  a	  bona	  fide	  Art1	  phosphatase	  would	  exhibit	  a	  canavanine	  sensitive	  phenotype.	  	  Therefore,	  by	  taking	  a	  similar	  approach	  as	  our	  kinase	  screen,	  we	  took	  all	  the	  viable	  phosphatase	  disruptants	  from	  the	  BY4741	  knockout	  collections	  and	  plated	  them	  on	  the	  canavanine	  plates	  to	  score	  for	  a	  canavanine	  sensitive	  phenotype.	  	  As	  Table	  2	  shows,	  5	  phosphatase	  deletion	  strains	  exhibited	  a	  canavanine	  sensitive	  phenotype	  while	  6	  disruptants	  exhibited	  a	  canavanine	  resistant	  phenotype.	  	  Of	  all	  the	  phosphatase	  mutants	  examined,	  Δppz1	  cells	  exhibited	  the	  most	  severe	  canavanine	  hypersensitivity,	  suggesting	  Ppz1	  may	  play	  a	  role	  in	  Can1	  endocytosis.	  	  	  	  	  	  	  	  	  	  	  To	  further	  explore	  a	  possible	  role	  for	  these	  candidate	  phosphatases	  in	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Table	  2.	  	  Canavanine	  screen	  of	  budding	  yeast	  phosphatome.	  	  All	  the	  viable	  phosphatase	  mutants	  from	  the	  yeast	  deletion	  collection	  were	  plates	  on	  the	  canavanine	  plates	  (0,	  0.6,	  0.8,	  1.0,	  2.0,	  4.0	  and	  6.0	  µg/ml	  canavanine)	  to	  score	  Can1	  endocytosis	  defect.	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endocytosis,	  we	  examined	  Can1	  trafficking	  in	  each	  phosphatase	  deletion	  strain	  	  exhibiting	  canavanine	  hypersensitivity.	  	  Can1-­‐GFP	  was	  expressed	  in	  BY4741	  WT	  cells	  as	  well	  as	  the	  phosphatase	  mutants	  and	  grown	  at	  30°C	  instead	  of	  26°C	  to	  increase	  the	  basal	  level	  of	  endocytosis.	  	  Cells	  were	  grown	  to	  midlog	  phase	  and	  imaged	  by	  fluorescence	  microscopy	  to	  score	  Can1	  endocytosis	  and	  vacuolar	  trafficking	  (Figure	  3.1A).	  	  In	  WT	  cells,	  some	  Can1	  localized	  at	  PM,	  however,	  a	  significant	  fraction	  of	  the	  GFP	  signal	  localized	  to	  the	  vacuole,	  consistent	  with	  vacuolar	  trafficking	  and	  degradation	  in	  response	  to	  heat	  stress	  (Figure	  3.1A,	  top	  left	  panel).	  	  Phosphatase	  mutants	  Δppq1,	  Δptc1	  and	  Δppg1,	  exhibited	  Can1	  trafficking	  pattern	  indistinguishable	  from	  WT	  cells,	  suggesting	  these	  phosphatases	  are	  not	  required	  for	  Can1	  endocytosis.	  	  Interestingly,	  Can1	  endocytosis	  was	  blocked	  in	  two	  phosphatase	  mutants,	  Δppz1	  and	  Δyvh1	  (Figure	  3.1A,	  bottom	  middle	  and	  bottom	  right,	  respectively).	  	  However,	  unlike	  the	  strong	  PM	  localized	  Can1-­‐GFP	  signal	  in	  
Δppz1	  mutants,	  there	  were	  several	  early	  endosome-­‐like	  Can1-­‐GFP	  accumulation	  in	  
Δyvh1	  mutants,	  suggesting	  Yvh1	  may	  function	  at	  early	  endosome	  maturation	  process	  rather	  than	  early	  endocytosis.	  	  This	  result	  is	  consistent	  with	  a	  possible	  role	  for	  the	  Ppz1	  phosphatase	  as	  a	  positive	  regulator	  of	  Can1	  endocytosis.	  
Ppz	  Phosphatases	  Positively	  Regulate	  Cargo	  Endocytosis	  	  	  	  	  	  	  	  	  The	  PP1	  family	  phosphatases	  Ppz1	  and	  Ppz2	  are	  two	  homologous	  Ser/Thr	  protein	  phosphatases	  (Sakumoto	  et	  al.,	  2002;	  Sakumoto	  et	  al.,	  1999).	  	  Deletion	  of	  PPZ1	  gene	  causes	  temperature	  and	  caffeine	  sensitive	  phenotypes	  while	  deletion	  of	  PPZ2	  gene	  alone	  has	  no	  significant	  phenotypes.	  	  However,	  the	  phenotypes	  can	  be	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Figure	  3.1.	  	  Ppz1	  and	  Ppz2	  phosphatases	  positively	  regulate	  endocytosis	  of	  different	  plasma	  membrane	  proteins	  	  (A)	  WT	  (background	  BY4741)	  cells,	  as	  well	  as	  potential	  endocytic	  phosphatase	  (Ppq1,	  Ptc1,	  Ppg1,	  Ppz1	  and	  Yvh1)	  mutants	  from	  the	  yeast	  deletion	  collection	  were	  transformed	  by	  Can1-­‐GFP	  to	  score	  for	  Can1	  endocytosis	  defect.	  	  Cells	  were	  cultured	  at	  30°C	  to	  increase	  the	  basal	  level	  of	  endocytosis	  and	  grown	  to	  midlog	  phase,	  and	  were	  subjected	  to	  microscopy	  imaging.	  	  (B)	  WT	  (background	  SEY6210)	  cells	  and	  Δppz1Δppz2	  double	  phosphatases	  knockouts	  were	  plated	  on	  canavanine	  plates	  to	  score	  for	  Can1	  endocytosis	  defect.	  	  (C)	  WT	  (background	  BY4741)	  cells	  and	  Ppz1	  phosphatase	  mutant	  from	  the	  yeast	  deletion	  collection	  were	  plated	  on	  thialysine	  plates	  to	  score	  for	  Lyp1	  endocytosis	  defect.	  	  (D)	  WT	  (blue)	  and	  Δppz1Δppz2	  (red)	  cells	  were	  grown	  to	  midlog	  phase	  and	  subjected	  to	  [3H]	  arginine.	  	  Samples	  were	  collected	  at	  5,	  15,	  and	  30	  minute	  time	  points.	  	  (E)	  Can1-­‐GFP	  was	  imaged	  in	  WT	  cells	  (with	  chromosomal	  tagged	  Vph1-­‐mCherry)	  and	  
Δppz1Δppz2	  cells	  under	  unstimulated	  (left	  panel)	  and	  30	  minutes	  of	  cycloheximide	  (50	  µg/ml)	  treatment	  (right	  panel)	  conditions.	  	  (F)	  Mup1-­‐GFP	  was	  imaged	  in	  WT	  cells	  (with	  chromosomal	  tagged	  Vph1-­‐mCherry)	  and	  Δppz1Δppz2	  cells	  under	  unstimulated	  (upper	  panel),	  30	  minutes	  of	  methionine	  treatment	  (middle	  panel)	  and	  90	  minutes	  of	  cycloheximide	  (50	  µg/ml)	  treatment	  (lower	  panel)	  conditions.	  	  (G)	  Fur4-­‐GFP	  was	  imaged	  in	  WT	  cells	  (with	  chromosomal	  tagged	  Vph1-­‐mCherry)	  and	  Δppz1Δppz2	  cells	  under	  unstimulated	  condition.	  	  (H)	  Mup1-­‐pHluorin	  was	  chromosomal	  tagged	  in	  both	  WT	  cells	  and	  Δppz1Δppz2	  mutants.	  	  After	  growing	  to	  midlog	  phase,	  WT	  cells	  and	  mutants	  were	  subjected	  to	  the	  flow	  cytometry	  and	  counted	  for	  fluorescent	  positive	  cells	  under	  unstimulated	  (upper	  panels)	  and	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methionine	  stimulated	  (lower	  panels)	  conditions.	  	  (I)	  Cells	  from	  Figure	  3.1(H)	  were	  stimulated	  by	  methionine	  and	  collected	  in	  every	  3.5	  minutes	  for	  a	  total	  of	  2.5	  hours.	  	  The	  percentage	  of	  fluorescent	  positive	  cells	  was	  counted	  by	  flow	  cytometry	  at	  every	  time	  point.	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intensified	  by	  deleting	  both	  PPZ	  genes,	  suggesting	  a	  partial	  functional	  redundancy	  of	  these	  two	  phosphatases	  (Sakumoto	  et	  al.,	  2002).	  	  Ppz	  phosphatases	  have	  been	  reported	  to	  be	  negative	  regulators	  for	  the	  potassium	  transporters	  Trk1	  and	  Trk2	  (Merchan	  et	  al.,	  2010),	  which	  are	  regulators	  of	  salt	  tolerance	  and	  pH	  homeostasis	  in	  the	  cells	  (Mulet	  et	  al.,	  1999;	  Posas	  et	  al.,	  1995;	  Yenush	  et	  al.,	  2002).	  	  It	  has	  been	  shown	  that	  the	  Hal4	  and	  Hal5	  kinases,	  which	  have	  high	  sequence	  similarities	  to	  Npr1	  kinase,	  activate	  Trk	  transporters	  by	  antagonizing	  Ppz	  phosphatases	  activity	  (Mulet	  et	  al.,	  1999).	  	  This	  data	  suggests	  that	  Npr1	  and	  Ppz	  phosphatases	  may	  function	  together	  to	  control	  plasma	  membrane	  cargos	  activities	  via	  Art1,	  and/or	  other	  Ub	  ligase	  adaptors	  (other	  ARTs,	  Buls,	  etc.).	  	  Although	  Ppz	  phosphatases	  have	  been	  shown	  to	  regulate	  ion	  homeostasis	  and	  salt	  tolerance,	  identification	  of	  their	  downstream	  effectors	  and	  signaling	  pathways	  remains	  lacking.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  To	  further	  characterize	  the	  trafficking	  function	  of	  Ppz1	  phosphatase,	  we	  made	  a	  
Δppz1	  strain	  in	  the	  SEY6210	  background	  and	  tested	  for	  canavanine	  hypersensitivity.	  	  However,	  we	  did	  not	  observe	  a	  significant	  difference	  between	  WT	  cells	  and	  Δppz1	  single	  knockout	  mutants	  (Figure	  3.1B,	  first	  two	  rows).	  	  Since	  functional	  redundancy	  between	  Ppz1	  and	  Ppz2	  phosphatases	  has	  been	  reported	  (Sakumoto	  et	  al.,	  2002),	  we	  tested	  whether	  the	  double	  knockout	  is	  sensitive	  to	  canavanine.	  	  As	  shown	  in	  Figure	  3.1B,	  the	  Δppz1Δppz2	  mutant	  is	  hypersensitive	  to	  canavanine	  while	  neither	  single	  mutant	  shows	  a	  canavanine	  sensitive	  phenotype,	  suggesting	  functional	  redundancy	  between	  these	  two	  phosphatases	  in	  the	  SEY6210	  background.	  	  To	  further	  analyze	  whether	  Ppz	  phosphatases	  regulate	  endocytosis	  of	  additional	  cargo	  molecules,	  we	  tested	  the	  endocytosis	  of	  the	  lysine	  permease	  Lyp1	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in	  the	  Δppz1	  mutant	  by	  plating	  it	  together	  with	  the	  BY4741	  WT	  cells	  in	  the	  presence	  of	  thialysine,	  a	  toxic	  lysine	  analog	  (Figure	  3.1C).	  	  Similar	  to	  the	  canavanine	  plating	  results,	  the	  Δppz1	  mutant	  showed	  a	  thialysine	  hypersensitive	  phenotype,	  suggesting	  Ppz	  phosphatases	  are	  involved	  in	  regulating	  the	  endocytosis	  of	  Lyp1.	  	  We	  further	  confirmed	  our	  canavanine	  plating	  results	  by	  directly	  measuring	  Can1	  amino	  acid	  transporting	  ability.	  	  By	  using	  an	  assay	  to	  quantify	  arginine	  uptake,	  we	  tested	  Can1	  transport	  function	  in	  Ppz	  phosphatases	  mutant	  (Figure	  3.1D).	  	  We	  found	  that	  arginine	  uptake	  is	  faster	  in	  Δppz1Δppz2	  double	  mutant	  cells	  compared	  to	  WT	  cells,	  consistent	  with	  Can1	  accumulation	  at	  the	  PM	  in	  Δppz1Δppz2	  mutant	  cells.	  	  	  	  	  	  	  	  	  	  	  To	  further	  explore	  the	  role	  of	  Ppz	  phosphatases	  in	  stimulus-­‐triggered	  endocytosis,	  Can1-­‐GFP	  was	  imaged	  in	  WT	  (chromosomal	  tagged	  with	  Vph1-­‐mCherry)	  and	  Δppz1Δppz2	  cells	  following	  30	  minutes	  of	  cycloheximide	  (CHX)	  treatment	  (Figure	  3.1E).	  	  Can1-­‐GFP	  localized	  to	  the	  PM	  in	  both	  WT	  and	  Δppz1Δppz2	  cells	  in	  the	  absence	  of	  any	  stimulation.	  	  However,	  CHX	  stimulation	  triggers	  significant	  vacuolar	  Can1-­‐GFPsignal	  in	  WT	  cells	  compared	  to	  mutants,	  suggesting	  Ppz	  phosphatases	  are	  required	  for	  stimuli-­‐mediated	  Can1	  endocytosis.	  	  In	  addition,	  methionine-­‐stimulated	  Mup1	  endocytosis	  was	  also	  defective	  in	  Δppz1Δppz2	  mutant	  cells	  (Figure	  3.1F,	  top	  and	  middle	  panels).	  	  Moreover,	  the	  basal	  level	  of	  Fur4	  endocytosis	  was	  blocked	  in	  Δppz1	  Δppz2	  mutant	  cells.	  	  These	  results	  suggest	  that	  Ppz	  phosphatases	  regulate	  the	  endocytosis	  of	  at	  least	  four	  different	  PM	  cargoes,	  including	  Can1,	  Lyp1,	  Mup1	  and	  Fur4.	  	  	  	  	  	  	  	  	  	  We	  wanted	  to	  determine	  if	  the	  trafficking	  defect	  in	  Δppz1Δppz2	  mutant	  cells	  is	  a	  block	  or	  a	  kinetic	  delay	  of	  cargo	  endocytosis.	  	  To	  distinguish	  between	  these	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possibilities	  and	  to	  better	  understand	  the	  kinetics	  of	  cargo	  degradation	  in	  Ppz	  phosphatase	  mutant,	  we	  performed	  flow	  cytometry	  analysis	  of	  cells	  expressing	  Mup1	  tagged	  with	  superecliptic	  pHluorin	  (Mup1-­‐pH)	  to	  monitor	  cargo	  delivery	  to	  the	  vacuole,	  as	  measured	  by	  fluorescence	  quenching	  (Prosser	  et	  al.).	  	  Upon	  methionine	  stimulation,	  Mup1-­‐pH	  traffics	  to	  the	  vacuole	  (pH	  ~6.2)	  where	  the	  fluorescence	  of	  superecliptic	  pHluorin	  is	  quenched.	  	  We	  grew	  WT	  and	  Δppz1Δppz2	  cells	  with	  chromosomal	  tagged	  Mup1-­‐pH	  to	  midlog	  phase	  and	  subjected	  them	  to	  the	  flow	  cytometry	  to	  score	  for	  the	  fluorescent	  positive	  cells	  (Figure	  3.1H).	  	  After	  2.5	  hours	  of	  methionine	  stimulation,	  only	  6.3%	  of	  cells	  retain	  the	  fluorescent	  signal,	  while	  31%	  of	  Δppz1Δppz2	  mutant	  cells	  were	  retained	  fluorescence.	  	  By	  collecting	  cell	  samples	  every	  3.5	  minutes	  post	  methionine	  stimulation,	  we	  found	  that	  the	  rate	  of	  Mup1-­‐pH	  quenching	  is	  slower	  in	  the	  phosphatase	  mutant	  (Figure	  3.1I).	  	  These	  results	  are	  consistent	  with	  the	  microscopy	  data	  and	  suggest	  that	  Ppz	  phosphatases	  regulate	  the	  endocytosis	  of	  several	  PM	  cargoes	  in	  response	  to	  different	  stimulation	  conditions.	  	  
Ppz	  phosphatases	  inhibitors	  Hal3	  and	  Vhs3	  Inhibit	  the	  Endocytosis	  of	  
Different	  Plasma	  Membrane	  Amino	  Acid	  Transporters	  	  	  	  	  	  	  	  	  Previous	  yeast	  genetic	  screens	  for	  genes	  involved	  in	  salt	  tolerance	  phenotypes	  identified	  both	  Ppz	  phosphatases	  as	  well	  as	  a	  complex	  of	  proteins	  (Hal3,	  Vhs3,	  and	  Cab3)	  that	  appears	  to	  negatively	  regulate	  Ppz	  phosphatase	  activity	  (de	  Nadal	  et	  al.,	  1998).	  	  Specifically,	  it	  has	  been	  reported	  that	  depletion	  of	  Ppz	  phosphatases	  resulted	  in	  increases	  salt	  tolerance,	  while	  depletion	  of	  Hal3	  and	  Vhs3	  results	  in	  decreased	  salt	  tolerance,	  suggesting	  that	  these	  proteins	  may	  antagonize	  Ppz	  phosphatases.	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Recent	  work	  has	  demonstrated	  that	  Hal3	  together	  with	  Vhs3	  and	  Cab3	  form	  a	  heteromeric	  complex	  (Ruiz	  et	  al.,	  2009).	  	  Hal3	  binds	  to	  the	  C-­‐terminal	  phosphatase	  catalytic	  domain	  of	  Ppz1	  to	  inhibit	  its	  enzymatic	  activity	  (Munoz	  et	  al.,	  2004).	  	  Therefore,	  depletion	  of	  Hal3	  or	  Vhs3	  can	  be	  used	  to	  hyperactivate	  Ppz	  phosphatases	  (Hirasaki	  et	  al.,	  2011;	  Yenush	  et	  al.,	  2005).	  	  By	  using	  the	  canavanine	  plating	  assay	  in	  phosphatases	  inhibitors	  mutants,	  we	  tested	  whether	  hyper-­‐activated	  Ppz1	  and	  Ppz2	  can	  trigger	  more	  Can1	  endocytosis.	  	  As	  shown	  in	  Figure	  3.2A,	  Δvhs3	  and	  Δhal3	  mutants	  showed	  a	  canavanine	  resistant	  phenotype,	  consistent	  with	  the	  previous	  studies	  that	  Vhs3	  and	  Hal3	  are	  negative	  regulators	  of	  Ppz	  phosphatases.	  	  	  	  	  	  	  	  	  Based	  on	  our	  canavanine	  plating	  result	  of	  Δvhs3	  and	  Δhal3	  mutants,	  we	  hypothesized	  that	  Vhs3	  and	  Hal3	  are	  involved	  in	  the	  endocytic	  pathway	  as	  negative	  regulators	  of	  Ppz	  phosphatases.	  	  To	  test	  whether	  Vhs3	  can	  regulate	  other	  cargo	  endocytosis,	  we	  plated	  Δvhs3	  mutant	  together	  with	  the	  BY4741	  WT	  cells	  on	  the	  thialysine	  plates.	  	  Consistent	  with	  the	  canavanine	  results,	  Δvhs3	  mutant	  cells	  exhibited	  thialysine	  resistance	  (Figure	  3.2B).	  	  Moreover,	  the	  endocytosis	  of	  Mup1	  was	  examined	  by	  monitoring	  Mup1-­‐GFP	  trafficking	  in	  cells	  lacking	  the	  inhibitory	  proteins.	  	  Mup1-­‐GFP	  was	  imaged	  in	  the	  WT	  cells	  (chromosomal	  tagged	  with	  Vph1-­‐mCheery)	  and	  both	  Δhal3	  (Figure	  3.2C)	  and	  Δvhs3	  (Figure	  3.2D)	  mutants	  under	  unstimulated	  condition.	  	  Mup1-­‐GFP	  vacuolar	  localization	  was	  increased	  compared	  to	  the	  WT	  cells.	  	  Furthermore,	  the	  Mup1-­‐GFP	  endocytosis	  was	  intensified	  in	  the	  
Δvhs3Δhal3	  double	  disruptants	  (Figure	  3.2E),	  which	  may	  indicate	  that	  both	  Hal3	  and	  Vhs3	  are	  important	  for	  Ppz	  phosphatases-­‐mediated	  cargo	  endocytosis.	  	  Of	  note,	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Figure	  3.2.	  	  Ppz1	  and	  Ppz2	  phosphatases	  inhibitors	  negatively	  regulate	  endocytosis	  of	  different	  plasma	  membrane	  proteins	  	  (A)	  WT	  (background	  SEY6210)	  cells	  and	  Ppz1	  Ppz2	  phosphatase	  inhibitor	  (Vsh3	  and	  Hal3)	  mutants	  were	  plated	  on	  canavanine	  plates	  to	  score	  for	  Can1	  endocytosis	  defect.	  	  (B)	  WT	  (background	  BY4741)	  cells	  and	  Ppz1	  Ppz2	  phosphatases	  inhibitor	  (Hal3)	  mutant	  from	  the	  yeast	  deletion	  collection	  were	  plated	  on	  thialysine	  plates	  to	  score	  for	  Lyp1	  endocytosis	  defect.	  	  (C)	  Mup1-­‐GFP	  was	  imaged	  in	  WT	  cells	  (with	  chromosomal	  tagged	  Vph1-­‐mCherry)	  and	  Δhal3	  cells	  under	  unstimulated	  condition.	  	  (D)	  Mup1-­‐GFP	  was	  imaged	  in	  WT	  cells	  (with	  chromosomal	  tagged	  Vph1-­‐mCherry)	  and	  Δvhs3	  cells	  under	  unstimulated	  condition.	  	  (E)	  Mup1-­‐GFP	  was	  imaged	  in	  WT	  cells	  (with	  chromosomal	  tagged	  Vph1-­‐mCherry)	  and	  Δhal3	  Δvhs3	  cells	  under	  unstimulated	  condition.	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the	  vacuole	  morphology	  is	  abnormal	  in	  Δvhs3Δhal3	  double	  disruptants.	  	  The	  increase	  in	  vacuolar	  Mup1-­‐GFP	  signal	  could	  be	  a	  side	  effect	  of	  an	  unknown	  pathway.	  	  Further	  studies	  are	  required	  to	  address	  this	  issue.	  
Ppz	  Phosphatases	  Function	  in	  Regulating	  the	  Early	  Steps	  of	  Endocytic	  Pathway	  	  	  	  	  	  	  	  	  To	  determine	  which	  step	  of	  the	  endocytic	  pathway	  is	  regulated	  by	  Ppz	  phosphatases,	  we	  tested	  each	  step	  of	  the	  endocytic	  pathway.	  	  First,	  vacuole	  morphology	  was	  analyzed	  in	  Ppz	  phosphatase	  mutants	  by	  using	  the	  FM4-­‐64	  staining	  (Figure	  3.3A).	  	  There	  was	  no	  significant	  defect	  of	  vacuole	  morphology	  in	  
Δppz1Δppz2	  mutants,	  which	  may	  suggest	  that	  endosomal	  sorting	  and	  vacuolar	  fusion	  are	  not	  affected.	  	  Second,	  by	  using	  GFP-­‐CPS,	  we	  examined	  the	  MVB	  sorting	  in	  the	  Ppz	  phsophatases	  mutants.	  	  GFP-­‐CPS	  was	  expressed	  and	  imaged	  in	  the	  WT	  cells	  (chromosomal	  tagged	  with	  Vph1-­‐mCheery)	  and	  Δppz1Δppz2	  mutants	  under	  unstimulated	  condition	  (Figure	  3.3B).	  	  In	  these	  cells,	  we	  did	  not	  observe	  E	  dot	  formation,	  a	  classic	  subcellular	  structure	  seen	  in	  the	  ESCRT	  mutants	  (Henne	  et	  al.,	  2011),	  suggesting	  Ppz	  phosphatases	  do	  not	  affect	  MVB	  sorting.	  	  Our	  data	  suggest	  that	  the	  Ppz	  phosphatases	  are	  not	  involved	  in	  regulating	  the	  late	  steps	  of	  endocytic	  pathway.	  	  	  	  	  	  	  	  	  Next,	  we	  analyzed	  Mup1	  degradation	  following	  methionine	  stimulation	  in	  the	  WT,	  Δppz1Δppz2	  and	  Δart1	  mutant	  cells	  (Figure	  3.3C).	  	  Importantly,	  degradation	  of	  Mup1	  is	  blocked	  in	  Δppz1Δppz2	  and	  Δart1	  mutant	  cells,	  consistent	  with	  the	  observed	  trafficking	  defect.	  	  	  Finally,	  we	  wanted	  to	  determine	  if	  Ppz	  phosphatases	  play	  a	  role	  in	  cargo	  ubiquitination.	  	  Mup1-­‐HTF	  was	  expressed	  and	  assayed	  by	  immunoblot	  in	  WT	  cells	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  Figure	  3.3.	  	  Ppz1	  and	  Ppz2	  phosphatases	  play	  roles	  in	  the	  early	  step	  of	  cargo	  endocytic	  pathway	  	  (A)	  Δppz1Δppz2	  cells	  were	  grown	  to	  midlog	  phase	  and	  subjected	  to	  vacuoles	  labeling	  by	  staining	  cells	  with	  FM4-­‐64	  for	  1	  hour.	  	  Vacuolar	  morphology	  was	  imaged	  by	  microscopy	  after	  staining	  and	  washing.	  	  (B)	  GFP-­‐CPS	  vacuolar	  sorting	  was	  imaged	  in	  WT	  cells	  (with	  chromosomal	  tagged	  Vph1-­‐mCherry)	  and	  Δppz1Δppz2	  cells	  under	  unstimulated	  condition.	  	  (C)	  Mup1-­‐HTF	  degradation	  kinetics	  after	  methionine	  stimulation	  was	  measured	  by	  Western	  blot.	  	  WT,	  
Δppz1Δppz2	  and Δart1	  cells	  with	  chromosomal	  tagged	  Mup1-­‐HTF	  were	  grown	  to	  midlog	  phase	  and	  subjected	  to	  methionine	  stimulation.	  	  Samples	  were	  collected	  at	  0,	  5,	  10,	  and	  20	  minute	  time	  points.	  	  	  (D)	  Mup1-­‐HTF	  ubiquitination	  kinetics	  after	  methionine	  stimulation	  was	  measured	  by	  Western	  blot.	  	  WT,	  Δppz1Δppz2	  and Δart1	  cells	  with	  chromosomal	  tagged	  Mup1-­‐HTF	  were	  grown	  to	  midlog	  phase	  and	  subjected	  to	  methionine	  stimulation.	  	  Samples	  were	  collected	  at	  0,	  5,	  10,	  and	  20	  minute	  time	  points.	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  and	  Δppz1Δppz2	  and	  Δart1	  (as	  negative	  controls)	  mutants	  in	  different	  time	  points	  after	  methionine	  stimulation	  (Figure	  3.3D).	  	  Consistent	  with	  previous	  studies	  (Lin	  et	  al.,	  2008),	  Mup1-­‐Ub	  is	  blocked	  in	  Δart1	  mutant	  (Figure	  3.3D,	  bottom	  panel).	  	  In	  
Δppz1Δppz2	  mutant	  cells,	  Mup1ubiquitination	  following	  methionine	  stimulation	  was	  still	  observed,	  but	  ubiquitination	  appeared	  to	  be	  kinetically	  delayed	  (10	  minutes)	  compared	  to	  WT	  cells	  (5	  minutes).	  	  This	  data	  is	  consistent	  with	  our	  Mup-­‐pH	  results	  in	  Figure	  3.1I,	  which	  demonstrated	  a	  delay	  in	  Mup1	  endocytosis.	  	  Taken	  together,	  these	  results	  suggest	  that	  Ppz	  phosphatases	  regulate	  early	  steps	  of	  the	  endocytic	  pathway,	  including	  cargo	  ubiquitination.	  
Ppz	  Phosphatases	  are	  Required	  for	  Art1-­‐mediated	  Cargo	  Endocytosis	  	  	  	  	  	  	  	  	  We	  hypothesized	  that	  Ppz	  phosphatases	  may	  function	  as	  upstream	  activators	  for	  Art1-­‐mediated	  endocytosis.	  	  To	  test	  this	  hypothesis,	  we	  over-­‐expressed	  Art1	  in	  
Δppz1Δppz2	  mutant	  cells	  to	  test	  the	  genetic	  interaction	  between	  them	  (Figure	  3.4A).	  	  Overexpression	  of	  Art1	  in	  WT	  cells	  confers	  a	  canavanine	  resistance	  phenotype	  compared	  to	  WT	  cells	  carrying	  an	  empty	  vector.	  	  However,	  Δppz1Δppz2	  mutant	  was	  canavanine	  hypersensitive	  even	  in	  the	  presence	  of	  Art1	  overexpression,	  suggesting	  that	  Art1-­‐mediated	  endocytosis	  of	  Can1	  is	  dependent	  on	  the	  function	  of	  the	  Ppz	  phosphatases.	  	  To	  further	  examine	  whether	  Ppz	  phosphatases	  can	  regulate	  Art1	  phosphorylation	  status,	  we	  measured	  Art1	  mobilityshift	  by	  SDS-­‐PAGE	  in	  
Δppz1Δppz2	  mutant	  cells	  (Figure	  3.4B).	  	  We	  did	  not	  observe	  a	  significant	  Art1	  band-­‐shift	  in	  Δppz1Δppz2	  mutant	  cells	  in	  the	  absence	  of	  stimulation,	  which	  is	  consistent	  with	  previous	  microscopy	  results	  (Figure	  3.1E).	  	  In	  order	  to	  see	  the	  Art1	  band-­‐shift	  	  
 	  	   132	  
	  






 	  	   133	  
	  Figure	  3.4.	  	  Ppz1	  and	  Ppz2	  phosphatases	  are	  required	  for	  Art1-­‐mediated	  Can1	  endocytosis	  	  (A)	  WT	  cells	  expressing	  empty	  vector,	  as	  well	  as	  WT	  and	  Δppz1Δppz2	  cells	  carrying	  Art1	  overexpression	  plasmids	  (driven	  by	  a	  TDH3	  promoter)	  were	  plated	  on	  canavanine	  plates	  to	  score	  for	  the	  ability	  of	  Art1-­‐mediated	  Can1	  endocytosis.	  	  (B)	  WT	  and	  Δppz1Δppz2	  cells	  were	  transformed	  by	  Art1-­‐HTF	  plasmids	  and	  treated	  with	  or	  without	  50	  µg/ml	  of	  cycloheximide	  for	  15	  minutes	  before	  collecting	  cell	  samples.	  	  Art1	  band-­‐shift	  was	  measured	  by	  Western	  blot	  in	  these	  samples.	  	  (C)	  WT	  and	  Δppz1Δppz2	  cells	  were	  transformed	  by	  Art1-­‐HTF	  plasmids	  and	  treated	  with	  or	  without	  YPD	  shift	  for	  1	  hour	  before	  collecting	  cell	  samples.	  	  Art1	  band-­‐shift	  was	  measured	  by	  Western	  blot	  in	  these	  samples.	  	  (D)	  WT	  and	  
Δppz1Δppz2	  cells	  were	  transformed	  by	  Npr1-­‐HA	  plasmids	  and	  treated	  with	  or	  without	  50	  µg/ml	  of	  cycloheximide	  or	  200	  ng/ml	  rapamycin	  for	  15	  minutes	  before	  collecting	  cell	  samples.	  	  Npr1	  band-­‐shift	  was	  measured	  by	  Western	  blot	  in	  these	  samples.	  	  (E)	  Δppz1Δppz2Δnpr1	  cells	  were	  plated	  on	  canavanine	  plates	  with	  WT,	  	  
Δnpr1	  and	  Δppz1Δppz2	  strains	  to	  test	  for	  genetic	  interactions	  between	  Npr1	  and	  the	  Ppz1	  Ppz2	  phosphatases.	  	  (F)	  Model	  of	  Art1	  phospho-­‐regulation.	  	  Art1	  is	  phosphorylated	  and	  inactivated	  by	  Npr1	  kinase;	  Art1	  is	  de-­‐phosphorylated	  and	  activated	  by	  Ppz1	  phosphatase.	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  that	  occurs	  during	  activation,	  we	  treated	  both	  WT	  cells	  and	  Δppz1Δppz2	  mutants	  with	  CHX	  to	  trigger	  the	  de-­‐phosphorylation	  event	  of	  Art1.	  	  Interestingly,	  this	  Art1	  dephosphorylation	  event	  is	  delayed	  in	  Δppz1Δppz2	  mutant	  cells.	  Similar	  results	  were	  observed	  following	  a	  shift	  to	  growth	  in	  YPD	  (Figure	  3.4C).	  	  These	  results	  indicate	  that	  Ppz	  phosphatases	  regulate	  Art1	  phosphorylation	  status	  during	  stimulation	  conditions.	  	  	  	  	  	  	  It	  has	  been	  reported	  that	  deletion	  of	  Ppz1	  causes	  a	  caffeine	  sensitive	  phenotypes	  (Hirasaki	  et	  al.,	  2011;	  Sakumoto	  et	  al.,	  2002)	  while	  deletion	  of	  Npr1	  leads	  to	  a	  caffeine	  resistant	  phenotypes	  (data	  not	  shown).	  	  Two	  potential	  explanations	  for	  these	  observations	  include:	  1)	  Ppz	  phosphatases	  function	  as	  the	  upstream	  regulators	  for	  Npr1	  kinase;	  2)	  Ppz	  phosphatases	  and	  Npr1	  kinase	  function	  in	  two	  parallel,	  antagonistic	  pathways	  that	  both	  converge	  on	  the	  regulation	  of	  Art1.	  	  To	  test	  the	  first	  possibility,	  we	  determined	  whether	  Npr1	  activity	  is	  mediated	  by	  Ppz	  phosphatases	  by	  looking	  at	  Npr1	  band-­‐shift	  under	  different	  treatments	  in	  
Δppz1Δppz2	  mutant	  cells	  (Figure	  3.4D).	  	  We	  did	  not	  observe	  any	  significant	  changes	  on	  Npr1	  mobility	  by	  SDS-­‐PAGE	  in	  Δppz1Δppz2	  mutant	  cells	  compared	  to	  WT	  cells,	  suggesting	  that	  Ppz	  phosphatases	  do	  not	  affect	  the	  phosphorylation	  of	  Npr1.	  	  To	  better	  understand	  the	  genetic	  interaction	  between	  Ppz	  phosphatases	  and	  Npr1	  kinase,	  the	  Δnpr1Δppz1Δppz2	  triple	  knockout	  was	  constructed	  and	  tested	  for	  growth	  in	  the	  presence	  of	  canavanine	  (Figure	  3.4E).	  	  The	  triple	  knockout	  showed	  a	  canavanine	  hypersensitive	  phenotype	  similar	  to	  that	  of	  Δppz1Δppz2	  mutant	  cells,	  suggesting	  that	  Ppz	  phosphatases	  are	  required	  for	  Art1	  hyperactivation	  in	  a	  Δnpr1	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mutant	  background.	  	  Our	  results	  suggest	  that	  Art1	  phospho-­‐regulatory	  cycle	  requires	  both	  Npr1	  kinase	  and	  Ppz	  phosphatases	  (Figure	  3.4F).	  	  However,	  we	  still	  do	  not	  know	  if	  Art1	  is	  a	  direct	  substrate	  of	  Ppz1	  or	  Ppz2	  and	  further	  studies	  are	  required	  to	  dissect	  the	  mechanism	  of	  Ppz-­‐mediated	  regulation	  of	  Art1	  function.	  	  	  	  
Ppz	  Phosphatases	  Activate	  Art1	  at	  the	  Plasma	  Membrane	  	  	  	  	  	  	  	  	  The	  regulation	  of	  protein	  subcellular	  localization	  is	  one	  key	  feature	  to	  control	  enzyme	  activity	  towards	  its	  substrate.	  	  For	  example,	  Npr1	  translocates	  to	  the	  PM	  to	  phosphoinhibit	  Art1	  during	  RAP	  treatment	  (Figure	  2.9H).	  	  At	  steady	  state,	  Ppz1-­‐GFP	  is	  localized	  to	  the	  cytosol	  and	  the	  PM	  (Figure	  3.5A,	  left	  panel)	  where	  it	  forms	  transient	  patches	  with	  half-­‐life	  less	  than	  3	  seconds	  (data	  not	  shown).	  	  Since	  CHX	  treatment	  triggers	  Art1	  activation,	  we	  tested	  whether	  CHX	  treatment	  can	  affect	  Ppz1	  PM	  localization	  or	  dynamics.	  	  However,	  neither	  the	  PM/cytosol	  signal	  ratio	  (Figure	  3.5A,	  middle	  panel)	  nor	  the	  Ppz1	  patch	  half-­‐life	  (data	  not	  shown)	  changed	  in	  response	  to	  CHX	  stimulation.	  	  We	  further	  tested	  whether	  RAP	  treatment	  can	  affect	  Ppz1	  PM	  localization.	  	  However,	  the	  Ppz1	  subcellular	  localization	  after	  RAP	  stimulation	  remained	  the	  same	  (Figure	  3.5A,	  right	  panel).	  	  Together,	  these	  results	  suggest	  that	  Ppz1	  associates	  with	  the	  PM	  but	  this	  localization	  pattern	  is	  not	  regulated	  in	  response	  to	  stimulation.	  	  	  	  	  	  	  	  	  	  	  It	  has	  been	  shown	  that	  following	  CHX	  stimulation,	  Art1	  is	  recruited	  to	  the	  PM	  and	  forms	  patches	  (Figure	  2.9C).	  	  However,	  this	  PM	  recruitment	  is	  intact	  in	  Δppz1	  
Δppz2	  mutants	  (data	  not	  shown),	  suggesting	  the	  Ppz	  phosphatases	  are	  not	  required	  for	  Art1	  PM	  recruitment	  (Art1	  PM	  translocation	  is	  the	  subject	  of	  Chapter	  4).	  	  Since	  both	  Art1	  and	  Ppz1	  form	  patches	  at	  the	  PM,	  we	  tested	  whether	  these	  patches	  co-­‐	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  Figure	  3.5.	  	  Ppz1	  partially	  co-­‐localized	  with	  Art1	  at	  the	  plasma	  membrane	  	  (A)	  Ppz1-­‐GFP	  was	  transformed	  to	  WT	  cells	  and	  subjected	  for	  microscopy	  image.	  	  Cells	  were	  grown	  to	  midlog	  phase	  and	  then	  treated	  with	  mock-­‐treatment	  or	  50	  µg/ml	  of	  cycloheximide	  or	  200	  ng/ml	  rapamycin	  for	  15	  minutes	  before	  imaging.	  	  (B)	  WT	  cells	  expressing	  both	  Art1-­‐GFP	  and	  Ppz1-­‐MARS	  were	  grown	  to	  midlog	  phase	  and	  then	  treated	  with	  50	  µg/ml	  of	  cycloheximide	  for	  15	  minutes	  to	  trigger	  Art1	  PM	  translocation.	  	  (C)	  A	  mechanism	  for	  Art1	  phospho-­‐regulation.	  	  (1)	  Following	  stimulation,	  the	  Art1-­‐Rsp5	  complex	  is	  recruited	  from	  the	  Golgi	  apparatus	  to	  the	  plasma	  membrane	  (the	  translocation	  mechanism	  is	  discussed	  in	  detail	  in	  chapter	  4).	  	  (2)	  The	  PM	  localized	  Art1	  is	  dephosphorylated	  and	  activated	  by	  Ppz1	  and	  Ppz2	  phosphatases.	  	  This	  Art1-­‐Rsp5	  complex	  further	  ubiquitinates	  and	  targets	  membrane	  cargoes	  for	  endocytosis.	  	  (3)	  In	  order	  to	  dampen	  this	  endocytic	  signal,	  the	  TORC1-­‐Npr1	  kinase	  cascade	  is	  activated	  to	  phosphorylate	  Art1.	  	  Phosphorylated	  Art1	  then	  releases	  from	  the	  PM	  finishing	  this	  phospho-­‐regulatory	  cycle.	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  localize	  in	  cells	  expressing	  Art1-­‐GFP	  and	  Ppz1-­‐MARS	  (Figure	  3.5B).	  	  Following	  CHX	  treatment	  to	  trigger	  Art1	  PM	  translocation,	  we	  detected	  partial	  co-­‐localization	  of	  Art1	  and	  Ppz1	  at	  the	  PM,	  suggesting	  Ppz1	  has	  the	  potential	  to	  activate	  Art1	  at	  the	  PM.	  	  We	  also	  observed	  a	  Ppz1	  mobility	  shift	  by	  SDS-­‐PAGE	  following	  a	  YPD	  shift	  (data	  not	  shown),	  suggesting	  that	  post-­‐translational	  modification	  may	  regulate	  Ppz1	  activity.	  	  Taken	  together,	  these	  results	  indicate	  that	  unknown	  signaling	  pathways	  may	  regulate	  Ppz1	  activity,	  which	  in	  turn	  can	  regulate	  Art1	  activity.	  	  Further	  studies	  are	  required	  to	  dissect	  the	  molecular	  mechanism	  of	  Ppz-­‐mediated	  regulation	  of	  Art1	  activity.	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DISCUSSION	  	  	  	  	  	  	  	  	  We	  have	  uncovered	  a	  novel	  Ppz	  phosphatase-­‐mediated	  Art1	  dephosphorylation	  mechanism	  that	  regulates	  the	  endocytosis	  of	  several	  PM	  proteins.	  As	  shown	  in	  Figure	  3.5C,	  we	  propose	  the	  following	  phospho-­‐regulatory	  cycle	  for	  Art1:	  	  (1)	  following	  stimulation,	  Art1	  is	  recruited	  to	  the	  PM	  where	  Ppz	  phosphatases	  reside,	  (2)	  Ppz	  phosphatases	  dephosphorylate	  and	  activate	  Art1	  to	  trigger	  PM	  cargo	  endocytosis,	  and	  (3)	  recruitment	  of	  Npr1	  causes	  Art1	  phosphorylation	  and	  inhibition,	  which	  completes	  the	  Art1	  phospho-­‐regulatory	  cycle.	  	  These	  findings	  not	  only	  characterize	  the	  regulation	  of	  endocytosis	  by	  Ppz	  phosphatases	  but	  also	  establish	  the	  foundation	  for	  understanding	  the	  dephospho-­‐activation	  mechanism	  of	  Art1	  by	  the	  PP1	  family	  Ppz	  phosphatases.	  
Identifying	  and	  Characterizing	  other	  Art1	  Phosphatases	  	  	  	  	  	  	  	  	  In	  our	  phosphatase	  canavanine	  screen,	  some	  mutants	  showed	  a	  canavanine	  resistant	  phenotype,	  which	  are	  interesting	  and	  may	  be	  involved	  in	  some	  novel	  endocytic	  regulatory	  pathways.	  	  Our	  primarily	  experimental	  design	  was	  to	  search	  for	  mutants	  with	  a	  canavanine	  sensitive	  phenotype.	  	  Future	  studies	  of	  these	  canavanine	  resistant	  phosphatase	  mutants	  may	  help	  us	  reveal	  new	  endocytosis	  regulators	  or	  pathways.	  	  	  	  	  	  	  	  	  Based	  on	  the	  sequence	  alignment	  of	  yeast	  phosphatases,	  we	  found	  that	  the	  catalytic	  domains	  from	  the	  same	  phosphatase	  family	  are	  highly	  conserved.	  	  Given	  their	  homology,	  many	  phosphatases	  exhibit	  overlapping	  functions	  which	  leads	  to	  phenotypic	  redundancy	  (Arino,	  2002;	  Sakumoto	  et	  al.,	  2002).	  	  In	  Figure	  3.4B,	  we	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observed	  the	  unphosphorylated	  form	  of	  Art1	  in	  Δppz1Δppz2	  mutant	  in	  the	  steady	  state.	  	  Furthermore,	  many	  of	  the	  phenotypes	  observed	  in	  Δppz1Δppz2	  mutant	  cells	  appear	  to	  be	  related	  to	  kinetic	  delays,	  but	  not	  complete	  block,	  of	  endocytosis.(Figure	  3.1I).	  	  These	  data	  suggest	  that	  there	  are	  phosphatases	  other	  than	  Ppz	  phosphatases	  which	  may	  be	  involved	  in	  Art1	  dephosphorylation.	  	  In	  our	  phosphatase	  canavanine	  screen,	  we	  identified	  five	  phosphatases	  with	  a	  canavanine	  hypersensitive	  phenotype.	  	  Although	  Δppz1	  mutant	  showed	  the	  strongest	  phenotype	  in	  both	  canavanine	  plating	  and	  Can-­‐GFP	  trafficking	  (Figure	  3.1A)	  assays,	  we	  cannot	  not	  rule	  out	  the	  possibility	  that	  other	  phosphatases	  are	  also	  involved	  in	  regulating	  Art1	  dephosphorylation.	  	  Moreover,	  one	  pitfall	  of	  our	  screen	  is	  that	  we	  cannot	  identify	  phosphatases	  that	  have	  redundant	  endocytic	  function.	  	  In	  order	  to	  identify	  all	  potential	  Art1	  phosphatases,	  I	  propose	  to	  make	  different	  deletion	  combinations	  of	  these	  five	  potential	  phosphatases	  and	  score	  for	  canavanine	  sensitivity	  and	  Art1	  phosphorylation.	  	  The	  other	  potential	  way	  to	  identify	  Art1	  phosphatases	  is	  to	  do	  a	  phosphatase	  repressor	  screen	  in	  the	  Npr1	  overexpressing	  strain	  to	  screen	  for	  any	  protein	  that	  suppresses	  Npr1	  canavanine	  phenotype.	  	  Further	  characterization	  will	  be	  required	  to	  determine	  how	  these	  phosphatases	  regulate	  Art1	  activity.	  	  For	  example,	  dissecting	  the	  regulatory	  mechanism	  will	  require	  precise	  mapping	  of	  phosphorylation	  sites	  in	  Art1	  that	  are	  regulated	  by	  Ppz	  phosphatases.	  	  	  	  
Dissecting	  the	  Molecular	  Mechanism	  of	  Ppz	  Phosphatases-­‐mediated	  
Endocytosis	  	  	  	  	  	  	  	  	  In	  Figure	  3.4B,	  we	  demonstrated	  that	  Art1	  dephosphorylation	  is	  delayed	  in	  
Δppz1Δppz2	  mutant	  cells	  during	  CHX	  stimulation.	  	  This	  result	  indicates	  that	  Ppz	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phosphatases	  are	  an	  upstream	  regulator	  of	  Art1	  phosphorylation.	  	  However,	  the	  phosphorylation	  sites	  regulated	  by	  Ppz	  phosphatases	  are	  still	  not	  known.	  	  Based	  on	  our	  Art1	  phosphoprofiling	  results	  showed	  in	  Chapter	  2,	  Npr1	  regulates	  the	  N-­‐terminal	  sites	  of	  Art1,	  while	  the	  Art1	  C-­‐terminal	  proline-­‐directed	  sites	  are	  regulated	  by	  another	  unknown	  kinase	  (discussed	  in	  Chapter	  5).	  	  These	  are	  the	  potential	  sites	  for	  Ppz	  phosphatases	  to	  regulate.	  	  In	  order	  to	  dissect	  which	  terminal	  of	  Art1	  do	  Ppz	  phosphatases	  regulate,	  we	  can	  use	  the	  same	  strategy	  shown	  in	  Figure	  2.7C.	  	  I	  will	  perform	  quantitative	  phosphoprofiling	  analysis	  of	  Art1-­‐FLAG	  expressed	  cells	  with	  or	  without	  Ppz	  phosphatases.	  	  In	  addition,	  we	  are	  also	  interested	  in	  identifying	  additional	  Ppz	  phosphatase	  substrates.	  	  To	  address	  this	  question,	  a	  Ppz1	  phosphoproteome	  can	  be	  performed	  to	  identify	  proteins	  with	  increased	  phosphorylation	  in	  the	  absence	  of	  Ppz	  phosphatases.	  	  Taken	  together,	  these	  proteomic	  approaches	  will	  help	  us	  to	  better	  understand	  the	  molecular	  mechanism	  of	  Ppz	  phosphatases-­‐mediated	  regulation	  of	  endocytosis.	  	  
Identifying	  and	  Characterizing	  the	  Ppz1	  Protein	  Interaction	  Network	  	  	  	  	  	  	  	  	  In	  the	  yeast	  genome,	  there	  are	  around	  3	  times	  more	  kinases	  than	  phosphatases	  (117:32).	  	  How	  phosphatases	  reverse	  the	  phosphorylation	  created	  by	  kinases	  in	  a	  specific	  manner,	  especially	  when	  most	  of	  the	  phosphatases	  share	  similar	  functions,	  is	  an	  important	  question.	  	  A	  general	  strategy	  for	  phosphatases	  to	  achieve	  substrate	  specificity	  is	  to	  recruit	  regulatory	  proteins.	  	  This	  strategy	  is	  especially	  common	  in	  the	  case	  of	  type	  1	  Ser/Thr	  phosphatase	  family	  (Bollen,	  2001;	  Cohen,	  2002).	  	  We	  have	  demonstrated	  that	  inhibitors	  of	  Ppz	  phosphatases	  also	  play	  a	  role	  in	  regulating	  endocytosis	  (Figure	  3.2).	  	  However,	  we	  speculate	  that	  there	  may	  be	  other	  Ppz	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phosphatase	  regulators	  that	  contribute	  to	  phosphatase	  activation	  or	  substrate	  recognition.	  	  In	  order	  to	  address	  this	  question,	  we	  hope	  to	  identify	  additional	  Ppz1	  regulators	  by	  performing	  SILAC	  followed	  by	  quantitative	  mass	  spectrometry	  in	  cells	  with	  or	  without	  FLAG	  tagged	  Ppz1.	  	  This	  experiment	  may	  identify	  novelPpz1	  interacting	  proteins	  and	  provide	  the	  framework	  for	  future	  investigation	  of	  Ppz	  phosphatase	  regulation	  and	  substrate	  targeting.	  	  	  	  	  
Determine	  the	  role	  of	  Ppz	  Phosphatases	  in	  the	  regulation	  of	  other	  Rsp5	  
Adaptors	  	  	  	  	  	  	  	  	  It	  has	  been	  reported	  that	  different	  cargoes	  can	  be	  recognized	  and	  targeted	  for	  endocytosis	  by	  different	  ARTs	  during	  specific	  stimulation	  conditions	  (Lin	  et	  al.,	  2008;	  Nikko	  and	  Pelham,	  2009).	  Heat	  stress-­‐induced	  endocytosis	  of	  Mup1	  is	  delayed	  in	  Ppz	  phosphatases	  (data	  not	  shown),	  which	  suggests	  that,	  in	  addition	  to	  Art1,	  Ppz	  phosphatases	  may	  regulate	  other	  ART	  family	  proteins.	  	  Moreover,	  our	  data	  suggests	  that	  Npr1	  kinase	  may	  also	  regulate	  Art2,	  Art3,	  Art4	  and	  Art6	  (Figure	  2.8B).	  	  To	  further	  characterize	  the	  other	  ARTs	  that	  Ppz	  phosphatases	  regulate,	  we	  can	  perform	  the	  SILAC	  followed	  by	  phospho-­‐peptide	  purification	  and	  quantitative	  mass	  spectrometry	  in	  Rsp5-­‐FLAG	  expressed	  cells	  with	  or	  without	  Ppz	  phosphatases.	  	  These	  results	  will	  be	  the	  foundation	  of	  understanding	  how	  Ppz	  phosphatases	  might	  control	  the	  abundance	  of	  cell	  surface	  proteins	  by	  regulating	  the	  broader	  network	  of	  ART	  family	  proteins.	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Chapter	  4	  
Golgi-­‐to-­‐PM	  Trafficking	  is	  Required	  for	  the	  Endocytic	  Targeting	  of	  Specific	  
Cargoes	  
INTRODUCTION	  	  	  	  	  	  	  	  	  Regulation	  of	  cellular	  localization	  is	  a	  key	  regulatory	  mechanism	  for	  controlling	  protein	  function.	  	  In	  mammalian	  cells,	  β-­‐arrestin	  translocates	  from	  the	  cytosol	  to	  the	  plasma	  membrane	  (PM)	  following	  stimulation	  of	  GPCRs	  (Shenoy	  and	  Lefkowitz,	  2005).	  	  In	  yeast,	  Art1	  normally	  localizes	  to	  the	  cytoplasm,	  Golgi	  puncta,	  and	  the	  PM	  (Lin	  et	  al.,	  2008b).	  	  However,	  following	  stimulation	  or	  in	  the	  absence	  of	  inhibitory	  factors	  (like	  the	  Npr1	  kinase	  (demonstrated	  in	  chapter	  2)),	  Art1	  PM	  localization	  is	  significantly	  increased	  (Figure	  2.9	  C	  and	  D).	  	  Given	  the	  localization	  pattern	  of	  Art1	  in	  steady	  state,	  I	  hypothesized	  two	  reasonable	  models	  for	  Art1	  translocation	  to	  the	  PM:	  	  (i)	  cytosol-­‐to-­‐PM	  translocation,	  and	  (ii)	  Golgi-­‐to-­‐PM	  translocation	  by	  a	  mechanism	  such	  as	  secretion.	  	  	  	  	  	  	  	  	  	  	  	  Protein	  translocation	  from	  cytosol	  to	  the	  PM	  is	  mainly	  achieved	  by	  simple	  diffusion,	  while	  the	  translocation	  from	  Golgi	  apparatus	  to	  the	  PM	  requires	  different	  machineries.	  	  It	  has	  been	  reported	  that	  Arf1,	  a	  small	  GTPase,	  plays	  important	  roles	  in	  many	  general	  membrane	  trafficking	  pathways	  at	  the	  Golgi	  apparatus	  (Palmer	  et	  al.,	  1993).	  	  In	  addition,	  Sec7,	  a	  guanine	  nucleotide	  exchange	  factor	  (GEF),	  has	  been	  shown	  to	  activate	  Arf1	  to	  recruit	  different	  secretion	  machineries	  to	  the	  TGN,	  which	  is	  critical	  for	  delivery	  of	  cargoes	  to	  the	  PM	  (Sata	  et	  al.,	  1998).	  	  One	  of	  the	  machinery	  that	  is	  regulated	  by	  Arf1	  is	  the	  exomer	  coat	  complex.	  	  The	  exomer	  coat	  complex	  is	  composed	  of	  a	  core	  protein,	  Chs5,	  and	  four	  other	  subunits	  named	  Chs5p-­‐Arf1p	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binding	  proteins	  (ChAPs)	  with	  the	  function	  of	  transporting	  proteins	  from	  the	  trans-­‐Golgi	  network	  (TGN)	  to	  the	  PM	  (Trautwein	  et	  al.,	  2006;	  Wang	  et	  al.,	  2006).	  	  Several	  cargoes,	  including	  Chs3	  and	  Fus1,	  have	  been	  reported	  to	  be	  transported	  by	  the	  exomer	  complex	  from	  TGN	  to	  the	  PM	  (Barfield	  et	  al.,	  2009;	  Sanchatjate	  and	  Schekman,	  2006).	  	  Although	  some	  of	  the	  ChAPs	  have	  been	  studied,	  a	  clear	  function	  for	  some	  ChAPs	  is	  still	  unknown.	  	  Although	  people	  have	  already	  understood	  how	  exomer	  complex	  is	  activated	  by	  Arf1,	  further	  studies	  are	  still	  required	  for	  finding	  novel	  exomer	  cargos.	  	  	  	  	  	  	  	  	  In	  this	  chapter,	  I	  explore	  potential	  mechanisms	  of	  Art1	  PM	  translocation.	  	  My	  findings	  suggest	  that	  the	  exomer	  complex,	  especially	  Chs5-­‐Bch1	  complex,	  plays	  an	  important	  role	  for	  Art1	  TGN-­‐to-­‐PM	  translocation.	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MATERIAL	  AND	  METHODS	  
Plasmids,	  Strains	  and	  Yeast	  Plating	  Assays	  All	  plasmids	  and	  yeast	  strains	  used	  in	  this	  study	  are	  listed	  in	  Table	  S1	  and	  Table	  S2,	  respectively.	  	  Canavanine	  plating	  assays	  were	  performed	  as	  previously	  described	  (Lin	  et	  al.,	  2008a).	  	  Briefly,	  yeast	  cultures	  grown	  overnight	  in	  YPD	  were	  normalized	  to	  1	  OD/mL,	  serially	  diluted	  and	  plated	  onto	  SCD	  plates	  using	  a	  pin-­‐frogger.	  	  The	  following	  concentrations	  of	  canavanine	  were	  tested	  in	  each	  experiment:	  	  0	  µg/mL,	  0.6	  µg/mL,	  0.8	  µg/mL,	  1.0	  µg/mL,	  2.0	  µg/mL,	  4.0	  µg/mL	  and	  6.0	  µg/mL.	  	  	  
SILAC	  and	  Quantitative	  Mass	  Spectrometry	  All	  quantitative	  mass	  spectrometry	  analysis	  was	  performed	  using	  SILAC	  labelling	  of	  yeast	  strains	  auxotrophic	  for	  lysine	  and	  arginine.	  	  Cells	  with	  or	  without	  chromosomal	  tagged	  Art1-­‐HTF	  were	  grown	  to	  mid-­‐log	  phase	  in	  the	  presence	  of	  heavy	  or	  light	  isotopes,	  respectively,	  (lysine	  and	  arginine).	  	  0.5	  mg/mL	  DSP	  was	  added	  prior	  to	  cell	  harvesting	  and	  affinity	  purification	  was	  performed	  by	  using	  flag	  M2	  beads	  (Sigma).	  	  Heavy	  and	  light	  purified	  samples	  were	  mixed	  and	  digested	  with	  1μg	  of	  trypsin	  for	  2	  hours	  at	  37˚C.	  	  For	  phosphoprofiling	  experiments,	  phosphopeptides	  were	  purified	  using	  IMAC	  chromatography	  as	  previously	  described	  (Albuquerque	  et	  al.,	  2008).	  	  Purified	  peptides	  were	  dried,	  reconstituted	  in	  0.1%	  trifluoroacetic	  acid,	  and	  analysed	  by	  LC-­‐MS/MS	  using	  an	  Orbitrap	  XL	  mass	  spectrometer.	  	  Database	  search	  and	  SILAC	  quantitation	  was	  performed	  using	  Sorcerer	  software.	  	  	  
Recombinant	  Protein	  Expression	  and	  Purification	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Full	  length	  Art1-­‐6xHis-­‐FLAG	  (pJAM583)	  and	  Rsp5-­‐StrepII	  (pJAM587)	  were	  transformed	  into	  Rosetta2	  competent	  cells	  (EMD	  Chemicals	  USA).	  	  1L	  cultures	  were	  grown	  to	  mid-­‐log	  phase	  (OD600=0.7)	  at	  37°C.	  	  1mM	  IPTG	  was	  added	  to	  bacteria	  cultures	  to	  induce	  protein	  expression	  at	  16°C	  for	  20	  hours.	  	  Cells	  were	  lysed	  by	  sonication	  in	  PBS	  with	  protease	  inhibitors.	  For	  Art1	  purification,	  TALON	  Metal	  Affinity	  Resin	  beads	  (Clontech)	  were	  added	  to	  cleared	  lysates	  and	  rotated	  for	  1	  hour	  at	  4	  °C.	  	  Beads	  were	  washed	  in	  PBS,	  and	  then	  eluted	  in	  elution	  buffer	  (PBS	  with	  200mM	  imidazole).	  	  For	  Rsp5	  purification,	  I	  followed	  the	  protocol	  of	  Strep-­‐tag	  Protein	  purification	  kit	  (Qiagen).	  	  
In	  vitro	  Liposome	  Binding	  Assays	  For	  nucleotide	  stripping,	  20	  µl	  of	  1	  mM	  major-­‐minor	  liposomes	  with	  DiR	  dye	  and	  1	  
µl	  0.05	  M	  EDTA	  was	  incubated	  with	  6	  µg	  of	  purified	  Arf1	  and	  1	  µl	  of	  10	  mM	  nucleotide	  (GDP	  or	  GMPPNP)	  for	  30	  minutes	  at	  room	  temperature.	  	  6	  µg	  of	  Chs5	  and	  Bch1	  were	  added	  to	  the	  nucleotide	  stripping	  reaction.	  1	  µl	  of	  2	  M	  MgCl2	  was	  added	  to	  each	  reaction	  and	  incubated	  for	  1	  hour	  at	  room	  temperature	  for	  liposome	  binding	  reaction.	  	  6	  µg	  of	  Art1	  and	  Rsp5	  were	  added	  to	  the	  exomer	  liposome	  reaction	  and	  brought	  the	  final	  volume	  to	  80	  µl	  with	  HK	  buffer	  (20	  mM	  HEPES	  pH	  7.4,	  150	  mM	  KOAc)	  for	  1	  hour	  at	  room	  temperature.	  	  50	  µl	  of	  2.5	  M	  sucrose	  in	  HKM	  (HK	  buffer	  plus	  1	  mM	  MgCl2)	  was	  added	  to	  each	  binding	  reaction	  and	  mixed	  well.	  	  100	  µl	  of	  the	  binding	  reactions	  were	  transferred	  to	  Beckman	  7x20	  mm	  PC	  ultracentrifuge	  tube	  and	  the	  remainder	  was	  saved	  as	  input	  samples.	  	  100	  µl	  of	  0.75	  M	  sucrose	  in	  HKM	  and	  20	  µl	  HKM	  was	  overlaid	  on	  top	  of	  the	  binding	  reaction.	  	  The	  sucrose	  gradient	  ultracentrifugation	  was	  performed	  at	  100	  krpm	  at	  20˚C	  for	  20	  minutes.	  	  30	  µl	  of	  the	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RESULTS	  
Art1	  Interacts	  with	  Specialized	  Secretion	  Machinery	  at	  the	  Golgi	  	  Complex	  	  	  	  	  	  	  	  	  In	  an	  attempt	  to	  identify	  factors	  important	  for	  Art1	  translocation	  to	  the	  PM,	  we	  used	  SILAC	  combined	  with	  quantitative	  mass	  spectrometry	  to	  identify	  Art1	  interacting	  proteins.	  	  However,	  the	  only	  Art1	  interacting	  protein	  identified	  from	  this	  analysis	  was	  Rsp5	  (data	  not	  shown).	  	  In	  order	  to	  capture	  weak	  or	  transient	  Art1-­‐interacting	  proteins,	  we	  added	  cross-­‐linkers	  into	  the	  media	  shortly	  before	  harvesting	  the	  cells.	  	  As	  shown	  in	  Figure	  4.1(A),	  addition	  of	  crosslinkers	  resulted	  in	  the	  identification	  of	  additional	  Art1	  interacting	  proteins.	  	  One	  of	  the	  top	  hits	  identified	  in	  this	  analysis	  is	  Bch1,	  a	  subunit	  of	  the	  exomer	  complex	  that	  localizes	  to	  the	  trans-­‐Golgi	  network	  (TGN)	  (Trautwein	  et	  al.,	  2006).	  	  	  	  	  	  	  	  	  	  	  To	  confirm	  this	  interaction,	  we	  analyzed	  the	  subcellular	  localization	  of	  both	  Art1	  and	  exomer	  complex	  by	  tagging	  the	  proteins	  with	  GFP	  and	  mCherry,	  respectively	  (Figure	  4.1B).	  	  As	  shown	  previously,	  Art1-­‐GFP	  localized	  to	  the	  PM	  and	  the	  cytoplasm	  (Lin	  et	  al.,	  2008b).	  	  Moreover,	  consistent	  with	  the	  Art1	  interactome	  experiment	  result,	  we	  detected	  a	  strong	  co-­‐localization	  of	  Art1	  and	  exomer	  at	  the	  Golgi.	  	  These	  results	  are	  consistent	  with	  our	  observation	  that	  Art1	  physically	  interacts	  with	  exomer,	  and	  suggests	  that	  this	  interaction	  occurs	  at	  the	  TGN.	  	  	  
The	  Exomer	  Complex	  Plays	  a	  Role	  in	  Art1-­‐mediated	  Cargo	  Endocytosis	  	  	  	  	  	  	  	  	  I	  wanted	  to	  better	  understand	  if	  interaction	  with	  exomer	  is	  required	  for	  Art1	  function.	  	  I	  hypothesized	  that	  if	  the	  exomer	  complex	  is	  required	  for	  Art1	  function,	  we	  would	  see	  canavanine	  sensitive	  phenotype	  in	  the	  exomer	  mutant,	  as	  Art1	  can	  no	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Figure	  4.1.	  	  Art1	  interacts	  with	  proteins	  in	  the	  secretion	  machinery	  at	  the	  Golgi	  apparatus	  (A)	  Art1	  SILAC	  interactome	  experiment	  with	  cross-­‐linker.	  	  X-­‐axis	  represents	  different	  proteins	  and	  Y-­‐axis	  represent	  gmean	  of	  each	  protein.	  	  WT	  (labeled	  with	  light	  isotope)	  and	  Art1-­‐FLAG	  tagged	  cells	  (labeled	  with	  heavy	  isotope)	  were	  collected	  and	  analyzed	  by	  FLAG	  immunoprecipitation.	  	  Samples	  were	  subjected	  to	  SILAC	  and	  quantitative	  mass	  spectrometry.	  	  We	  made	  the	  gmean	  cutoff	  line	  at	  20	  to	  rule	  out	  some	  less	  strong	  bindings	  (Emi2,	  Car1,	  Hxk1	  and	  Aro4)	  and	  found	  that	  besides	  the	  known	  Art1	  interacting	  protein	  Rsp5,	  Bch1,	  the	  ChAP	  of	  exomer	  complex,	  also	  showed	  physical	  interaction	  with	  Art1.	  	  The	  inset	  table	  shows	  proteins	  containing	  peptides	  with	  more	  than	  a	  20-­‐fold	  increase	  in	  Art1-­‐FLAG	  tagged	  cells	  compare	  to	  WT	  cells.	  	  (B)	  WT	  cells	  expressing	  both	  Art1-­‐GFP	  and	  Chs5-­‐mCherry	  were	  grown	  to	  midlog	  phase	  and	  subjected	  to	  microscopy	  imaging	  (arrows	  show	  the	  co-­‐localization	  of	  the	  two	  proteins).	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longer	  be	  recruited	  to	  the	  PM	  to	  turnover	  Can1.	  	  By	  using	  the	  canavanine	  plating	  assay	  in	  the	  exomer	  mutants,	  we	  tested	  whether	  Art1	  PM	  trafficking	  is	  dependent	  on	  the	  exomer	  complex.	  	  As	  shown	  in	  Figure	  4.2A,	  Δchs5	  mutant	  shows	  a	  canavanine	  sensitive	  phenotype,	  suggesting	  that	  the	  exomer	  complex	  is	  required	  for	  Art1	  function.	  	  Moreover,	  Δbch1	  mutant	  shows	  a	  canavanine	  sensitive	  phenotype	  while	  
Δchs6	  mutant	  grows	  just	  like	  WT.	  	  This	  result	  is	  consistent	  with	  our	  Art1	  SILAC	  interactome	  experiment,	  which	  demonstrates	  that	  Bch1	  is	  the	  major	  ChAP	  that	  binds	  to	  Art1.	  	  Furthermore,	  the	  Δbud7	  mutant	  also	  shows	  a	  canavanine	  sensitive	  phenotype,	  though	  it	  is	  not	  as	  severe	  as	  Δbch1	  mutant.	  	  As	  previously	  reported,	  Bch1	  and	  Bud7	  have	  the	  highest	  sequence	  similarity	  among	  all	  the	  ChAPs	  (Barfield	  et	  al.,	  2009;	  Sanchatjate	  and	  Schekman,	  2006).	  	  This	  result	  suggests	  the	  redundancy	  of	  Bch1	  and	  Bud7	  in	  regulating	  Art1	  function.	  	  	  To	  further	  explore	  Art1	  function	  in	  exomer	  mutants,	  we	  directly	  measured	  arginine	  uptake	  by	  Can1	  (Figure	  4.2B).	  	  Consistent	  with	  the	  canavanine	  plating	  assay,	  Can1	  is	  more	  activated	  to	  transport	  arginine	  in	  the	  Δchs5	  mutant	  compare	  to	  WT	  cells,	  suggesting	  that	  there	  are	  more	  functional	  Can1	  at	  the	  PM	  in	  the	  exomer	  mutants.	  	  Can1	  activity	  in	  the	  Δbch1	  mutant	  is	  also	  higher	  than	  the	  WT,	  although	  it	  is	  not	  as	  high	  as	  the	  Δchs5	  mutant,	  which	  is	  probably	  due	  to	  the	  redundancy	  of	  Bch1	  and	  Bud7.	  	  	  	  	  	  	  	  	  Since	  both	  the	  exomer	  and	  Art1	  mutants	  are	  hypersensitive	  to	  canavanine,	  we	  examined	  the	  effect	  of	  Art1	  overexpression	  in	  exomer	  mutants	  (Figure	  4.2C).	  	  Overexpression	  of	  Art1	  in	  WT	  cells	  leads	  to	  a	  canavanine	  resistant	  phenotype	  in	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Figure	  4.2.	  	  Exomer	  complex	  is	  required	  for	  Art1-­‐mediated	  Can1	  endocytosis	  (A)	  WT	  (background	  BY4741)	  cells	  ,	  as	  well	  as	  exomer	  core	  protein	  (Chs5)	  and	  ChAPs	  (Bch1,	  Chs6,	  and	  Bud7)	  mutants	  from	  the	  yeast	  deletion	  collection	  were	  plated	  on	  canavanine	  plates	  to	  score	  for	  Can1	  endocytosis	  defect.	  (B)	  WT	  (blue),	  Δchs5	  (red),	  and	  Δbch1	  (green)	  cells	  were	  grown	  to	  midlog	  phase	  and	  subjected	  to	  [3H]	  arginine.	  Samples	  were	  collected	  at	  5,	  15,	  and	  30	  minute	  time	  points.	  (C)	  WT	  cells	  expressing	  empty	  vector,	  as	  well	  as	  WT,	  Δchs5,	  and	  Δbch1	  cells	  carrying	  Art1	  overexpression	  plasmids	  (driven	  by	  a	  TDH3	  promoter)	  were	  plated	  on	  canavanine	  plates	  to	  score	  for	  the	  ability	  of	  Art1-­‐mediated	  Can1	  endocytosis.	  (D)	  Can1-­‐GFP	  was	  imaged	  in	  WT	  cells	  expressing	  empty	  vector	  or	  Art1	  over-­‐expression	  (Art1	  OE)	  plasmids	  (with	  chromosomal	  tagged	  Vph1-­‐mCherry)	  in	  the	  left	  panel.	  Can1-­‐GFP	  was	  imagined	  in	  both	  WT	  cells	  (marked	  by	  chromosomal	  tagged	  Vph1-­‐mCherry)	  and	  exomer	  mutants	  (Δchs5	  and	  Δbch1	  cells	  for	  the	  middle	  and	  the	  right	  panels,	  respectively)	  carrying	  Art1	  OE	  plasmids.	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comparison	  to	  WT	  cells	  carrying	  empty	  vector.	  	  However,	  this	  canavanine	  resistant	  phenotype	  is	  dependent	  on	  the	  presence	  of	  both	  Chs5	  and	  Bch1,	  suggesting	  that	  Art1-­‐mediated	  Can1	  endocytosis	  is	  dependent	  on	  the	  function	  of	  exomer	  complex.	  	  In	  addition,	  Can1	  trafficking	  to	  the	  vacuole	  upon	  Art1	  overexpression	  is	  dependent	  on	  the	  exomer	  complex.	  	  (Figure	  4.2D,	  middle	  and	  right	  panel,	  respectively).	  	  This	  result	  is	  consistent	  with	  the	  canavanine	  plating	  assay	  and	  suggests	  that	  the	  exomer	  complex	  is	  required	  for	  Art1	  regulation	  of	  Can1	  endocytosis.	  
The	  Exomer	  Complex	  Mediates	  Art1	  PM	  Recruitment	  and	  Phosphorylation	  	  	  	  	  	  	  	  	  	  	  	  	  	  Given	  our	  observations	  that	  exomer	  plays	  a	  role	  in	  Art1	  function,	  we	  wanted	  to	  decipher	  the	  molecular	  mechanism	  by	  which	  exomer	  positively	  mediates	  cargo	  turnover.	  	  Because	  one	  major	  function	  of	  the	  exomer	  complex	  is	  to	  transport	  proteins	  from	  the	  TGN	  to	  the	  PM,	  we	  hypothesized	  that	  the	  exomer	  complex	  may	  recruit	  Art1	  to	  the	  PM	  during	  stimulation.	  	  To	  test	  this	  hypothesis,	  we	  expressed	  Art1-­‐GFP	  in	  both	  WT	  (marked	  by	  chromosomal	  tagged	  Mup1-­‐mCherry)	  and	  ∆chs5	  cells	  and	  subsequently	  treated	  the	  cells	  with	  CHX	  for	  15	  minutes	  to	  trigger	  Art1	  PM	  translocation	  (Figure	  4.3A).	  	  After	  stimulation,	  Art1-­‐GFP	  was	  recruited	  to	  the	  PM	  in	  the	  WT	  cells.	  	  However,	  this	  PM	  recruitment	  is	  diminished	  in	  the	  Δchs5	  mutants,	  suggesting	  that	  the	  exomer	  complex	  is	  required	  for	  efficient	  translocation	  of	  Art1	  to	  the	  PM.	  	  This	  result	  suggests	  that	  exomer	  plays	  a	  specific	  role	  in	  translocation	  of	  Art1	  to	  the	  PM,	  and	  is	  consistent	  with	  the	  endocytic	  defects	  observed	  in	  exomer	  mutants.	  	  	  	  	  	  	  	  	  	  	  Previously,	  we	  reported	  that	  Npr1	  phosphorylates	  Art1	  at	  the	  PM,	  and	  this	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Figure	  4.3.	  Art1	  PM	  recruitment	  and	  phosphorylation	  is	  partially	  dependent	  on	  the	  exomer	  complex	  (A)	  WT	  (marked	  by	  chromosomal	  tagged	  Mup1-­‐Mars)	  and	  Δchs5	  cells	  were	  grown	  to	  midlog	  phase	  and	  then	  treated	  with	  cycloheximide	  (50mg/ml)	  for	  15	  minutes.	  Art1-­‐GFP	  PM	  recruitment	  was	  imaged	  in	  both	  WT	  and	  Dchs5	  cells.	  (B)	  Model	  for	  exomer-­‐mediated	  Art1	  PM	  recruitment	  and	  phosphorylation.	  In	  WT	  cells,	  the	  exomer	  translocates	  Art1	  from	  Golgi	  to	  the	  PM	  where	  it	  is	  phosphorylated	  by	  Npr1	  (left	  panel).	  However,	  in	  the	  exomer	  mutant,	  Art1	  is	  unable	  to	  reach	  the	  PM	  (right	  panel).	  PM	  localization	  of	  Art1	  is	  critical	  for	  its	  phosphorylation	  by	  Npr1	  (C)	  Western	  blot	  of	  Art1	  band-­‐shift	  in	  WT,	  exomer	  mutants,	  and	  Δnpr1	  cells.	  The	  ratio	  of	  phosphorylated	  Art1	  to	  dephosphorylated	  Art1	  is	  quantified	  in	  the	  lower	  panel.	  	  (D)	  WT,	  Δnpr1	  Δchs5	  and	  Δnpr1	  Δbch1	  cells	  were	  plated	  on	  canavanine	  plates	  to	  test	  for	  genetic	  interactions	  between	  Npr1	  and	  the	  exomer.	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phosphoregulation	  is	  important	  to	  inhibit	  Art1	  activity	  (demonstrated	  in	  chapter	  2).	  	  Moreover,	  provided	  that	  the	  exomer	  complex	  plays	  a	  role	  in	  Art1	  PM	  recruitment,	  we	  hypothesized	  that	  Npr1-­‐mediated	  phosphorylation	  of	  Art1	  should	  not	  takes	  place	  in	  exomer	  mutants	  (model	  is	  illustrated	  in	  Figure	  4.3B).	  	  To	  test	  this	  hypothesis,	  we	  performed	  the	  Art1	  band-­‐shift	  assay	  to	  see	  if	  there	  is	  any	  Art1	  phosphorylation	  change	  in	  the	  exomer	  mutants	  (Figure	  4.3C).	  	  Using	  this	  approach,	  we	  found	  a	  reduction	  in	  Art1	  phosphorylation	  in	  exomer	  mutants	  compared	  to	  WT	  cells.	  	  Additionally,	  Δchs5,	  Δbch1,	  and	  Δbud7	  mutants	  showed	  less	  Art1	  phosphorylation	  in	  comparison	  to	  Δchs6	  mutants,	  which	  supports	  our	  previous	  finding	  that	  the	  Bch1	  exomer	  complex	  is	  the	  major	  exomer	  complex	  responsible	  for	  Art1	  PM	  recruitment.	  	  Nevertheless,	  none	  of	  the	  exomer	  mutants	  showed	  complete	  Art1	  dephosphorylation	  as	  Δnpr1	  mutants	  showed.	  	  This	  result	  shows	  that	  exomer	  mutants	  cannot	  completely	  block	  Art1	  phosphorylation	  and	  may	  suggests	  the	  existence	  of	  perhaps	  a	  secondary	  Art1	  PM	  translocation	  route	  in	  addition	  to	  the	  exomer	  complex.	  	  	  	  	  	  	  	  	  	  	  To	  better	  understand	  the	  genetic	  interaction	  between	  the	  exomer	  complex	  and	  Npr1,	  the	  Δnpr1Δchs5	  and	  Δnpr1Δbch1	  double	  knockouts	  were	  made	  and	  tested	  by	  the	  canavanine	  plating	  assay.	  	  If	  the	  exomer	  complex	  is	  required	  for	  Art	  PM	  translocation,	  I	  proposed	  the	  model	  shown	  in	  Figure	  4.3B.	  	  In	  this	  model,	  the	  double	  knockouts	  should	  lead	  to	  canavanine	  sensitive	  phenotype	  because	  of	  a	  reduction	  in	  PM	  localized	  Art1.	  	  However,	  although	  the	  double	  knockouts	  were	  more	  sensitive	  to	  canavanine	  compare	  to	  Δnpr1	  mutants,	  they	  grew	  similar	  to	  or	  a	  little	  better	  than	  the	  WT	  cells.	  	  These	  results	  suggest	  that	  the	  exomer	  complex	  may	  not	  be	  the	  only	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pathway	  to	  recruit	  Art1	  to	  the	  PM.	  	  Thus,	  Art1	  may	  be	  recruited	  to	  the	  PM	  via	  additional	  pathways,	  which	  will	  be	  discussed	  more	  in	  the	  DISCUSSION.	  
Art1	  Interacts	  with	  the	  Exomer	  Liposome	  in	  vitro	  	  	  	  	  	  	  	  	  In	  order	  to	  confirm	  the	  observed	  in	  vivo	  interaction	  between	  Art1	  and	  exomer,	  and	  to	  prove	  that	  it	  is	  not	  through	  an	  indirect	  binding	  or	  an	  artifact	  of	  crosslinking,	  we	  examined	  Art1	  binding	  to	  exomer	  using	  an	  in	  vitro	  liposome	  binding	  assay.	  	  First,	  we	  purified	  the	  recombinant	  Art1-­‐6xHis	  from	  E.	  coli	  and	  then	  checked	  the	  protein	  expression	  by	  coomassie	  blue	  staining	  (Figure	  4.4A).	  	  Although	  we	  observed	  some	  protein	  degradation	  during	  the	  purification	  process,	  the	  major	  band	  in	  the	  elution	  was	  the	  full	  length	  Art1.	  	  Since	  Art1	  and	  Rsp5	  form	  a	  complex	  in	  the	  cell,	  we	  reasoned	  that	  the	  formation	  of	  the	  complex	  might	  be	  important	  for	  Art1	  protein	  stabilization	  or	  for	  Art1	  function.	  	  Thus,	  we	  also	  purified	  the	  recombinant	  Rsp5-­‐StrepII	  from	  E.	  coli	  and	  checked	  the	  protein	  expression	  by	  coomassie	  blue	  staining	  (Figure	  4.4B).	  	  Compared	  to	  recombinant	  Art1,	  Rsp5	  was	  relatively	  stable.	  	  In	  order	  to	  measure	  the	  amount	  of	  the	  purified	  Art1	  and	  Rsp5,	  both	  proteins	  were	  stained	  by	  coomassie	  blue	  and	  subjected	  to	  quantification	  by	  the	  Odessey	  imaging	  system	  (Figure	  4.4C).	  	  	  	  	  	  	  	  	  	  	  It	  has	  been	  reported	  that	  the	  exomer	  complex	  can	  be	  recruited	  to	  liposomes	  via	  activated	  Arf1	  (Wang	  et	  al.,	  2006).	  	  We	  wanted	  to	  determine	  whether	  the	  exomer	  complex	  has	  the	  ability	  to	  recruit	  Art1	  to	  liposomes.	  	  To	  do	  this,	  we	  first	  incubated	  liposomes	  with	  activated	  (GDPPNP	  was	  added)	  and	  inactivated	  (GDP	  was	  added)	  Arf1	  and	  then	  incubated	  these	  Arf1	  liposomes	  with	  Chs5-­‐Bch1	  exomer	  complex.	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Figure	  4.4.	  	  Art1	  is	  recruited	  to	  the	  exomer	  liposome	  in	  vitro	  (A)	  Recombinant	  Art1-­‐His-­‐tagged-­‐FLAG	  was	  purified	  from	  E.	  coli	  and	  stained	  by	  Coomassie	  blue	  in	  the	  6%	  SDS-­‐PAGE.	  (WCL:	  whole	  cell	  lysate,	  FT:	  flow	  through,	  Beads	  Bef	  Elu:	  beads	  before	  elute).	  (B)	  Recombinant	  Rsp5-­‐StrepII	  was	  purified	  from	  E.	  coli	  and	  stained	  by	  Coomassie	  blue	  in	  the	  6%	  SDS-­‐PAGE.	  (C)	  Purified	  Art1	  and	  Rsp5	  were	  subjected	  to	  6%	  SDS-­‐PAGE	  and	  the	  intensity	  of	  the	  bands	  were	  measured	  by	  Odyssey	  imaging	  system.	  (D)	  Purified	  recombinant	  proteins	  (Chs5,	  Bch1,	  Art1,	  and	  Rsp5)	  were	  incubated	  with	  liposomes	  with	  and	  without	  activated	  Arf1,	  GDPPNP-­‐	  and	  GDP-­‐bound	  respectively.	  Liposome	  fractions	  were	  analyzed	  by	  Western	  blot	  to	  detect	  the	  liposome	  binding	  ability	  of	  Chs5	  and	  Art1.	  	  	  	  	  	  	  	  	  	  	  	  	  	  
 	  	   165	  
After	  obtaining	  exomer-­‐bound	  liposomes,	  recombinant	  Art1-­‐Rsp5	  (with	  1:1	  ratio)	  was	  added	  and	  liposomes	  were	  isolated	  by	  flotation.	  	  As	  Figure	  4.4D	  shows,	  Chs5	  can	  only	  bind	  to	  the	  activated	  Arf1	  (GDPPNP	  bound	  form),	  which	  is	  a	  positive	  control	  for	  this	  in	  vitro	  binding	  assay.	  	  Consistent	  with	  our	  in	  vivo	  binding	  result,	  Art1	  binds	  the	  activated	  Arf1	  liposome	  with	  Chs5-­‐Bch1	  complex	  while	  we	  cannot	  detect	  the	  binding	  of	  Art1	  to	  the	  Arf1	  inactivated	  liposome.	  	  Taken	  together,	  these	  results	  confirm	  our	  in	  vivo	  binding	  result	  and	  demonstrate	  that	  Art1	  can	  be	  recruited	  to	  the	  liposome	  through	  direct	  binding	  to	  the	  Arf1-­‐exomer	  complex.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
 	  	   166	  
DISCUSSION	  	  	  	  	  	  	  	  	  We	  have	  uncovered	  a	  possible	  role	  of	  the	  exomer	  complex	  in	  transporting	  Art1	  from	  TGN	  to	  the	  PM	  (Figure	  4.5).	  	  Specifically,	  we	  have	  shown	  that	  (1)	  the	  exomer	  complex	  plays	  a	  role	  in	  Art1-­‐mediated	  cargo	  endocytosis	  and	  (2)	  the	  exomer	  complex	  is	  implicated	  in	  Art1	  PM	  recruitment.	  	  These	  findings	  not	  only	  demonstrate	  the	  regulatory	  mechanism	  of	  Art1	  function	  by	  the	  exomer	  complex	  but	  also	  establish	  the	  foundation	  to	  understand	  why	  Art1	  localizes	  to	  the	  Golgi	  apparatus	  and	  how	  Art1	  maintains	  its	  PM	  localization	  after	  stimulation.	  	  
Art1	  can	  be	  Recruited	  to	  the	  PM	  via	  an	  Exomer-­‐independent	  Mechanism	  	  	  	  	  	  	  	  	  The	  results	  from	  the	  Art1	  band-­‐shift	  assay	  in	  the	  exomer	  mutants	  (Figure	  4.3C)	  and	  Npr1	  exomer	  double	  knockout	  canavanine	  plating	  assay	  (Figure	  4.3D)	  suggest	  that	  the	  exomer	  machinery	  may	  not	  be	  the	  only	  mechanism	  for	  Art1	  PM	  recruitment.	  	  Given	  our	  analysis	  of	  Art1	  subcellular	  localization,	  Art1	  can	  be	  recruited	  to	  the	  PM	  from	  either	  the	  cytosol	  or	  the	  Golgi	  apparatus.	  	  As	  such,	  three	  possible	  routes	  of	  PM	  translocation	  include:	  1)	  direct	  targeting	  of	  Golgi	  vesicles	  to	  the	  PM;	  2)	  indirect	  targeting	  from	  the	  Golgi	  apparatus	  to	  the	  PM	  via	  trafficking	  to	  and	  sorting	  at	  endosomes;	  3)	  direct	  recruitment	  of	  cytosolic	  Art1	  to	  the	  PM	  by	  diffusion.	  	  The	  first	  two	  possibilities	  require	  vesicle	  trafficking	  and	  thus	  can	  be	  tested	  using	  mutant	  strains	  defective	  for	  secretion	  from	  the	  Golgi	  apparatus	  (sec1ts,	  
sec7ts,	  and	  pik1ts	  )	  (Strahl	  and	  Thorner,	  2007);	  (Wang	  et	  al.,	  2006),	  Golgi-­‐to-­‐endosome	  traffic	  (Δgga1Δgga2,	  Δlaa1)	  (Bonifacino	  and	  Hurley,	  2008),	  or	  general	  	  membrane	  traffic	  (sec18ts).	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Figure	  4.5.	  	  A	  functional	  model	  for	  the	  exomer	  complex	  mediation	  of	  Art1	  subcellular	  localization.	  	  (1)	  Under	  unstimulated	  condition,	  the	  Art1-­‐Rsp5	  complex	  is	  inactive	  and	  localizes	  at	  the	  cytosol	  and	  Golgi	  apparatus.	  	  Following	  stimulation,	  the	  exomer	  complex	  recruits	  the	  Art1-­‐Rsp5	  complex	  to	  the	  TGN	  and	  transports	  it	  the	  PM.	  	  (2)	  After	  reaching	  the	  PM,	  the	  Art1-­‐Rsp5	  complex	  ubiquitinates	  cargoes,	  such	  as	  Can1,	  and	  targets	  them	  for	  endocytic	  degradation.	  	  Through	  binding	  to	  PI(4,5)P2	  at	  the	  PM,	  the	  Art1-­‐Rsp5	  complex	  maintains	  its	  PM	  localization	  and	  triggers	  more	  cargo	  endocytosis	  locally.	  	  (3)	  In	  order	  to	  dampen	  this	  endocytic	  signal,	  Npr1	  can	  then	  be	  activated	  and	  recruited	  to	  the	  PM	  to	  phosphorylate	  Art1.	  	  Inactivated	  Art1-­‐Rsp5	  complex	  releases	  from	  the	  PM,	  thus	  finishing	  this	  regulatory	  cycle.	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  However,	  if	  Art1	  PM	  translocation	  is	  shown	  to	  be	  independent	  of	  membrane	  trafficking	  in	  the	  cell,	  we	  can	  then	  test	  the	  role	  of	  the	  cytoskeleton.	  	  By	  using	  pharmacological	  inhibitors	  of	  cytoskeletal	  dynamics	  such	  as	  latrunculin	  and	  nocodazole,	  we	  can	  determine	  if	  actin	  or	  microtubule	  polymerization	  are	  required	  for	  Art1	  localization	  to	  the	  PM	  or	  the	  Golgi	  apparatus.	  	  If	  the	  results	  indicate	  that	  Art1	  PM	  recruitment	  is	  independent	  of	  membrane	  trafficking	  and	  cytoskeletal	  dynamics,	  then	  we	  may	  consider	  the	  possibility	  that	  Art1	  diffuses	  directly	  from	  the	  cytosol	  to	  the	  PM.	  	  Since	  cytosolic	  diffusion	  of	  Art1	  should	  be	  constant,	  it	  is	  possible	  that	  PM	  recruitment	  may	  result	  from	  a	  decreased	  off	  rate	  of	  Art1	  from	  the	  PM	  during	  stimulation.	  	  Although	  we	  have	  shown	  that	  Npr1	  is	  important	  for	  releasing	  Art1	  from	  the	  PM,	  the	  detailed	  mechanism	  is	  still	  unknown.	  	  One	  possibility	  is	  that	  the	  massive	  amount	  of	  Art1	  N-­‐terminal	  phosphorylations	  by	  Npr1	  can	  create	  a	  lot	  of	  negative	  charges,	  which	  may	  subsequently	  increase	  the	  repulsion	  force	  of	  Art1	  off	  the	  PM.	  However,	  further	  studies	  are	  needed	  to	  dissect	  the	  mechanism	  of	  how	  both	  Npr1	  and	  the	  exomer	  complex	  regulate	  Art1	  PM	  localization.	  
Arf1	  is	  Required	  for	  Art1-­‐mediated	  Cargo	  Endocytosis	  	  	  	  	  	  	  	  	  Based	  on	  the	  results	  of	  our	  in	  vitro	  exomer	  liposome	  binding	  assay	  (Figure	  4.3D)	  and	  other	  publications	  (Wang	  et	  al.,	  2006),	  we	  can	  conclude	  that	  Arf1	  is	  required	  for	  activating	  exomer	  complex.	  	  Therefore,	  we	  hypothesize	  that	  Arf1	  is	  also	  required	  for	  Art1-­‐mediated	  cargo	  endocytosis	  since	  Arf1	  is	  an	  upstream	  regulator	  of	  the	  exomer	  complex.	  	  By	  testing	  canavanine	  sensitivity	  of	  the	  Δarf1	  mutant,	  we	  found	  that	  the	  mutant	  showed	  the	  same	  sensitive	  phenotype	  as	  did	  exomer	  mutants	  (data	  not	  shown),	  suggesting	  that	  Arf1	  plays	  a	  role	  in	  Can1	  mediated	  endocytosis.	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  Furthermore,	  we	  tested	  whether	  Arf1	  activity	  is	  essential	  for	  Art1-­‐mediated	  cargo	  endocytosis	  by	  performing	  a	  genetic	  test	  of	  Art1	  and	  Arf1.	  	  In	  brief,	  we	  over-­‐expressed	  Art1	  in	  both	  WT	  and	  Δarf1	  mutant	  cells,	  and	  then	  plated	  them	  on	  canavanine	  plates.	  	  Similar	  to	  the	  exomer	  mutants,	  the	  Δarf1	  mutant	  blocked	  the	  Art1	  over-­‐expressed	  canavanine	  resistant	  phenotype	  (data	  not	  shown).	  	  This	  result	  suggests	  that	  Arf1	  may	  function	  upstream	  of	  Art1	  and	  may	  positively	  regulate	  Art1	  function.	  	  Additionally,	  we	  detected	  less	  phosphorylation	  in	  the	  Δarf1	  mutant	  compare	  to	  WT	  cells	  (data	  not	  shown),	  indicating	  that	  Art1	  PM	  recruitment	  is	  inhibited.	  	  All	  together,	  these	  results	  indicate	  that	  Arf1,	  like	  exomer	  complex,	  is	  required	  for	  Art1	  PM	  recruitment	  and	  phosphorylation.	  	  	  
Dissect	  the	  Molecular	  Mechanism	  of	  Art1	  Membrane	  Recruitment	  and	  
Maintenance	  	  	  	  	  	  	  	  	  Although	  we	  have	  shown	  that	  Art1	  can	  be	  recruited	  to	  the	  exomer	  liposome,	  we	  do	  not	  know	  if	  all	  the	  elements	  tested	  in	  our	  experiment	  are	  required	  (Figure	  4.3D).	  	  For	  example,	  Art1	  might	  bind	  to	  the	  exomer	  liposome	  even	  without	  forming	  the	  complex	  with	  Rsp5	  and	  could	  be	  recruited	  to	  the	  liposome	  in	  the	  absence	  of	  the	  Chs5-­‐Bch1	  complex.	  	  By	  testing	  Art1’s	  ability	  to	  bind	  to	  different	  exomer	  complexes	  (such	  as	  Chs6	  and	  Bud7)	  in	  vitro,	  we	  can	  confirm	  that	  Art1	  binds	  to	  the	  Bch1	  exomer	  complex	  but	  not	  to	  the	  Chs6	  exomer	  complex.	  To	  address	  these	  questions,	  further	  experiments	  are	  required	  to	  clarify	  the	  Art1	  liposome	  binding	  mechanism.	  	  	  	  	  	  	  	  	  	  It	  is	  possible	  that	  Art1	  membrane	  association	  could	  be	  dependent	  on	  lipids	  binding.	  	  First,	  we	  can	  test	  the	  binding	  of	  Art1	  to	  the	  PIPs.	  	  We	  can	  also	  use	  yeast	  genetics	  to	  test	  the	  role	  of	  other	  lipids,	  such	  as	  ergosterol	  or	  sphingolipids,	  in	  Art1	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Chapter	  5	  
Conclusions	  and	  Future	  Directions	  
CONCLUSIONS	  	  	  	  	  	  	  	  	  Regulated	  endocytosis	  is	  critical	  to	  many	  cellular	  processes	  including	  cell	  growth,	  cell	  differentiation,	  and	  protein	  quality	  control.	  	  Previously,	  we	  demonstrated	  that	  a	  family	  of	  proteins	  in	  yeast	  called	  ARTs	  function	  to	  target	  ubiquitin	  ligase	  activity	  to	  specific	  plasma	  membrane	  (PM)	  proteins	  in	  order	  to	  regulate	  endocytosis.	  	  Here,	  we	  show	  that	  Art1	  activity	  is	  mediated	  by	  a	  phosphoregulatory	  cycle,	  including	  1)	  phosphoinhibition	  by	  a	  sequential	  repression	  mechanism	  involving	  TORC1-­‐Npr1	  kinases	  signaling	  pathway	  and	  2)	  dephosphoactivation	  by	  Ppz	  phosphatases.	  	  In	  this	  negative	  kinase	  cascade,	  Art1	  phosphoinhibition	  is	  mediated	  by	  the	  Npr1	  kinase,	  which	  is	  itself	  negatively	  regulated	  by	  the	  activity	  of	  the	  TORC1	  kinase.	  	  TORC1	  inactivation	  results	  in	  dephosphorylation	  and	  PM	  recruitment	  of	  Npr1,	  where	  it	  co-­‐localizes	  with	  Art1.	  	  Npr1	  inhibits	  endocytosis	  by	  phosphorylation	  of	  the	  N-­‐terminus	  of	  Art1,	  a	  modification	  which	  prevents	  Art1	  PM	  recruitment.	  	  Thus,	  TORC1	  tunes	  the	  abundance	  of	  transporters	  at	  the	  PM	  in	  response	  to	  changes	  in	  nutrient	  availability,	  demonstrating	  how	  signaling	  networks	  coordinate	  complex	  cellular	  processes	  to	  regulate	  cell	  growth.	  	  On	  the	  other	  hand,	  Ppz	  phosphatases	  are	  required	  for	  Art1-­‐mediated	  PM	  cargo	  turnover.	  	  Depletion	  of	  Ppz	  phosphatases	  causes	  inhibition	  of	  Art1	  dephosphorylation	  and	  leads	  to	  delayed	  cargo	  ubiquitination	  and	  endocytosis	  during	  stimulation	  conditions.	  	  Moreover,	  we	  demonstrate	  that	  Art1	  translocation	  from	  tans-­‐Golgi	  network	  (TGN)	  to	  PM	  by	  the	  exomer	  machinery	  is	  important	  for	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Art1	  activation.	  	  Art1	  PM	  translocation	  and	  Art1-­‐mediated	  cargoes	  endocytosis	  are	  inhibited	  in	  the	  exomer	  mutants.	  	  	  These	  findings	  reveal	  the	  phosphoregulatory	  cycle	  and	  subcellular	  localization	  regulation	  are	  important	  for	  Art1	  function	  and	  provide	  the	  foundation	  for	  studying	  the	  regulation	  of	  ART	  family	  proteins.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
 	  	   176	  
MATERIAL	  AND	  METHODS	  
In	  vitro	  Protein-­‐lipid	  Overlay	  PIP	  Blot	  Assays	  Different	  PIPs	  were	  suspended	  in	  the	  resuspension	  buffer	  (250	  µl	  Chloroform,	  500	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FUTURE	  DIRECTIONS	  
Endocytosis	  as	  an	  Effector	  of	  TORC1-­‐mediated	  Growth	  Control	  	  	  	  	  	  	  	  	  In	  the	  chapter	  2,	  we	  elucidate	  a	  mechanism	  by	  which	  TORC1	  controls	  the	  abundance	  of	  the	  Can1	  arginine	  transporter	  at	  the	  PM.	  	  Importantly,	  by	  regulating	  the	  abundance	  of	  amino	  acid	  transporters	  at	  the	  plasma	  membrane,	  TORC1	  can	  finely	  tune	  amino	  acid	  influx	  in	  response	  to	  various	  cellular	  signals	  and	  environmental	  conditions.	  	  For	  example,	  the	  prototype	  mechanism	  described	  in	  this	  study	  affords	  the	  cell	  very	  fine	  control	  over	  intracellular	  arginine	  concentration:	  	  Can1	  is	  stabilized	  at	  the	  PM	  during	  starvation	  conditions	  but	  Can1	  endocytosis	  is	  activated	  when	  the	  cell	  is	  nutrient	  replete.	  	  Additional	  studies	  will	  be	  required	  to	  determine	  how	  signals	  upstream	  of	  TORC1	  are	  integrated	  to	  control	  endocytosis,	  but	  the	  reported	  canavanine	  and	  thialysine	  hypersensitivity	  phenotypes	  reported	  for	  ∆rheb1	  yeast	  strains	  indicate	  that	  the	  signals	  are	  integrated	  upstream	  of	  Rheb	  (Holz	  et	  al.,	  2005;	  Urano	  et	  al.,	  2000).	  	  Furthermore,	  proteomic	  analysis	  of	  Npr1	  indicates	  that	  it	  can	  interact	  not	  only	  with	  TORC1	  but	  also	  with	  Snf1	  (Breitkreutz	  et	  al.,	  2010),	  suggesting	  that	  Npr1	  function	  may	  integrate	  several	  modes	  of	  regulation.	  	  Thus,	  although	  our	  results	  demonstrate	  that	  regulation	  of	  endocytosis	  is	  an	  important	  branch	  of	  the	  TORC1	  response,	  future	  studies	  will	  be	  required	  to	  determine	  how	  signals	  upstream	  of	  TORC1	  as	  well	  as	  orthogonal	  signals	  are	  integrated	  to	  mediate	  this	  endocytic	  downregulation	  response.	  	  	  	  	  	  	  	  	  It	  is	  intriguing	  to	  consider	  how	  the	  regulation	  of	  endocytosis	  contributes	  to	  the	  adaptive	  growth	  strategies	  mediated	  by	  TORC1	  signaling.	  	  Interestingly,	  recent	  work	  in	  mammalian	  cells	  has	  demonstrated	  that	  nutrient	  transporters	  at	  the	  cell	  surface	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that	  facilitate	  the	  influx	  of	  leucine	  are	  required	  for	  TORC1	  activity	  (Nicklin	  et	  al.,	  2009).	  	  Thus,	  it	  is	  possible	  that	  TORC1-­‐mediated	  endocytosis	  of	  amino	  acid	  transporters	  provides	  an	  autoinhibitory	  feedback	  loop	  that	  limits	  TORC1	  activation	  (Figure	  5.1A),	  consistent	  with	  our	  analysis	  of	  TORC1	  signaling	  during	  a	  YPD	  shift	  timecourse	  (Figure	  5.1B	  and	  C).	  	  Furthermore,	  the	  ability	  of	  TORC1	  to	  sense	  misfolded	  proteins	  and	  respond	  by	  activating	  endocytosis	  could	  promote	  the	  turnover	  of	  misfolded	  or	  damaged	  proteins	  at	  the	  PM.	  	  Additionally,	  the	  role	  of	  TORC1	  signaling	  as	  both	  a	  positive	  regulator	  of	  endocytosis	  and	  a	  negative	  regulator	  of	  autophagy	  is	  intriguing.	  	  In	  such	  an	  inversely-­‐coordinated	  system,	  dampened	  TORC1	  signaling	  during	  starvation	  conditions	  simultaneously	  activates	  autophagy	  and	  inhibits	  endocytosis	  of	  the	  arginine	  transporter	  at	  the	  PM,	  both	  of	  which	  contribute	  to	  the	  availability	  of	  amino	  acids.	  	  TORC1	  coordination	  of	  two	  distinct	  membrane	  trafficking	  pathways	  towards	  a	  cooperative	  outcome	  is	  an	  elegant	  example	  of	  how	  signaling	  networks	  can	  harness	  complex	  cellular	  processes	  to	  regulate	  cell	  growth.	  
Investigate	  Cargo	  Phosphorylation	  as	  a	  Determinant	  of	  Art1	  Recognition	  	  	  	  	  	  	  	  	  We	  demonstrate	  that	  the	  phosphorylation	  of	  Art1	  by	  Npr1	  is	  governed	  by	  global	  stress	  response	  signaling	  pathways	  in	  order	  to	  regulate	  the	  turnover	  of	  many	  PM	  cargos.	  	  However,	  Art1	  phosphorylation	  does	  not	  seem	  to	  play	  a	  role	  in	  methionine-­‐induced	  uptake	  of	  another	  Art1	  target,	  the	  methionine	  transporter	  Mup1.	  	  We	  hypothesize	  that	  in	  cases	  of	  such	  “acute”	  stimulation,	  cargo	  phosphorylation	  may	  also	  serve	  to	  regulate	  Art1	  activity.	  	  It	  has	  been	  demonstrated	  that	  the	  translational	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Figure	  5.1.	  	  A	  potential	  model	  for	  feedback	  in	  the	  TORC1-­‐Npr1-­‐Art1	  pathway	  	  (A)	  A	  model	  for	  the	  TORC1-­‐Npr1-­‐Art1	  pathway	  that	  highlights	  a	  potential	  feedback	  mechanism.	  	  By	  this	  model,	  Can1-­‐mediated	  amino	  acid	  influx	  would	  activate	  TORC1	  signaling.	  	  Such	  a	  feedback	  mechanism	  could	  facilitate	  a	  highly	  adaptive	  circuit:	  	  increased	  TORC1	  activity	  would	  trigger	  increased	  Art1	  activation,	  which	  in	  turn	  would	  decrease	  influx	  of	  amino	  acids	  and	  thus	  decrease	  TORC1	  signaling.	  	  In	  the	  other	  direction,	  loss	  of	  TORC1	  activity	  would	  inactivate	  Art1,	  causing	  a	  stabilization	  of	  amino	  acid	  transporters	  at	  the	  surface	  with	  the	  potential	  to	  increase	  amino	  acid	  uptake	  and	  activate	  TORC1	  signaling.	  	  (B)	  Analysis	  of	  Npr1	  phosphorylation	  in	  response	  to	  a	  YPD	  shift	  timecourse.	  	  (C)	  Quantitation	  of	  results	  in	  (B).	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control	  of	  Gap1	  plays	  a	  minor	  role	  for	  its	  response	  to	  stimuli	  while	  posttranslational	  	  control	  is	  the	  key	  regulatory	  mechanism	  (Stanbrough	  and	  Magasanik,	  1995).	  	  Furthermore,	  in	  the	  previous	  reports,	  different	  posttranslational	  modifications	  after	  cargo	  stimulation	  have	  been	  observed	  (Kelm	  et	  al.,	  2004)	  and	  phosphorylation	  is	  a	  prerequisite	  for	  endocytosis	  of	  these	  cargoes	  (Hicke	  et	  al.,	  1998).	  	  	  	  	  	  	  	  	  	  	  To	  examine	  the	  relationship	  between	  cargo	  phosphorylation	  and	  Art1	  recognition	  during	  acute	  stimulation,	  we	  will	  first	  perform	  phosphoprofiling	  analysis	  of	  cargo	  proteins	  during	  stimulated	  uptake.	  	  If	  candidate	  phosphosites	  are	  identified,	  we	  will	  perform	  functional	  analysis	  and	  trafficking	  assays	  on	  phospho-­‐point	  mutants	  of	  the	  cargo.	  	  	  Finally,	  if	  candidate	  phosphosites	  on	  cargo	  are	  identified,	  we	  will	  perform	  biochemical	  experiments	  to	  determine	  if	  cargo	  phosphorylation	  specifies	  ART	  interaction.	  	  This	  will	  be	  done	  either	  by	  co-­‐immunoprecipitation,	  yeast	  two-­‐hybrid,	  or	  protein	  complementation	  assays.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  In	  addition,	  the	  Art1	  recognition	  element	  lies	  in	  the	  N-­‐terminal	  cytosolic	  tail	  of	  Can1	  (Lin	  et	  al.,	  2008).	  	  If	  cargo	  phosphoprofiling	  does	  not	  reveal	  candidate	  phosphosites,	  we	  will	  mutate	  all	  Ser/Thr	  residues	  in	  the	  N-­‐terminal	  cytosolic	  tail	  to	  determine	  if	  phosphorylation	  may	  be	  required	  for	  cargo	  turnover.	  	  If	  crucial	  phosphosites	  are	  identified	  in	  cargo	  and	  shown	  to	  mediate	  ART	  interaction,	  then	  it	  will	  be	  important	  to	  identify	  the	  cargo	  protein	  kinase.	  To	  identify	  candidate	  cargo	  kinases,	  we	  will	  first	  test	  known	  permease	  kinases	  for	  their	  ability	  to	  phosphorylate	  specific	  cargo.	  	  Proteomic	  analysis	  of	  cargo	  interacting	  proteins	  can	  also	  be	  used	  to	  identify	  potential	  cargo	  kinases.	  	  These	  experiments	  may	  help	  identify	  specific	  cargo	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protein	  kinases,	  which	  could	  ultimately	  provide	  another	  mechanism	  of	  ART-­‐cargo	  specificity.	  	  	  
Two-­‐step	  Phosphorylation	  of	  Art1	  	  	  	  	  	  	  	  	  We	  demonstrated	  that	  loss	  of	  Npr1	  in	  vivo	  causes	  a	  bandshift	  that	  cannot	  be	  reconstituted	  in	  vitro	  (Figure	  2.4J).	  	  By	  using	  point	  mutagenesis,	  we	  were	  able	  to	  determine	  that	  the	  bandshift	  is	  the	  result	  of	  phosphorylation	  at	  a	  C-­‐terminal	  residue,	  T619	  (Figure	  2.7I).	  T619	  is	  a	  proline-­‐directed	  phosphorylation	  site,	  and	  thus	  is	  not	  a	  substrate	  for	  Npr1	  phosphorylation	  (Prosser	  et	  al.,	  2010).	  	  In	  addition,	  the	  alanine	  substitution	  of	  T619	  gives	  a	  canavanine	  resistant	  phenotype	  (Figure	  5.2A),	  which	  suggests	  that	  this	  residue	  is	  also	  important	  of	  Art1	  activity	  regulation.	  	  However,	  phosphorylation	  at	  T619	  is	  regulated	  by	  Npr1	  (Figure	  2.7C).	  	  We	  proposed	  two	  models	  that	  might	  explain	  these	  observations	  (Figure	  5.2B).	  	  Based	  on	  our	  model,	  we	  will	  first	  try	  to	  identify	  this	  second	  Art1	  regulating	  kinase.	  	  Since	  this	  Art1	  C-­‐terminal	  kinase	  is	  a	  proline-­‐directed	  kinase	  and	  there	  are	  only	  limited	  amount	  of	  proteins	  in	  this	  kinase	  family,	  we	  can	  adapt	  the	  same	  strategy	  used	  in	  the	  phosphatase	  screen	  to	  identify	  the	  potential	  Art1	  C-­‐terminal	  kinase.	  	  After	  identifying	  and	  characterizing	  the	  kinase,	  we	  will	  also	  be	  interested	  in	  understanding	  whether	  there	  is	  cross	  talk	  between	  the	  N-­‐terminus	  and	  C-­‐terminus	  phosphorylations.	  
Art1-­‐Rsp5	  Complex	  Binds	  to	  PI(4,5)P2	  in	  vitro	  	  	  	  	  	  	  	  	  	  Although	  our	  results	  suggest	  that	  the	  exomer	  complex	  may	  play	  a	  role	  in	  transporting	  Art1	  from	  the	  TGN	  to	  the	  PM,	  how	  Art1	  maintains	  its	  PM	  localization	  is	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Figure	  5.2.	  	  Art1	  is	  regulated	  by	  2	  kinases	  	  (A)	  Thr619	  alanine	  substitution	  mutant	  allele	  of	  Art1	  and	  Δart1	  were	  analyzed	  for	  growth	  in	  the	  presence	  of	  canavanine.	  	  	  (B)	  Two	  potential	  models	  for	  Art1	  2-­‐step	  phosphorylation:	  1)	  Followed	  by	  Npr1	  kinase-­‐mediated	  N	  terminus	  phosphorylation	  of	  Art1,	  another	  C	  terminus	  kinase	  then	  can	  phosphorylate	  Art1;	  2)	  Art1	  can	  be	  phosphorylated	  by	  two	  kinases	  at	  N	  and	  C	  terminus	  independently.	  	  However,	  the	  N	  terminus	  Npr1	  kinase	  may	  have	  crosstalk	  to	  the	  C	  terminus	  phosphorylation.	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still	  largely	  unknown.	  	  Upon	  stimulation,	  Art1	  traffics	  to	  the	  PM	  and	  forms	  small	  transient	  patches.	  	  These	  Art1	  patches	  differ	  from	  PM	  subdomains	  that	  contain	  Can1	  (Pil	  patches)	  or	  endocytic	  machinery	  (Ede1	  patches)	  in	  terms	  of	  size,	  localization,	  and	  stability	  (data	  not	  shown),	  suggesting	  the	  Art1	  PM	  association	  occurs	  independent	  of	  these	  subdomains.	  	  In	  mammalian	  cells,	  β-­‐arrestin	  and	  arrestin3	  can	  bind	  to	  phosphoinositides,	  an	  interaction	  that	  appears	  to	  be	  required	  for	  β2-­‐adrenergic	  receptor	  endocytosis	  (Gaidarov	  et	  al.,	  1999).	  	  Based	  on	  these	  observations,	  we	  hypothesized	  that	  Art1	  interacts	  with	  phosphoinositides	  and	  that	  such	  an	  interaction	  could	  play	  a	  role	  for	  Art1	  association	  with	  the	  PM.	  	  	  	  	  	  	  	  	  	  It	  is	  well-­‐established	  that	  phosphoinositides	  (PIPs)	  are	  produced	  by	  specific	  PI-­‐kinases	  that	  localize	  to	  specific	  membrane	  compartments	  in	  the	  cell	  (Behnia	  and	  Munro,	  2005).	  	  Abolishing	  these	  kinases	  can	  spatially	  deplete	  PIPs	  in	  a	  compartment-­‐specific	  manner.	  	  To	  test	  if	  Art1	  membrane	  association	  is	  PIP-­‐dependent,	  I	  adopted	  a	  genetic	  approach	  by	  taking	  advantage	  of	  temperature-­‐sensitive	  alleles	  of	  yeast	  PI	  kinases	  known	  to	  control	  PIP	  levels	  on	  the	  Golgi	  (pik1ts)	  and	  PM	  (stt4ts,	  mss4ts)	  (Baird	  et	  al.,	  2008).	  	  However,	  during	  heat-­‐shock	  stimulation,	  Art1	  will	  also	  be	  activated	  and	  recruited	  to	  the	  PM.	  	  Therefore,	  when	  we	  tested	  Art1	  localization	  in	  these	  mutant	  strains	  under	  the	  non-­‐permissive	  temperature,	  we	  could	  still	  see	  Art1	  PM	  recruitment	  (data	  not	  shown).	  	  This	  result	  does	  not	  rule	  out	  the	  possibility	  that	  Art1	  translocates	  to	  the	  PM	  before	  the	  PIPs	  are	  depleted	  from	  the	  cells.	  	  	  	  	  	  	  	  	  	  	  	  	  	  To	  determine	  if	  Art1	  could	  associate	  with	  the	  PM	  by	  binding	  to	  PIPs,	  I	  performed	  a	  PIP	  binding	  assay.	  PIP	  strips	  were	  incubated	  with	  Art1-­‐Rsp5	  complex	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and	  subjected	  to	  immunoblot	  for	  detecting	  its	  PIP	  binding	  specificity.	  	  Among	  all	  the	  PIP	  species	  tested,	  Rsp5-­‐Art1	  complex	  binds	  to	  PI(4,5)P2	  specifically	  (Figure	  5.3),	  suggesting	  the	  protein	  complex	  may	  associate	  with	  the	  PM	  through	  binding	  to	  PI(4,5)P2.	  	  Additionally,	  neither	  the	  single	  Art1	  nor	  Rsp5	  has	  the	  ability	  to	  bind	  to	  any	  PIP,	  which	  suggests	  that	  the	  formation	  of	  the	  complex	  is	  critical	  for	  its	  PIP	  binding	  ability.	  	  These	  results	  also	  imply	  the	  existence	  of	  a	  conformational	  change	  that	  may	  expose	  the	  PIP	  binding	  domain	  of	  the	  protein	  to	  the	  membrane	  during	  the	  formation	  of	  the	  Art1-­‐Rsp5	  complex.	  	  	  We	  propose	  a	  model	  that	  under	  stimulation,	  exomer	  complex	  can	  transport	  Art1-­‐Rsp5	  complex	  from	  the	  TGN	  to	  the	  PM.	  	  After	  the	  Art1-­‐Rsp5	  complex	  reaches	  the	  PM,	  it	  starts	  to	  ubiquitinate	  and	  turnover	  the	  membrane	  proteins.	  	  	  By	  binding	  to	  PI(4,5)P2,	  the	  complex	  can	  associate	  with	  the	  PM	  and	  locally	  triggers	  cargo	  endocytosis.	  	  In	  order	  to	  prevent	  excessive	  cargo	  endocytosis,	  Npr1	  will	  then	  be	  recruited	  to	  the	  PM	  and	  phosphorylates	  Art1	  to	  eject	  it	  from	  the	  PM	  to	  finish	  this	  regulatory	  cycle.	  	  	  	  	  	  	  	  	  It	  has	  been	  reported	  that	  the	  N-­‐terminus	  of	  Rsp5,	  the	  C2	  domain,	  has	  the	  affinity	  to	  bind	  to	  all	  species	  of	  PIPs	  in	  vitro	  (Dunn	  et	  al.,	  2004).	  	  However	  in	  our	  PIP	  binding	  assay,	  Rsp5	  bound	  very	  weakly	  to	  PI3P	  (Figure	  4.5A).	  	  Based	  on	  these	  observations,	  I	  proposed	  that	  there	  might	  exist	  some	  auto-­‐inhibitory	  domains	  in	  Rsp5	  that	  serve	  to	  block	  its	  C2	  domain	  from	  binding	  to	  PIPs.	  	  After	  binding	  to	  Art1	  through	  the	  WW	  domains,	  which	  is	  in	  close	  proximity	  to	  the	  N	  terminal	  C2	  domain	  (Lin	  et	  al.,	  2008),	  Rsp5	  may	  not	  only	  exposes	  its	  C2	  domain	  to	  the	  PIPs	  but	  also	  gains	  the	  binding	  specificity	  to	  PI(4,5)P2.	  	  On	  the	  other	  hand,	  this	  PIP	  binding	  ability	  of	  the	  Art1-­‐Rsp5	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Figure	  5.3.	  	  Art1-­‐Rsp5	  complex	  binds	  to	  PI(4,5)P2	  in	  vitro.	  	  Purified	  recombinant	  Art1,	  Rsp5	  and	  Art1-­‐Rsp5	  complex	  were	  incubated	  with	  PIPs	  strips	  and	  then	  subjected	  to	  Western	  blot	  to	  detect	  the	  PIPs	  binding	  ability	  of	  each	  protein.	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complex	  could	  be	  contributed	  by	  Art1,	  rather	  than	  Rsp5.	  	  Protein	  conformational	  changes	  could	  occur	  after	  forming	  the	  complex	  with	  Rsp5,	  which	  could	  promote	  its	  binding	  to	  PI(4,5)P2.	  	  Further	  studies	  will	  be	  required	  for	  a	  better	  understanding	  of	  the	  mechanism	  of	  how	  Rsp5	  and	  Art1	  bind	  to	  PI(4,5)P2.	  	  	  	  
Determine	  the	  Art1	  Membrane	  Interaction	  Domain	  	  	  	  	  	  	  	  	  	  	  Based	  on	  our	  results,	  Art1	  can	  be	  divided	  into	  3	  general	  regions:	  the	  N	  terminus	  of	  Art1	  (amino	  acids	  1-­‐134)	  which	  undergoes	  phosphoregulation	  by	  Npr1,	  the	  predicted	  arrestin	  domain	  (amino	  acids	  135-­‐397),	  and	  a	  C	  terminal	  region	  (amino	  acids	  398-­‐818)	  which	  includes	  the	  PY	  motifs	  and	  critical	  proline-­‐directed	  phosphorylation	  sites.	  	  To	  determine	  if	  any	  of	  these	  regions	  are	  sufficient	  for	  membrane	  interaction,	  we	  will	  express	  these	  domains	  fused	  to	  GFP	  in	  yeast	  cells	  and	  score	  localization	  to	  both	  PM	  and	  Golgi.	  	  Once	  a	  minimal	  membrane	  interaction	  domain	  is	  established,	  we	  can	  use	  binding	  assays	  to	  test	  if	  specific	  lipids	  are	  sufficient	  to	  mediate	  the	  interaction.	  	  These	  results	  may	  help	  identify	  novel	  membrane	  interaction	  motifs	  within	  Art1.	  	  For	  any	  membrane	  interaction	  domain	  that	  is	  identified	  it	  will	  be	  interesting	  to	  assess	  the	  level	  of	  conservation	  within	  the	  ART	  family	  of	  proteins.	  	  	  	  	  	  	  	  	  Given	  the	  fact	  that	  Art1	  PM	  recruitment	  is	  highly	  regulated	  and	  may	  be	  subject	  to	  control	  by	  various	  signaling	  pathways,	  it	  is	  possible	  that	  we	  will	  not	  be	  able	  to	  isolate	  a	  fragment	  of	  Art1	  sufficient	  for	  membrane	  recruitment.	  	  If	  this	  is	  the	  case,	  we	  will	  examine	  the	  functional	  consequences	  of	  adding	  lipid	  modification	  motifs	  (palmitoylation	  and/or	  myristoylation)	  to	  Art1,	  which	  should	  result	  in	  constitutive	  PM	  localization	  independent	  of	  cellular	  signals.	  	  Once	  established,	  I	  will	  determine	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the	  functional	  effect	  of	  constitutive	  Art1	  PM	  localization	  using	  canavanine	  sensitivity	  and	  cargo	  trafficking	  assays.	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  Table	  S1.	  Strains	  used	  in	  this	  study	  
Strain	   Genotype	   Source	  
SEY6210	   MATα	  leu2-­‐3,	  112	  ura3-­‐52	  his3-­‐	  Δ200	  trp1-­‐Δ901	  lys2-­‐801	  suc2-­‐	  Δ9	  
Robinson	  et	  al.,	  
1988	  
SEY6210.1	   MATa	  leu2-­‐3,	  112	  ura3-­‐52	  his3-­‐	  Δ200	  trp1-­‐Δ901	  lys2-­‐801	  suc2-­‐	  Δ9	  
Robinson	  et	  al.,	  
1988	  
BY4741	   MATa	  ura3-­‐Δ0	  	  his3-­‐Δ1	  leu2-­‐Δ0	  met15-­‐Δ0	  	  	  	  	   ResGen™	  Collection	  
∆tco89	   ∆tco89::KanMX6	  (BY4741)	   ResGen™	  Collection	  
∆bit61	   ∆bit61::KanMX6	  (BY4741)	   ResGen™	  Collection	  
∆avo2	   ∆avo2::KanMX6	  (BY4741)	   ResGen™	  Collection	  
∆npr1	   ∆npr1::KanMX6	  (BY4741)	   ResGen™	  Collection	  
∆nnk1	   ∆nnk1::KanMX6	  (BY4741)	   ResGen™	  Collection	  
∆fmp48	   ∆fmp48::KanMX6	  (BY4741)	   ResGen™	  Collection	  
∆rck1	   ∆rck1::KanMX6	  (BY4741)	   ResGen™	  Collection	  
∆sky1	   ∆sky1::KanMX6	  (BY4741)	   ResGen™	  Collection	  
∆ksp1	   ∆ksp1::KanMX6	  (BY4741)	   ResGen™	  Collection	  
∆atg1	   ∆atg1::KanMX6	  (BY4741)	   ResGen™	  Collection	  
JMY527	   ∆npr1::HIS3MX6	  (SEY6210)	   This	  study	  
PHY501	   ∆npr1::KanMX6	  ∆tco89::HIS3MX6	  (BY4741)	   This	  study	  
CLY461	   Δart1::HIS3MX6	  (SEY6210.1)	   Lin	  et	  al.,	  2008	  
PHY1	   ∆npr1::HIS3MX6	  Δart1::TRP1MX6	  (SEY6210)	   This	  study	  
JMY827	   ∆arg4::KanMX6	  ART1::6xHIS-­‐TEV-­‐3xFLAG-­‐TRP1MX6	  (SEY6210)	   This	  study	  
JMY898	   ∆npr1::HIS3MX6	  (JMY827)	   This	  study	  
∆ppq1	   ∆ppq1::KanMX6	  (BY4741)	   ResGen™	  Collection	  
∆ptc1	   ∆ptc1::KanMX6	  (BY4741)	   ResGen™	  Collection	  
∆ppg1	   ∆ppg1::KanMX6	  (BY4741)	   ResGen™	  Collection	  
∆ppz1	   ∆ppz1::KanMX6	  (BY4741)	   ResGen™	  Collection	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Table	  S1.	  Strains	  used	  in	  this	  study	  (continued)	  
Strain	   Genotype	   Source	  
∆yvh1	   ∆yvh1::KanMX6	  (BY4741)	   ResGen™	  Collection	  
∆hal3	   ∆hal3::KanMX6	  (BY4741)	   ResGen™	  Collection	  
PHY147	   ∆ppz1::HIS3MX6	  (SEY6210)	   This	  study	  
PHY151	   ∆ppz2::TRP1MX6	  (SEY6210)	   This	  study	  
PHY647	   ∆ppz1::HIS3MX6	  ∆ppz2::TRP1MX6	  (SEY6210)	   This	  study	  
NBY40	   Mup1-­‐pH::KanMX6	  (SEY6210.1)	   This	  study	  
PHY743	   Mup1-­‐pH::KanMX6	  ∆ppz1::HIS3MX6	  ∆ppz2::TRP1MX6	  (SEY6210)	   This	  study	  
PHY716	   ∆ppz1::HIS3MX6	  ∆ppz2::TRP1MX6	  ∆npr1::HIS3MX6	  (SEY6210.1)	   This	  study	  
PHY726	   Ppz1-­‐GFP::TRP1MX6	  (SEY6210)	   This	  study	  
PHY727	   ∆hal3::HIS3MX6	  (SEY6210)	   This	  study	  
PHY728	   ∆vhs3::HIS3MX6	  (SEY6210)	   This	  study	  
PHY729	   ∆vhs3::HIS3MX6	  ∆hal3::KanMX6	  (SEY6210.1)	   This	  study	  
JMY78	   Mup1-­‐HTF::TRP1MX6	  (SEY6210)	   This	  study	  
JMY212	   Mup1-­‐HTF::TRP1MX6	  Δart1::HIS3MX6	  (SEY6210)	   This	  study	  
PHY739	   ∆ppz1::HIS3MX6	  ∆ppz2::TRP1MX6	  Mup1-­‐HTF::TRP1MX6	  	  (SEY6210.1)	   This	  study	  
PHY746	   Ppz1-­‐MARS::TRP1MX6	  (SEY6210)	   This	  study	  
CFY207	   ∆chs5::TRP1MX6	  (SEY6210.1)	   This	  study	  
CFY258	   ∆bud7::KanMX6	  (SEY6210.1)	   This	  study	  
Strain	   Genotype	   Source	  
CFY260	   ∆bch1::KanMX6	  (SEY6210.1)	   This	  study	  
CFY256	   ∆chs6::KanMX6	  (SEY6210.1)	   This	  study	  
PHY232	   ∆chs5::TRP1MX6	  ∆npr1::HIS3MX6	  (SEY6210.1)	   This	  study	  
PHY233	   ∆bch1::KanMX6	  ∆npr1::HIS3MX6	  (SEY6210.1)	   This	  study	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Table	  S2.	  Plasmids	  used	  in	  this	  study	  
Plasmid	   Description	   Source	  
pCHL571	   pRS416-­‐PCAN1-­‐CAN1-­‐GFP	   Lin	  et	  al.,	  2008	  
pCHL642	   pRS416-­‐PMUP1-­‐MUP1-­‐GFP	   Lin	  et	  al.,	  2008	  
pSR21	   pRS416-­‐PFUR4-­‐FUR4-­‐GFP	   Lin	  et	  al.,	  2008	  
pJAM463	   pRS415-­‐PNPR1-­‐3xFLAG-­‐NPR1	   This	  study	  
pJAM478	   pRS415-­‐PNPR1-­‐3xFLAG-­‐npr1	  K467R	   This	  study	  
pJAM479	   pRS415-­‐PNPR1-­‐3xFLAG-­‐npr1	  G581W	   This	  study	  
pJAM480	   pRS415-­‐PNPR1-­‐3xFLAG-­‐npr1	  D561A	   This	  study	  
pJAM536	   pRS415-­‐PCPY-­‐3xFLAG-­‐NPR1	   This	  study	  
pJAM537	   pRS415-­‐PADH1-­‐3xFLAG-­‐NPR1	   This	  study	  
pJAM538	   pRS415-­‐PTDH3-­‐3xFLAG-­‐NPR1	   This	  study	  
pCHL641	   pRS416-­‐PART1-­‐ART1-­‐3xHA	   Lin	  et	  al.,	  2008	  
pJAM367	   pRS416-­‐PART1-­‐ART1-­‐3xFLAG	   This	  study	  
pCHL582	   pRS416-­‐PCAN1-­‐CAN1-­‐6xHis-­‐TEV-­‐3xFLAG	   Lin	  et	  al.,	  2008	  
pJAM548	   pRS415-­‐PADH1-­‐3xFLAG-­‐npr1	  K467R	   This	  study	  
pJAM589	   pRS416-­‐PART1-­‐art1-­‐(S/T	  79,	  82-­‐85,	  96,	  99,	  100	  A)-­‐3xFLAG	   This	  study	  
pCHL639	   pRS416-­‐PART1-­‐ART1-­‐GFP	   Lin	  et	  al.,	  2008	  
pJAM599	   pRS416-­‐PART1-­‐art1-­‐(S/T	  79,	  82-­‐85,	  96,	  99,	  100	  A)-­‐GFP	   This	  study	  
425-­‐GFP-­‐
CPS	   pRS425-­‐PCPS-­‐GFP-­‐CPS	   This	  study	  
pJAM556	   pRS415-­‐PTDH3-­‐ART1-­‐HA	   This	  study	  	  	  
